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ABSTRACT 
 
       The phytochemical studies on Lindera oxyphylla and Litsea costalis (Nees) 
Kosterm from the family Lauraceae were performed. The extraction process was carried 
out using various solvent such as hexane, dichloromethane and methanol and the 
separation was conducted using column chromatography followed by preparative TLC 
or PTLC and finally the structural elucidation of isolated compounds was established 
on the basis of spectroscopic studies such as UV, IR, CD, OR,  1D and 2D NMR 
and MS (LC-MS) experiments.  
        A total of thirty compounds were isolated from Lindera oxyphylla and Litsea 
costalis (Nees) Kosterm and these plant species have never been investigated before. 
From the bark of Lindera oxyphylla yielded six compounds which are (+)-onysilin, (+)-
pinostrobin, (+)-pinocenbrin, flavokawain B, linderone and linderone A is a new 
compound. Seven compounds were isolated from the leaves of this species and these 
known compounds are one flavanone, kaempferol, one ketone methylinderone, (+)-
laurotetanine, N-methyllaurotetanine, (+)-norboldine, (+)-10-O-methyl-N-
methylhernovine and (+)-norisoboldine. 
       Nine compounds were isolated from the bark of Litsea costalis (Nees) Kosterm and 
five known compounds namely cinnamaldehyde, 2-hydroxy-5-methoxybenzaldehyde, 
2, 5-dimethoxybenzaldehyde, bisengenol and (E)-4-styrylphenol and four new 
compounds namely biseugenol A, biseugenol B, biseugenol C and litsin. Eight 
compounds were isolated from the leaves of this species. These seven known 
compounds are namely cinnamide, 2, 4-dimethoxybenzamide, 3, 4- 
dimethoxybenzamide, (+)- pinostrobin, (+)-onysilin, (+)-pinocembrin  and 4-allyl-1,2-
dimethoxybenzene and one new compound namely costalin.  
       The DPPH experiments for the isolated compounds from Lindera oxyphylla 
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showed the IC50  of LOB15 was 8.5 μg/mL strong activity, LOB4 was 78.97 μg/mL 
low activity, LOB2 was 41.32 μg/mL low activity, LOB28 was 157.58 μg/mL and  
LOB25 was 149.45 μg/mL both low activity. The IC50 for the isolated compounds from 
Litsea costalis (Nees) Kosterm showed that IC50 for LCB17 was 16.34 μg/mL strong 
activity, LCB15 was 161.81 μg/mL low activity, LCB10 was 81.92 μg/mL low activity, 
LCB11 was 81.92 μg/mL low activity, LCB3 was 4.77 μg/mL strong activity, LCB7 
was 73.24 μg/mL low activity, LCB4 was  26.69 μg/mL strong activity and LCL7 was  
76.45 μg/mL low activity.  Ascorbic acid was used as a standard with IC50 4.62 µg/mL. 
 The FRAP experiments for the isolated compounds from Lindera oxyphylla 
showed LOB15 was 1.0 ± 0.06, LOB4 was 0.6 ± 0.01, LOB2 was 0.7 ± 0.02, LOB28 
was 0.5 ± 0.02 and LOB25 was  0.5 ± 0.03. 
 Metal chelating assay for the isolated compounds showed LOB15 was 33.37 ± 
0.1, LOB4 was 25.69 ± 0.01, LOB2 was 26.11 ± 0.01, LOB28 was 13.09 ± 0.006 and 
LOB25 was 13.51 ± 0.01. 
 The cytotoxic activity  were performed using  a series of different doses on 
A549, PC-3,  A375,  HT-29,  CEMSS, WRL-68, HEPG2,  Jurkat and  MCF-7 cell lines. 
The EC50  for LOB4 was 79.57 µg/mL for MCF-7 and 30.12 μg/mL for PC-3, LOB2 
showed  EC50 for PC-3 was 90.13 μg/mL , LOB25 showed EC50 for MCF-7 was 96.33 
μg/mL, LCB17 was 1.4 ± 0.1 µg/mL for MCF-7, 1.0 ± 0.1 μg/mL for HepG2, 1.32 ± 
0.1 μg/mL for  HT29 and 1.22 ± 0.1 for Jurkat. LCB3 was 48 ± 3.05 µg/mL for MCF-7 
and 18 ± 2.1 μg/mL for PC3. The EC50 for  LCB10 was 81.73 ± 3.7 µg/mL for 
WRL68, 1.19 ± 0.19 μg/mL for CEMSS and 85.13 ± 7.3 µg/mL for A549.  
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ABSTRAK 
 
 Kajian fitokimia terhadap Lindera oxyphylla dan Litsea costalis (Nees) Kosterm 
dari keluarga Lauraceae telah dijalankan. Proses pengektrakan telah dijalankan 
menggunakan  pelbagai  pelarut  seperti  heksana, diklorometana dan metanol dan 
proses  pemisahan  sebatian  tulen  telah  dilakukan  menggunakan  kaedah  
kromatografi diikuti oleh TLC  atau PTLC dan akhir sekali elusidasi struktur telah 
dibuat berdasarkan kajian spektroskopi seperti UV, IR, CD, OR, 1D  dan 2D NMR dan 
MS (LC-MS).  
 Sejumlah 30 sebatian telah dipisahkan dari Lindera oxyphylla dan Litsea costalis 
(Nees) Kosterm dan tumbuhan ini  belum  pernah  dikaji  sebelum  ini. Bahagian kulit 
dari Lindera oxyphylla menghasilkan enam sebatian, (+)-onysilin, (+)-pinostrobin, (+)-
pinocembrin,  flavokawain B, linderone dan linderone A adalah merupakan sebatian 
baru.  Daripada bahagian daun spesies ini tujuh  sebatian  telah dipisahkan dan sebatian 
ini ialah satu flavanon, kaempferol, satu keton methylinderone, (+)-laurotetanine, N-
metillaurotetanine, (+)-norboldine , (+)-10-O-N-methylhernovine dan (+)-
norisoboldine. 
 Sembilan sebatian telah dipisahkan dari Litsea costali (Nees) Kosterm dan lima 
sebatian ini ialah cinnamaldehyde, 2-hydroxy-5-metoksibenzaldehyde, 2,5-
dimetoksibenzaldehyde, bisngenol and (E)-4-styrylphenol dan empat daripadanya 
merupakan sebatian baru dari kumpulan neolignan dan dinamakan sebagai 
biseugenol A,  biseugenol B, biseugenol C,  dan litsin. Lapan sebatian telah 
dipisahkan dari bahagian daun spesies ini dan tujuh sebatian ini adalah cinnamide, 
2,4-dimethoxybenzamide, 3,4- dimethoxybenzamide, (+)-pinostrobin, (+)-onysilin, (+)-
pinocembrin dan 4-allyl-1,2-dimetoksibenzene dan satu sebatian  baru merupakan dari  
kumpulan  kroman  dan dinamakan sebagai costalin.   
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 Pemisahan sebatian dari Lindera oxyphylla menunjukkan aktiviti 
antioksidan dengan DPPH. Hasil ujikaji menunjukkan IC50 bagi LOB15 ialah 8.5 
μg/mL tinggi aktiviti, LOB4 ialah 78.97 μg/mL rendah aktiviti, LOB2 ialah 41.32 
μg/mL rendah aktiviti, LOB28  ialah 157.58μg/mL dan LOB25 ialah 149.45 μg/mL, 
kedua-duanya menunjukkan rendah aktiviti. Sebatian  yang  dipisahkan  dari  Litsea  
costalis (Nees) Kosterm menunjukkan IC50 bagi LCB17 ialah 16.34 μg/mL tinggi 
aktiviti, LCB15 ialah 161.81 μg/mL rendah aktiviti, LCB10 ialah 81.92 μg/mL rendah 
aktiviti, LCB11 ialah 81.92 μg/mL rendah aktiviti, LCB3 4.77 μg/mL tinggi aktiviti, 
LCB7 ialah 73.24 μg/mL rendah aktiviti, LCB4 ialah 26.69 μg/mL tinggi aktiviti dan 
LCL7 ialah 76.45 μg/mL rendah aktiviti.  Asid askorbik digunakan sebagai  standard 
dengan IC50 4.62 µg/mL. 
 Ujikaji FRAP untuk sebatian yang dipisahkan dari Lindera oxyphylla 
menunjukkan bahawa  penyerapan bagi LOB15 ialah 1.0±0.06, LOB4 ialah 0.6±0.01, 
(+)-LOB2 ialah 0.7±0.02, LOB28 ialah 0.5±0.02 dan LOB25  ialah 0.5±0.03. 
 Asai pencelatan logam untuk sebatian yang telah dipisahkan menunjukkan 
bahawa penyerapan bagi LOB15 ialah 33.37±0.1,  LOB4 ialah 25.69±0.01, LOB2 ialah 
26.11±0.01, LOB28  ialah  13.09± 0.006  dan  LOB25 ialah 13.51± 0.01. 
 Kesan sitotoksik aktiviti dalam dos yang  berbeza keatas beberapa sel kanser 
A549, PC-3, A375, HT-29, GEMSS, WRL-68, HEPG2, Jurkat dan  MCF-7 telah 
dijalankan. Keputusan  menunjukkan  EC50  untuk LOB4  adalah  79.57 µg/mL merujuk 
kepada sel MCF-7 dan 30.12 μg/mL untuk PC-3, manakala EC50 untuk LOB2 kepada 
sel kanser PC-3 adalah 90.13 μg/mL dan LOB25 menunjukkan EC50 untuk MCF-7 
adalah 96.33 μg/mL, seterusnya untuk LCB17 adalah 1.4 ± 0.1 µg/mL kepada kanser 
sel MCF-7, 1.00 ± 0.1 μg/mL untuk  HepG2, 1.32 ± 0.1 μg/mL kepada kanser  sel HT29 
and 1.22 ± 0.1 untuk Jurkat. LCB3 adalah 48± 3.05 µg/mL kepada sel kanser MCF-7 
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dan 18 ± 2.1 μg/mL kepada sel kanser PC3. Tahap EC50  LCB10 adalah 81.73± 3.7 
µg/mL kepada sel kanser WRL68, manakala 1.19± 0.19 μg/mL kepada sel kanser 
CEMSS dan 85.13± 7.3 µg/mL kepada sel kanser A549.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9 
 
 
 
 
 
 
To 
Whom I love and those who love me 
 
 
 
 
 
 
 
 
 
 
10 
 
ACKNOWLEDGEMENTS 
 
 This study would not have been possible without the help and assistance of 
many people. First and foremost, I would like to express my deepest and sincere 
gratitude to my supervisor, Professor Datuk Dr. A. Hamid A. Hadi, for his guidance and 
the continuous support of my study, for his patience, motivation, enthusiasm, and 
immense knowledge. His guidance helped me throughout this work and writing of this 
thesis. I am indebted to Allahyarham Associate Professor Dr. Mat Ropi Mukhtar, for his 
guidance, concern, precious understanding, constant encouragement, kind and  support 
throughout  the development of this research project.  May his soul rest in peace. It is 
also a great pleasure and honour to express my thanks to my supervisor Dr. Jamaludin 
bin Mohamad from ISB and let me worked in his lab. Special thanks to my co-
supervisor Dr. Mohammad Ali khalilzadeh from Azad University of Ghaemshahr, Iran 
for his invaluable guidance throughout this study.  I am also thankful to Dr Syam from 
Department of Pharmacy, University of Malaya for helping me in bioassay. 
  I wish to express my recognition to all the technical and non-technical staff of 
the Department of Chemistry, University of Malaya. My deepest appreciation is also 
dedicated to the Herbarium staffs; Mr. Din, Mr. Teo, Mr. Ujang and Mr. Rafly for their 
help in sample collection, the LC-MS and NMR staffs; Assoc. Prof. Dr. Azhar Arifin, 
Ms. Norzalida Zakaria, Mrs. Suwing Eh Vit, Mr. Fateh Ngaliman for NMR services 
and Mrs. Dara Fiona Mohamad for NMR and UV spectra recording, also, Mr. 
Mohammad and Hazrina for LC-MS equipment and without their help, this research 
work could not be completed.  
 To my colleagues in C-10 lab and C-110 lab I would like to collectively thank 
the group for providing helpful and critical discussions and I am proud to be one of 
them. I would like to thank my friends Mr. Mehran, Mr. Arshia, Ms. Joey, Dr.Yasoda, 
11 
 
Mrs. Nadia, Mrs. Faizah, Mrs. Nurul, Ms. Ayu, Mrs. Aziana, Ms. Chan, Mrs. Hanita, Dr 
Hamid Khaledi, Dr. Key, Ms. Ainnul, Ms Azie, Ms. Afifah, Mrs. Hairin Taha for 
reading  my thesis   and others for their kind help, support and friendship. Aside from 
my lab mates, I would like to thank my friend Mrs. Mona Yaeghoobi for her valuable 
comments and stimulating suggestions. 
 This work was supported by a research grant from the University of Malaya 
(PS265/2010B). I also truly appreciate Ministry of Higher Education, Malaysia for High 
Impact Research HIR-MOHE (F000009-21001) grant for financial support.  
 Lastly, I would like to thank my family for all their love and encouragement. My 
parents deserve special mention for their inspirable support and prayers. Father, in the 
first place was the person who put the fundamental of my learning character, showing 
me the joy of intellectual pursuit since I was a child. Mother, is the one who sincerely 
raised me with her caring and gently love. 
 Special thanks to my great and respectful brother in law Dr. Ebrahimi and my 
lovely sister Maliheh, for their financial and moral supports. To my lovely siblings, 
thanks for being attentive and caring during these often very difficult times.  
 
 
 
 
 
 
 
12 
 
TABLE OF CONTENTS                                                                                                                                                                                              
ABATRACT                i                          
ABSTRAK               iii 
ACKNOWLEDGEMENT            vii 
LIST OF SCHEMES             xiv 
LIST OF FIGURES             xvi 
LIST OF TABLES            xxv 
LIST OF ABBREVIATIONS          xxx 
           
PART I 
CHAPTER 1 : INTRODUCTION                                
 1
1.0   General 1                    
1.1   Lauraceae: General Appearance and Morphology                                                    4 
1.2   Lauraceae: Distribution and Habitat                  6 
1.3   Classification of Tribe and Lauraceae Classification           7 
1.4   The Genus Lindera                              9 
        Lindera oxyphylla (KL5359)              9 
1.5   The Genus Litsea              10 
        Litsea costalis (Nee) Kosterm (KL5410)                                11     
1.6   Objectives of study                               
13 
 
CHAPTER 2: GENERAL AND CHEMICAL ASPECTS 
2.1 Introduction                 14 
      Sources of natural products            14 
2.2 Aromatic Compounds: Phenolics            15 
        2.2.1. The C6 Simple Phenol compounds            16 
        2.2.2. The C6-C1 Phenolic acids and related compounds         17 
        2.2.3  The C6-C2 acetophenones and phenyl acetic acids           17 
         2.2.4  The C6-C3 Cinnamic acid and related compounds         17 
2.3  The C15Flavonoids                         18 
2.4  Benzophenones, Xanthones, Stilbens            21 
2.5  Lignan and Neolignans               21 
2.6  Alkaloids                23 
 2.6.1  Classification of the Alkaloids                 24 
13 
 
2.6.1.1True Alkaloid  24 
2.6.1.2 Pseudo Alkaloid  25 
2.6.1.3 Proto Alkaloid  25 
2.7   Chemical Constituents of Lindera species 26 
2.8   Chemical Constituents of Litsea species 27 
 
CHAPTER 3: RESULTS AND DISCUSSION  
PART I 
 3.0   Introduction      30 
 3.1  Chemical constituents from bark and leaves Lindera oxyphylla 30 
 3.1.1  Flavanone LOB4: (+)-Onysilin 33 
 3.1.2  Flavanone LOB7: (+)-Pinostrobin                      40 
 3.1.3  Chalcone LOB15: FlavokawainB                      46 
 3.1.4  Flavanone LOB2: (+)-Pinocembrin  54 
 3.1.5  Linderone LOB28: Linderone 59 
 3.1.6  LinderoneLOB25: LinderoneA                      69 
 3.1.7  Linderone LOL34: Methyllinderone 78 
 3.1.8  Flavonol LOL5:   Kaempferol 82 
 3.1.9  Alkaloid LOL20: (+)-Laurotetanine  88 
 3.1.10 Alkaloid LOL35: N-Methyllaurotetanine  95  
 3.1.11 Alkaloid LOL50: (+)-Norboldine           99 
 3.1.12 Alkaloid LOL63: (+)-10-O-Methyl-N-methylhernovine      103 
 3.1.13 Alkaloid LOL65: (+)-Norisoboldine 106 
PART II 
3.2   Chemical constituents from bark and leaves Litsea costalis (Nee)Kosterm    110 
       3.2.1 Aldehyde LCB7: 3',4' Dimethoxycinnamaldehyde      113 
       3.2.2  Aldehyde LCB11: Salicylaldehyde             121 
       3.2.3  BenzaldehydeLCB15: 2, 5-Dimethoxybenzaldehyde      129           
       3.2.4  Neolignan LCB3: Biseugenol A          133 
       3.2.5  Neolignan LCB9: Biseugenol         142 
       3.2.6  OxyneolignanLCB10:Biseugenol B        145  
       3.2.7  4-allyi-1,2-dimethoxybenzene LCL15        153 
       3.2.8  BiphenylydrazineLCB17:Biseugenol C    156   
                 Electrochemical investigation  164 
14 
 
3.2.9  Phenolic compoundLCB4: Litsin         166 
3.2.10  E-4-styryphenol           174 
3.2.11  Cinnamide LCL4                        178 
3.2.12  2, 4 –Dimethoxybenzamide LCL2                   183 
3.2.13   3, 4 –Dimethoxybenzamide LCL5                   190 
3.2.14  Flavonoid LCL7: Costalin                     193 
3.2.15  Flavanone LCL9: (+)-Pinostrobin                    206  
3.2.16  Flavonol LCL14  (+)-Pinocembrin          206 
3.2.17  Flavanone LCL13: (+)-Onysilin          207 
3.2.18  Lignan LCL17: Eugenol                     208 
 
CHAPTER 4: Bioactivity     
4.1   Introduction            213 
4.2  Antioxidant: Free radicals and oxidation         214 
4.3   Determination of antioxidant activity          215 
4.4   DPPH Radical Scavenging Activity Assay         215 
        4.4.1 Material              216 
         4.4.2 Preparations of solutions          216 
                 A.  Preparation of extracts          216 
                 B.  Preparation of Ascorbic                     216 
                 C.  Preparation of DPPH            217 
                  D. Determination of DPPH activity of compounds        217 
                  E.  Determination of percentage of inhibition of DPPH                              217 
4.5 Ferric Reducing Power Assay (FRAP)          219 
       4.5.1 Material             219 
       4.5.2 Preparations of solutions          220 
               A.  Preparation of 1% Potassium FerricyanideK3 [Fe (CN)6]       220                                             
     B.  Preparation of 10% Trichloroacetic acid (TCA)      220                                                                       
      C.  Preparation of 0.1% Ferric chloride solution       220 
     D.  Preparation of 0.2 M , buffer solution         220 
                E. Determination of FRAP Assay         221 
4.6  Metal Chelating Activity Assay          222 
      4.6.1 Material            222 
       4.6.2 Preparation of solution                     222 
                              A.  Preparation of 5mM Ferrozine        222 
15 
 
                         B. Preparation of 2mM Ferrous chloride (FeCl2))       222 
                      C.  Preparation of standard EDTA        222 
                      D.  Determination of metal chelating activity of Compounds       222 
                      E.  Determination of percentage of inhibition of Ferrozine           223 
 4.7    Results and Discussion             224 
          4.7.1  DPPH Radical Scavenging Activity Assay       224 
          4.7.2  Antioxidant of lindera Species         226 
          4.7.3  Antioxidant of litsea Species         226 
          4.7.4  FRAP (Ferric Reducing Power Assay)                    241 
          4.7.5 Metal Chelating Assay          248                                                
4.8   Anticancer: Cytotoxicity Activity         255 
         4.8.1 Anti-cancer of Lindera Species         257 
         4.8.2 Anticancer of Litsea Species          257 
         4.8.3 Materials & Methods          257 
                  4.8.3.1 Cell culture                     257 
                  4.8.3.2 Cellular viability assay           258 
                  4.8.3.3 Statistical analyses                    258        
        4.8.4   Results                       259 
                   4.8. 4.1 MTT assay costalin LCL7        262 
                   4.8.4.2 Clonogenic assay costalinLCL7        263 
                   4.8.4.3. Quantification of apoptosis (AO/PI) costalinLCL7     264 
                   4.8.4.4  Cell viability study of  biseugenol A LCB3and biseugenol  
                               BLCB10           266 
        4.8.4.5  Clonogenic assay biseugenol A LCB3and biseugenol B LCB10 267                                                                                   
                   4.8.4.6  Quantification of apoptosis biseugenolALC3 and BiseugenolB  
                                LCB10             268 
                   4.8.4.7 Quantification of apoptosis (Ao/PI) biseugenolA LCB3and 
                               biseugenol B LCB10          269 
        4.8.4.8  MTT assay Litsin LCB4         270 
            4.8.4.9 Clonogenic assay Litsin LCB4        270 
                   4.8.4.10 Quantification of apoptosis (AO/PI) Litsin LCB4     271 
                   4.8.4.11 LitsinLCB4-induced caspase-3/7, 8, and 9 Activations    272 
                   4.8.4.12 BC inhibitions TNF-α-induced NF-KB nuclear Trans location   275 
                   4.8.4.13 BC induced caspases activition        277 
                   4.8.4.14 BC up-regulated Bax and suppressed the expression of Bcl2 and 
16 
 
                            HSP70 protein          278                        
                  4.8.4.15 BC-induced apoptosis in MCF7 cells       279 
 
CHAPTER 5  
 Conclusion             282 
CHAPTER 6: Experimental  
6.1 Solvent             283 
6.2   Instruments            283 
6.3   Chromatography            284 
        6.3.1 Thin Layer Chromatography TLC         284  
        6.3.2 Column chromatographic          284 
        6.3.3 High Performance Liquid Chromatography (HPLC)      285 
6.4  Plant Materials             285 
6.5   Reagents             286 
       6.5.1 Mayer 
,
s reagent  (Potassium mercuric iodide       286 
       6.5.2 Dragendorff’s, s reagent (Potassium bismuth iodide)       287             
6.6   Extraction and Isolation           287 
        6.6.1  Extraction and isolation Lindera oxyphylla       287    
         6.6.2  Extraction and isolation Litsea costalis (Nees) Kosterm     297 
6.7   Physical propertion and Spectral Data of Isolated compounds      307 
        6.7.1 Bark of Lindera oxyphylla (KL 5359)        307 
         6.7.2 Leaves of Lindera oxyphylla (KL 5359)         310 
         6.7.3 Bark of Litsea costalis (KL5410)                    313 
         6.7.4 Leaves of Litsea costalis (KL5410)         317 
 
 REFERENCE               327 
 LIST OF PUBLICATIONS           342 
 APPENDIX 343 
 
 
 
17 
 
 
LIST OF SCHEMES 
Scheme  Page 
4.1 Radical-scavenging abilities of DPPH through H-donating agents 215 
6.1 Isolation and purification of chemical constituents from plant 296 
6.2 Isolation and purification of chemical constituents from N-hexane 
crude extract of Lindera oxyphylla (bark) 
297 
6.3 Isolation and purification of chemical constituents from 
dicholoromethane  crude extract of  Lindera oxyphylla (bark) 
 298 
 
6.4 Isolation and purification of chemical constituents from methanol 
crude extract of Lindera oxyphylla (bark) 
 299 
 
6.5 Isolation and purification of chemical constituents from N-hexane 
crude extract of Lindera oxyphylla (Laves) 
  300 
 
6.6 Isolation and purification of chemical constituents from 
dicholoromethane crude extract of Lindera oxyphylla (Leaves) 
  301 
6.7 Isolation and purification of chemical constituents from methanol 
crude extract of Lindera oxyphylla (Leaves) 
  302 
6.8 Isolation and purification of chemical constituents from n-hexane 
crude extract of Litsea costalis (bark) 
 306 
6.9 Isolation and purification of chemical constituents from 
dicholoromethane crude extract of Litses costalis (bark) 
 307 
6.10 Isolation and purification of chemical constituents from methanol 
crude extract of Litsea costalis (bark) 
  308 
6.11  Isolation and purification of chemical constituents from n-Hexane 
crude extract of Litsea costalis (Leaves) 
 309 
18 
 
6.12 Isolation and purification of chemical constituents from 
dicholoromethane crude extract of Litsea costalis (Leaves)                 
 310 
LIST OF FIGURES 
 
Figure                                                                                                                          page 
 
1.1        Drugs isolated from plants                                                                                2 
 
1.2         The Leaf and Bark of Lindera  oxyphylla (KL 5359)                                     10 
 
1.3         The  Bark and Flowers of Litsea costalis                                                        12 
 
1.4         The  Leaf of Litsea costalis (Nees) Kosterm                                                   12 
 
3.1          LC-MS Spectrum of (+) – Onysilin LOB4                                                     33 
 
  3.2         
1
H NMR Spectrum of (+) – Onysilin LOB4                                                    36 
 
3.3        COSY Spectrum of (+) – Onysilin LOB4                                                                     
37 
 
3.4       
13
C NMR / DEPT Spectra of (+) – Onysilin LOB4                                           38 
 
3.5       HMBC Spectrum of (+) – Onysilin LOB4                                                         39 
 
3.6       LC-MS Spectrum of (+)-pinostrobin LOB7                                                       40 
 
3.7       
1
H NMR Sectrum of (+)-pinostrobin LOB7                                                       43 
 
3.8        COSY Spectrum of (+)-pinostrobin LOB7                                                        44 
 
3.9       
13
CNMR / DEPT Spectra of (+)-pinostrobinLOB7                                            45 
 
3.10      LC-MS Sectrum of Flavokawain BLOB15                                                      46 
 
3.11      
1
H NMR Spectrum of Flavokawain BLOB15                                                   49 
3.12       Cosy Sectrum of  Flavokawain BLOB 15                                                        50 
 
3.13      
13
C NMR / DEPT Spectra of Flavokawain B LOB 15                                      51 
 
3.14      HMQC Spectrum of  Flavokawain B LOB15                                                    54 
3.15       HMBC Spectrum of  Flavokawain B LOB 15                                                  52 
 
3.16      LC-MS Spectrum of (+)-Pinocembrin LOB2                                                    54 
2 
1 3 4 4a 
5 
6 7 
8 
8a 
1ꞌ 
2ꞌ 
3ꞌ 
4ꞌ 5ꞌ 
6ꞌ 
2 8 6 
4ꞌ,6ꞌ 
19 
 
 
3.17      
1
 H NMR Spectrum of (+)-Pinocembrin LOB2                                                 57 
 
3.18      
13
 C NMR/ DEPT Spectra of (+)-Pinocembrin LOB2                                       58 
 
3.19       LC-MAS Spectrum of Linderone LOB28                                                        59 
 
3.20      
1
H NMR Spectrum of Linderone LOB28                                                           62                                                
 
3.21       COSY Spectrum of Linderone LOB28                                                             63 
 
3.22      
13
 C NMR / DEPT Spectra of Linderone LOB28                                              64 
 
3.23        HSQC Spectrum of Linderone LOB28                                                            65 
 
3.24        HMBC Spectrum of Linderone LOB28                                                           66 
 
3.25        X-ray Crystallographic Structure monoclinic of LOB28                                 67 
 
3.26       X-ray Crystallographic Structure Triclinic of LOB28                                      68 
 
3.27      IR Spectrum of Linderone A LOB25                                                                 69 
 
3.28       LC-MS Spectrum of Linderone ALOB25                                                        70 
 
3.29       
1
H NMR Spectrum of LinderoneA LOB25                                                      73 
 
3.30       COSY Spectrum of Linderone A LOB25                                                         74 
 
3.31     
13
C NMR / DEPT Spectra of Linderone A LOB25                                            75 
 
3.32       HMQC Spectrum of Linderone A LOB25                                                        76 
 
3.33       HMBC Spectrum of Linderone A LOB25                                                        77 
 
3.34      LC-MS Spectrum of methyllinderone LOL34                                                   78 
 
3.35    
1
H NMR Spectrum of Methyllinderone LOL34                                                  80 
 
3.36      
13
C NMR / DEPT Spectra of Methyllinderone LOL34                                     81 
3.37      LC-MS Spectrum of kaempferol LOL5                                                             82 
 
3.38      
1
H NMR Spectrum of kaempferol LOL5                                                          85 
 
3.39       COSY Spectrum of kaempferol LOL5                                                             86 
 
20 
 
3.40      
13
C NMR Spectrum of kaempferol LOL5                                                         87 
 
3.41      LC-MS Spectrum of (+)-laurotetanine LOL20                                                  88 
 
3.42      
1
H NMR Spectrum of (+)-laurotetanine LOL20                                                91 
 
3.43     
13
C-NMR/DEPT Spectra of (+)-laurotetanine LOL20                                       92 
 
3.44     HMQC Spectrum of (+)-laurotetanine LOL2                                                     93 
 
3.45      HMBC Spectrum of (+)-laurotetanine LOL20                                                  94 
 
3.46     LC-MS Spectrum of N-methyllaurotetanine LOL35                                          95 
 
3.47     
1
H NMR Spectrum of N-methyllaurotetanine LOL3                                          97 
 
3.48    
13
C-NMR/DEPT Spectra of N-methyllaurotetanine LOL35                               98 
  
3.49      LC-MS Spectrum of (+)-Norboldine LOL50                                                    99 
 
3.50     
1
H-NMR Spectrum of (+)-Norboldine LOL50                                                 101 
 
3.51     
13
C-NMR/DEPT Spectra of (+)-Norboldine LOL50                                        102 
 
3.52    LC-MS Spectrum of (+)-10-O-N-methylhernovineLOL6                                 103 
 
3.53     
1
H NMR Spectrum of (+)-10-0-N-methylhernovine LOL63                           105 
 
3.54      LC-MS Spectrum of (+)-Norisoboldine LOL65                                              106 
 
3.55       
1
H-NMR Spectrum of (+)-Noisoboldine LOL65                                           108 
 
3.56       
13
C-NMR Sectrum of (+)-Norisoboldine LOL65                                           109 
 
3.57       LC-MS Spectrum of 3',4'- Dimethoxycinnamaldehyde LCB7                       113 
 
3.58      
1
H NMR Spectrum of 3',4'-Dimethoxycinnamaldehyde LCB7                       116 
 
3.59       COSY Spectrum of 3',4'-Dimethoxycinnamaldehyde LCB7                          117 
 
3.60      
13
C NMR/ DEPT Spectra of 3',4'-Dimethoxycinnamaldehyde LCB7             118 
 
3.61      HMQC Spectrum of 3',4'-Dimethoxycinnamaldehyde LCB7                         119 
3.62      HMBC Sectrum of 3',4'-Dmethoxycinnamaldehyde LCB7                            120 
 
3.63     LC-MS Spectrum of salicylaldehyde LCB11                                                   121 
 
21 
 
3.64     
1
H NMR Spectrum of salicylaldehyde LCB11                                                 124 
 
3.65     COSY Spectrum of salicylaldehyde LCB11                                                     125 
 
3.66     
13
C-NMR / DEPT Spectra of salicylaldehyde LCB11                                      126 
 
3.67      HMQC Spectrum of salicylaldehyde LCB11                                                  127 
 
3.68      HMBC Spectrum of salicylaldehyde LCB11                                                   128 
 
3.69     LC-MS Spectrum of  2,5-Dimethoxybenzaldehyde LCB15                             129 
 
3.70    
1
H NMR Spectrum of  2,5-Dimethoxybenzaldehyde LCB15                            131 
 
3.71   
13
C-NMR/ DEPT Spectra of  2,5-Dmethoxybenzaldehyde LCB15                   132 
 
3.72     IR Spectrum of biseugenol A LCB3                                                                 135 
 
3.73      LC-MS Spectrum of biseugenol A LCB3                                                        134 
 
3.74     
1
H NMR Spectrum of biseugenol A LCB3                                                      137 
. 
3.75     COSY Spectrum of biseugenol A LCB                                                         138 
 
3.76     
13
C-NMR/DEPT Spectra of biseugenol A LCB3                                             139 
 
3.77      HMQC Spectrum of biseugenol ALCB3                                                         140 
 
3.78      HMBC Spectrum of biseugenol ALCB3                                                         141 
 
3.79     
1
H NMR Spectrum of biseugenol  LCB9                                                    144   
 
3.80      IR Spectrum of biseugenol B LCB10                                                              145 
 
3.81:      LC-MS Spectrum of biseugenol B LCB10                                                     146 
 
3.82      
1
H NMR Spectrum of biseugenol B LCB10                                                    148 
 
3.83       COSY Spectrum of biseugenol B LCB10                                                       149 
3.84     
13
C-NMR/DEPT Spectra of biseugenol B LCB10                                            150 
 
3.85      HMQC Spectrum of biseugenol B LCB10                                                      151 
 
3.86      HMBC Spectrum of biseugenol B LCB10                                                      152 
 
3.87    LC-MS Spectrum of 4-allyl-1,2-d4-allyl-1,2-dimethoxybenzene LCL15        153 
22 
 
 
3.88     
1
H NMR Spectrum of 4-allyl-1,2-d4-allyl-1,2-dimethoxybenzene LCL15     155 
 
3.89      IR Spectrum of biseugenol CLCB17                                                               156 
 
3.90      LC-MS Spectrum of biseugenol C LCB17                                                      157 
 
3.91     
1
H NMR Spectrum of biseugenol C LCB17                                                     159 
  
3.92     COSY Spectrum of biseugenol CLCB17                                                          160 
 
3.93     
13
C-NMT/DEPT Spectra of biseugenol CLCB17                                            161 
 
3.94      HMQC Sectrum of biseugenol CLCB17                                                         162 
 
3.95      HMBC Spectrum of biseugenol C LCB17                                                      163 
 
3.96   (a)Cyclic voltammogram of carbon nanotube paste electrode in 0.1 M phosphate 
                buffer solution (pH 6.0) in the presence of 500 µM biseugenol Cat scan rate 
                 50mV
-1
, (b)asa)intheabsenceofbiseugenolC                                                164                                                                   
 
3.97  Current–pH curve for electrooxidation of 500 μMbiseugenol C.at carbon 
           Nanotubes paste electrode with a scan rate of 50 mV s
−1
. Inset) influence of pH 
           on cyclic voltammograms of biseugenol C at the surface of the modified 
           electrode, (pH 4.0, 5.0, 6.0, 7.0, 8.0, and 9.0, respectively)                               165 
                                                                             
3.98    IR Spectrum of Litsin LCB4                                                                              166 
 
3.99     LC-MS Spectrum of Litsin LCB4                                                                     167 
 
3.100     
1
H NMR Spectrum of Litsin LCB4                                                                 169 
 
3.101     COSY Spectrum of Litsin LCB4                                                                    170 
 
3.102    
13
C-NMR/DEPT Spectra of Litsin LCB4                                                        171 
 
3.103     HMQC Spectrum of Litsin LCB4                                                                   172 
 
3.104     HMBC Spectrum of Litsin LCB4                                                                   173 
 
3.105     LC-MS Spectrum of   Stilbene LCB5                                                             174 
 
3.106     
1
H-NMR spectrum of Stilbene LCB5                                                             176 
 
 3.107    
13
C- NMR Spectrum of Stilbene LCB5                                                          177 
 
3.108      LC-MS Spectrum of Cinnamide LCL4                                                         188 
 
3.109      
1
H NMR Spectrum of Cinnamide LCL4                                                       181 
 
3.110     
13
C-NMR Spectrum of Cinnamide LCL4                                                       182 
23 
 
 
3.111      LC-MS Spectrum of 2, 4 –Dimethoxybenzamide LCL2                               183 
 
3.112     
1
H NMR Sectrum of  2, 4 –Dimethoxybenzamide LCL2                               186 
 
3.113    
13
C-NMR/DEPT Spectra of 2, 4 –Dimethoxybenzamide LCL2                     187 
 
3.114    HMQC Spectrum of  2, 4 –Dimethoxybenzamide LCL2                                188 
 
3.115      HMBC Spectrum of  2, 4 –Dmethoxybenzamide LCL                                 189 
 
3.116      LC-MS Spectrum of  3, 4 –Dimethoxybenzamide LCL5                              190 
 
3.117    
1
H NMR Spectrum of  3, 4 –Dimethoxybenzamide LCL5                              192 
 
3.118    
13
C-NMR/DEPT Spectra of  3, 4 –Dmethoxybenzamide LCL5                     193 
 
3.119      IR Spectrum of Costalin LCL7                                                                      194 
 
3.120      LC-MS Spectrum of Costalin LCL7                                                              195 
 
3.121     
1
H NMR Spectrum of Costalin LCL7                                                             198 
 
3.122     COSY Spectrum of Costalin LCL7                                                               199 
 
3.123      
13
C-NMR/DEPT Spectra of Costalin LCL7                                                  200 
 
3.124      HMQC Spectrum of Costalin LCL7                                                              201 
 
3.125      HMBC Spectrum of Costalin LCL7                                                              202 
 
3.126       NOESY Spectrum of Costalin LCL7                                                            203 
 
3.127      3D Structure  of Costalin LCL7                                                                     204 
 
3.128      CD structure of Costalin LCL7 205 
 
3.129     LC-MS Spectrum of eugenol LCL17  208 
 
3.130    
1
H NMR Spectrum of eugenol LCL17 211 
 
3.131    
13
C NMR Spectrum of eugenol LCL17 212 
 
4.1       Graph of concentration (μg/mL) as %inhibition DPPH radical scavaging activity 
            of ascorbic acid                                                                                       227 
 
24 
 
4.2      Graph of concentration (μg/mL) as %inhibition DPPH radical scavaging activity 
          of flavokawain B                                                                                       228 
                                                                                                 
4.3      Graph of concentration (μg/mL) as %inhibition DPPH radicalscavaging activity 
          of (+) - Onysilin                                                                                       229 
 
4.4     Graph of concentration (μg/mL) as %inhibition DPPH radicalscavaging activity 
          of (+)-Pinocembrin                                                                                230 
4.5     Graph of concentration (μg/mL) as %inhibition DPPH radicalscavaging activity 
          of  Linderone                                                                                          231 
                                                                                          
 4.6     Graph of concentration (μg/mL) as %inhibition DPPH radicalscavaging activity 
          of Linderone A                                                                                         232 
 
4.7     Graph of concentration (μg/mL) as %inhibition DPPH radicalscavaging activity 
          of biseugenol C                                                                                        233 
 
4.8     Graph of concentration (μg/mL) as %inhibition DPPH radicalscavaging activity 
          Of 2,5-dimethoxybenzaldehyde                                                                  234                      
 
4.9       Graph of concentration (μg/mL) as %inhibition DPPH radicalscavaging activity 
          of biseugenol B                                                                                       235 
 
4.10   Graph of concentration (μg/mL) as %inhibition DPPH radicalscavaging activity 
          Of 2-hydroxy-5-methoxybenzaldehyde                                                         236                                                                                                                                                                                                                          
 
4.11    Graph of concentration (μg/mL) as %inhibition DPPH radicalscavaging activity 
          of biseugenol A                                                                                         237 
 
4.12    Graph of concentration (μg/mL) as %inhibition DPPH radicalscavaging activity 
           of Cinnamaldehyde                                                                                     238 
 
4.13     Graph of concentration (μg/mL) as %inhibition DPPH radicalscavaging activity 
            of Litsin                                                                                                      239 
 
4.14      Graph of concentration (μg/mL) as %inhibition DPPH radicalscavaging activity 
           of Costalin                                                                                                240 
 
4.15       Absorbance of BHA standard                                                                          245 
 
4.16       Absorbance of flavokawain B                                                                         246 
 
4.17       Absorbance of (+)-Pinocembrin                                                                      247 
 
4.18       Absorbance of (+)- Onysilin                                                                            248 
    5 11 
N-Me 
 
25 
 
 
4.19       Absorbance of Linderone                                                                                249 
 
4.20        Absorbance of Linderone A                                                                           250 
 
4.21        Chelating activity of  EDTA                                                                         249 
 
4.22       Chelating activity of Flavokawain B                                                            250 
 
 4.23      Chelating activity of (+)-Pinocenbrin                                                           251 
 
4.24       Chelating activity of  (+)-Onysilin                                                              252 
 
4.25       Chelating activity of   Linderone                                                                 253 
 
4.26        Chelating activity of Linderone A                                                               254 
 
4.27        EC50 (µg/ml) of five compounds of Lindera oxyphylla                               260 
 
4.28     Effect of costalin treatment in the human hepatocellular carcinoma HEpG2 
           Cells                                                                                                               263 
 
4.29    Comparison of colony formation rate  at different concentrations of costalin on 
           HepG2 cells at 24 hr. Data are mean ± SD(n=3)                                                264                                                                                                    
  
4.30    HepG2 cells stained with AO/PI. Panel (A) shows the green viable HepG2 cells 
with diffused chromatin as control (Magnification, 20X).                                265                                                                 
 
4.31 Comparison of colony formation rate using different concentrations of 
compounds biseugenol A  and biseugenol B on HepG2 and PC-3 cell line      268 
                                                                                                                                     
4.32   Apoptosis quantification of HepG2 and PC-3 cells stained with AO/PI. Panel (A) 
and (C) show the green viable HepG2 and PC-3 cells                               269 
 
4.33  Percentage viability of MCF-7 cells treated with different concentration meagured 
after 48 hours using MTT assey.                                                                 270 
4.34  Comparison of colony formation rate using different concentrations of Litsin On 
MCF-7after 48 hr                                                                                           271 
 
4.35 MCF-7 cells stained with AO/PI. Panel (A) shows the green viable MCF-7 cells 
with diffused chromatin as control (Magnification, 20X).                           272 
 
4.36    Relative luminescence expression of Caspase 3/7 in the MCF7 cells treated with 
different concentrations of Litsin.                                                                    273 
 
4.37   Relative luminescence expression of caspase 8 in the MCF7 cells treated with 
26 
 
different concentrations of Litsin.                                                                    273 
 
4.38    Relative luminescence expression of Caspase 9in the MCF7 cells treated with 
different concentrations of Litsin.                                                                    274 
 
4.39     NF-KB fluorescent intensity                                                                      276 
 
4.40      NF-kB fluorescent intensity in the nuclei                                                    277 
 
4.41    Active caspases in BC-treated cells                                                                    278 
4.42    The changes occurred to the MMP and cytochrome c release led us to confirm 
           the role of mitochondria in the apoptosis occurred by BC                                 279 
 
4.43    MCF7 cells by determining nuclear condensation and fragmentation hallmark for 
           Apoptosis                                                                                                            280 
 
4.44   Quantitative analysis of BC mediated apoptosis parameter.Changes in A) total  
          nuclear intensity, B)cell permeability,C) mitochondrial membrane potential and  
          D) cytochrome localization were all measured simultaneously in MCF7cells.  281 
 
5.1   Submitted structures of chemical constituents from two genera                          288 
 
6.1    HPLC spectrum of LCB10 and LCB17                                                               304 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
27 
 
 
LIST OF TABLES 
 
Table                                                                                                                          page 
 
1.1       Classification of Lauraceaer family                                                                      8            
 
2.1       Category of phenolic compounds in plants                                                         16 
 
  2.2        Chemical constituents isolated from Lindera species                                        26 
 
2.3        Chemical constituents isolated from Litsea species                                           27 
 
3.1        Chemical constituents from the bark of Lindera oxyphylla                               31 
 
3.2        Chemical Constituents of leave Lindera oxyphylla                                            32 
 
3.3      
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of (+) – onysilin 
             LOB4                                                                                                                 35 
 
3.4     
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of (+)-pinostrobin 
            LOB7                                                                                                                   42 
 
 3.5    
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of flavokawain B 
            LOB15                                                                                                                 48  
 
 3.6    
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of (+)-pinocembrin 
              LOB2                                                                                                                 56 
 
3.7    
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of linderone LOB28 
                                                                                                                                         61  
 
3.8     1D (
1
H and 
13
C ) and 2D(COSY and HMBC) NMR spectral data of linderoneA 
          LOB25                                                                                                                   72                                                                                                                                
  
3.9     
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of Methyllinderone 
           LOL34                                                                                                                  79 
 
3.10    
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of kaempferol  
           LOL5                                                                                                                    84                                                                                                                          
 
3.11     
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of (+)-laurotetanine 
              LOL20                                                                                                               90 
28 
 
 
3.12     
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of N-methyl 
              laurotetanine LOL35                                                                                         96   
 
3.13     
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of (+)-Norboldine 
             LOL50                                                                                                              100 
 
3.14      
1
H NMR (400 MHz) spectral data of (+)-10-O-Methyl-N-methylhernovine 
              LOL63                                                                                                             104  
  
3.15      
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of (+)- Noriso 
              boldine  LOL65                                                                                               107  
 
3.16      Chemical Constituents of Bark Litsea  costalis                                                111 
 
3.17      Chemical Constituents of Leaves Litsea costalis                                             112 
 
3.18     
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of 3,4-Dimethoxy 
              cinnamaldehyde LCB7                                                                                    115 
 
3.19     
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of salicylaldehyde 
             LCB11                                                                                                              123 
 
3.20     
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of 2,5-Dimethoxy 
              benzaldehyde LCB15                                                                                      130                               
 
3.21        1D (
1
H and 
13
C ) and 2D (COSY and HMBC) NMR spectral data of   
               biseugenolA LCB3                                                                                         136 
 
3.22        1D (
1
H and 
13
C ) and 2D (COSY and HMBC) NMR spectral data of 
               Biseugenol LCB9                                                                                           143                                                                                                                                                                                                                     
 
3.23     1D (
1
H and 
13
C ) and 2D(COSY and HMBC) NMR spectral data of biseugenol  
           B LCB10                                                                                                            146 
 
3.24      1D (
1
H and 
13
C ) and 2D(COSY and HMBC) NMR spectral data of biseugenol 
            C  LCB17                                                                                                          158 
 
3.25     1D (
1
H and 
13
C ) and 2D(COSY and HMBC) NMR spectral data of litsin LCB4 
                                                                                                                                       168 
 
3.26     
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of stilbene LCB5  
                                                                                                                                       175 
 
3.27     
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of cinnamide 
              LCL4                                                                                                               180 
 
3.28     
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of 2, 4 –Dimethoxy 
            benzamide LCL2                                                                                               185 
 
3.29     
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of 3, 4 –Dimethoxy 
29 
 
             benzamideLCL5                                                                                               191 
 
3.30     1D (
1
H and 
13
C ) and 2D(COSY and HMBC) NMR spectral data of costalin 
              LCL7                                                                                                               197 
 
3.31     
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of eugenol 
            LCL17                                                                                                               210                                                                                        
  
4.1         DPPH and different concentration of standard  ascorbic acid                         218                                           
 
4.2        Metal chelating of standard EDTA                                                                   223 
 
4.3       Antioxidant of some selected chemicals in species of Lindera                         226 
 
4.4      Antioxidant of some selected chemicals in species of Litsea                             226 
 
4.5       DPPH radical scavenging activity ascorbic acid                                               227 
 
4.6      DPPH radical scavenging activity of flavokawain B.LOB15                            228 
 
4.7      DPPH radical scavenging activity of (+) - onysilin LOB4                                229 
 
4.8      DPPH radical scavenging activity of (+)-pinocembrin LOB2                           230 
 
4.9      DPPH radical scavenging activity of linderone LOB28                                    231 
 
4.10     DPPH radical scavenging activity of linderoneA LOB25                                232 
 
4.11     DPPH radical scavenging activity of biseugenolC LCB17                             233 
 
4.12     DPPH radical scavenging activity of 2, 5-Dimethoxybenzaldehyde LCB15   234                                                                                                                             
 
4.13     DPPH radical scavenging activity of biseugenol B LCB10                             235 
 
4.14      DPPH radical scavenging activity of 2-hydroxy-5-methoxybenzaldehyde 
              LCB11                                                                                                             236 
 
4.15       DPPH radical scavenging activity biseugenolA LCB3                                  237 
 
4.16      DPPH radical scavenging activity of  cinnamaldehyde LCB7                        238 
 
4.17      DPPH radical scavenging activity of litsin LCB4                                           239   
 
4.18       DPPH radical scavenging activity of costalin LCL7                                      240        
 
4.19      FRAP of BHA standard                                                                                    242    
30 
 
 
4.20      FRAP of flavokawain B LOB25                                                                      243                                                          
 
4.21      FRAP of (+)-pinocenbrin LOB2                                                                      244         
 
4.22     FRAP of  (+)- onysilin LOB4                                                                           245          
 
4.23     FRAP of linderone LOB28                                                                               246 
 
4.24      FRAP of linderone  A LOB25                                                                         247 
 
4.25      Metal Chelating Assay of EDTA                                                                     249 
 
4.26     Metal Chelating Assay of flavokawain B LOB25                                            250 
 
4.27     Metal Chelating Assay of (+)-pinocembrin LOB2                                           251 
 
4.28     Metal Chelating Assay of (+)-onysilin LOB4                                                  252 
 
4.29      Metal Chelating Assay of linderone LOB28                                                    253 
 
4.30      Metal Chelating Assay of linderone A LOB25                                               254 
                                               
4.32  Anticancer of some selected chemicals in species of Ltsea                                  257 
 
4.33    Effect of compounds from Lindera oxyphylla   on different cells type expressed 
           as EC50 values in 24 hours MTT assay                                                               261                                           
 
4.34    EC50 values of compounds in different celllines from Litsea costalis               261 
 
4.35    The cloning efficiency (CE) of the LCL7on HepG2 cell line after 24 hrs        263 
 
4.36    EC50 values of biseugenol ALCB3 and biseugenol BLCB10 in different cell line 
                                                                                                                                       266 
4.37   The cloning efficiency (CE) of the biseugenol A LCB3on HepG2 cells in 48 hrs 
                                                                                                                                       267 
4.38 The cloning efficiency (CE) of the biseugenol B on PC-3 cells in 48 hrs           
              268 
4.39    The cloning efficiency (CE) of the new compound litsin LCB4on MCF-7 Cells 
         after 48 hrs                                                                                                            271   
                                                                          
5.1      Chemical constituent from Lindera oxyphylla and Litsea costalis                    285 
 
6.1    Yield of crude extracted from Lindera oxyphylla  and Litsea costalis (Nees) 
4.31  Anticancer of some selected chemicals in species of Lindera                          257   
31 
 
          Kosterm (Lauraceae)                                                                                           292 
 
6.2  Chromatography solvent systems and the yield of compounds isolated from 
        Lindera oxyphylla (KL5359)                                                                                311 
 
6.3  Chromatography solvent systems and the yield of compounds isolated from 
        Litsea costalis (Nee.)Kosterm (KL5410)                                                              312 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
32 
 
LIST OF SYMBOLS AND ABBREVIATIONS 
[α]                               Specific rotation 
Aq                               Aqueous 
α 
 
Alpha   
β 
 
Beta 
λ(max) 
 
Maximum wave length  maximum of UV light) 
δ 
 
Chemical shift      nuclei) 
υ(max)  Frequency  
Kg 
 
Kilogram 
M 
 
Molar 
mM 
 
Milimolar 
µM 
 
Micromolar 
mg/mL 
 
Milligram per Milliliter 
ml  
 
Milliliter 
M Meter 
 
MHz 
 
Mega Hertz 
Hz 
 
Hertz 
UV 
 
Ultraviolet 
IR 
 
Infrared 
Ppm 
 
Part per million 
eV 
 
Electron Volt 
PTLC 
 
Preparative Thin Layer Chromatography 
33 
 
 
                                                                           
 
conc.      
                     
Concentrated 
DCM 
 
Dichloromethane (CH2Cl2) 
DMSO 
 
Dimethylsulphoxide 
HPLC 
 
High-performance liquid chromatography 
pH 
 
Potency of Hydrogen 
TLC 
 
Thin Layer Chromatography 
CC 
 
Column Chromatography 
NMR 
 
Nuclear Magnetic Resonance 
FT-NMR       
          
Fourier Transform Nuclear Magnetic Resonance 
Cm
-1 
             
           
Per centimeter 
nm 
 
Nanometer 
J 
 
Coupling constant 
d     Doublet 
Dd Doublet of doublet
 
 
T Triplet 
dt 
 
Doublet of triplet 
M Multiplet 
1D-NMR      
 
One Dimensional Nuclear Magnetic Resonance 
2D-NMR       
 
Two Dimensional Nuclear Magnetic Resonance 
1
H-NMR     
 
Proton NMR 
13
C-NMR      
 
13-Carbon NMR 
COSY 
 
1
H -
1
H Correlation Spectroscopy 
34 
 
                                                                                  
 
 
  
DEPT 
 
Distortioness Enhancement by Polarization Transfer
 
HMQC 
 
Heteronuclear Multiple Quantum Correlation
 
HSQC 
 
Heteronuclear Single Quantum Correlation
 
HMBC Heteronuclear Multiple Bond Correlation 
 
NOESY 
 
Nuclear Overhauser Effect Spectroscopy
 
LC-MS                     Liquid Chromatography-Mass Spectroscopy 
MS Mass Spectroscopy 
 
HRESIMS 
 
High Resolution Electrospray Ionization Mass 
Spectroscopy 
 
EIMS 
 
Electron Impact Mass Spectroscopy 
ESI 
 
Electrospray Ionization 
OD 
 
Optical density 
m/z                       
 
Mass per charge rate (mass of the ion divided by its 
charge) 
 
DMF Dimethylformamide 
 
[M+H]
+
                    Pseudo-molecular ion (molecular mass +1)    
 
[M+Na]
 +
     
 
Pseudo-molecular ion (molecular mass +23)    
AR 
 
Analytical Reagent Grade 
IC50 Inhibitory Concentration 
 
EC50 Effect Concentration 
 
LOL Lindera oxyphylla Leaves 
 
LOB Lindera oxyphylla Bark 
 
LCL 
 
Litsea costalis Leaves 
LCB 
 
Litsea costalis Bark 
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br 
 
broad 
 
DPPH   
 
1, 1-Diphenyl-2-picryl hydrazyl 
FRAP 
 
 
Ferric reducing antioxidant properties 
μg 
 
microgram 
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INTRODUCTION 
1.0 General  
  Archaeological confirmation indicates humans have used plants to treat and 
avoid diseases for more than 5000 year (Swerdlow et al ., 2000). Many cultures have a 
rich history of medicinal plant usase dating back thousands of years. Today plant 
materials are important sources of new drugs. For examples, from 1981-2000, 
compounds isolated from either plants or microbes have lead to 60% of cancer drugs 
and 75% of pharmaceuticals for contagious disease (Cragg, 1997; da Rocha et al ., 
2001; Newman et al. 2003). 
 A huge variety of  natural products (also called secondary metabolites) are 
organic compounds  such as alkaloids, terpenes, polyphenols and saponins  are 
synthesised exclusively by  plants for various purposes (Chew et al., 2009). More than 
35,000 plant species have been reported to be used in various mankind around the world 
for medical purposes (Lewington et al., 1993). Natural products are very important in 
health care and prevention of diseases. For example, apomorphine 1 was isolated from 
poppy (Papaver somniferum) in 2004 has extensive use in the treatment Parkinson’s 
disease  (Chen et al. 2005). Tiotropium bromide 2 was identified from Atropa 
belladonna (Solanaceae) in 2004 was used for the treatment of bronchospasm linked 
with chronic obstructive pulmonary disease (COPD). Nitisinone 3 (Koumis et al ., 
2005) was extracted from  plant (Callistemon citrinus) in 2002.  It had been used 
clinically  in the  treatment of hereditary tyrosinaemia type 1 (HT-1) and used to  
reduced urinary HGA levels in patients with alkaptonuria  (Onojafe  et al., 2005). 
Galantamine 4 was isolated from Galanthus nivalis in 2001 and was used traditionally 
in Bulgaria, Iran and Turkey for neurological conditions and poliomyelitis in children 
(Berkov et al., 2009; Howes et al  2003). Arteether 5 was isolated from Artemisia annua 
(Asteraceae) in 2000 and it has been developed  artemisinin, a sesquiterpene lactone 
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(Dewick, et al., 2009; van Agtmael et al ., 1999). 
 
 
 
  
  
 
 
 
           Figure 1.1: Drugs isolated from plants. 
 Herbal medicines role an important ingredient in preparations linked to human 
culture since early time. In 1993, studies conducted by the World Health Organization 
(WHO) reported 80% of the world’s population rely on traditional medicine. In other 
words, despite the advances of modern medicine, the practice of traditional medicine 
persists 90% comes either directly or indirectly from plant sources (Benowitz et al., 
1996). Fourty-seven percentage of the anticancer drugs in the market come from natural 
products ( Newman et al., 2007).  
 Malaysia is one of  the richest and oldest rain forests in the world. It may be 
attributed to the warm and nearly uniform which is suitable for the growth of the 
tropical rain forest. Malaysia is considered as a stable region and this has made possible 
for their persistence over 50 million years ago (Keng.,1978) . The flora of Malaysia is 
very rich and is conservatively estimated to number contain 15,000 species of flowering 
plants and more than 1,000  species of ferns. Malaysia, widely recognized as one of the 
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centres of biological diversity, is richly endowed with plants, animals and microbial 
genetic resources. If exploited and managed wisely, these genetic resources could 
provide renewable useful products for not only the present but also the future generation
 
(Soepadmo et al., 1999).   
 In Malaysia, the practice of traditional medicine is still common among various 
ethnic groups, Malay, Chinese and Indian. This traditional medicine knowledge has 
been passed on through many generations (Ali et al., 1999). 
 In the last decades, many different types of  natural products had been isolated, 
which possess different types of biological activities. Some of the diverse classes of 
natural products,  acetogenins, alkaloids, biflavonoids, coumarins, terpenoids and 
xanthonoids  were  isolated from the family of Annonaceae, Apocynaceae, Guttiferae, 
Meliaceae, Rubiaceae, Rutaceae, Verbenaceae  (Rahmani et al.,  2001).
  
 
The flowering plants and in particular the tree species have received 
comprehensive studies through the Tree Flora of Malaya project and on-going Tree 
Flora of Sabah and Sarawak project. After the completion of the Tree Flora of Malaya, a 
total of more than 2830 tree species were documented and of these 746 species or 
26.4% of the total are found to be endemic to Peninsular Malaysia. For the Peninsular 
Malaysia the number of non-tree species which comprise shrubs, herbs, parasites, 
epiphytes, saprophytes, climbers and others may be more than that of trees, but their 
taxonomy and diversity remain uncertain because there is no similar efforts to study 
their taxonomy, distribution and endemicity like that of tree species (Zakri et al., 2000). 
 Recently, there is a trend that people are turning towards natural products as 
remedy. One of the main reason stems from the fact that modern pharmaceuticals 
frequently utilize chemicals and synthetic drugs that may have adverse effect on 
human’s health. Additionally, some these drugs have so far away failed to cure certain 
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chronic disease, e.g. hypertension, cancer, HIV. Herbal plants suppose  have less side 
affect but they are unusual for disease avoidance and healing. The medicinal value of 
plants is found in roots, leaves or other plants parts. Their efficiency and attractiveness 
depend on new research achievements and knowledge of traditional treatment, ethnic 
beliefs and the availability of plant materials (Bhakuni et al., 1978). 
 Natural products (secondary metabolites) and their derivatives (including 
antibiotics) characterize more than 50% of all drugs used in the world. Higher plants 
contribute less than 25 % of the total drugs and about 100 drugs nowadays earn from 
natural products in USA. Some known example of plant derived medicines are 
strychine, ziconotide, codeine, colchinine, athropine, reserpine and digixin. Important 
new anticancer drugs such as taxol and vincristine have been developed from plants. 
The international consumer market for herbs and botanicals is estimated at about USD 
18 billion, which is just under half of the total market for supplements (including 
minerals, vitamins, homoeopathic products and sport supplements), estimated more than 
USD 50 billion (Bhakuni et al., 1981). 
 Plant materials are not only use as drugs but many of them can be used as 
chemical models or templates for the design, synthesis and semi-synthesis of novel 
substances for treating human  diseases. 
 
1.1 Lauraceae: General Appearance and Morphology 
Most of the species are evergreen, tough intermittent in flowering and in the 
development of new leaves. The colors of new leaves vary from nearly white to pink, 
purple, red or brown. The leaves are simple, spiral, alternate, opposite, subopposite or 
whorled, entire, leathery, without stipules; usually with numerous gland dots, and often 
aromatic when crushed; secondary veins pinnate; sometimes with only one pair of veins 
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(trinerved) as in Cinnamomum, occasionally with more than one pair but basal pair 
enhanced so that the leaf base appeared trinerved. The leaves of some species have 
domatias in the axils of the nerves, inhabited by mites. 
The bark is usually smooth, rarely fissured, scaly or dippled, often covered with 
large lenticels, grey-brown to reddish-brown. The inner bark is usually very thick, 
granular, mottled or laminated, often with strong aromatic smell, yellow, orange-brown, 
pinkish or reddish. Sapwood is pale yellow to pale brown with satiny lustre when 
freshly cut. Terminal bud naked or covered with bud scales which sometimes appear 
like small leaves.  
The flowers are protogynous, often with a complex flowering system to prevent 
inbreeding. The flowers are pollinated chiefly by flies and beetles which are attracted by 
the smell emitted from the flowers. Their flowers are small, regular, greenish white or 
yellow, fragrant or with rancid smell with 6 petals in two rows (4 tepals in 2 rows in 
Neolitsea); tepals equal or outer whorl smaller, perianth tube either reciduous or 
persistent appearing as a cup at the base of the fruit or completely enclosing the fruit.  
The fruits of this family are small to large one-seeded berry, sometimes 
enveloped by the accrescent perianth tube or the perianth persisting and clasping the 
base of the fruit. In some genera perianth lobes dropping but the tube developing into a 
shallow or deep cup at base of fruit or perianth absent or the perianth lobes spreading or 
reflexed in fruit. Fruit stalk enlarging and becoming highly coloured in some species of 
Alseodaphne and Dehaasia. 
The seed without albumen, with thin testa. Cotyledons are very large, flat 
convex, pressed against each other. The fruit are eaten by monkeys, squirrels, bats, 
musangs and birds. However, some of the species are not touch by these animals. Wood 
of Lauraceae is soft to moderately hard, light to moderately heavy to varying from 350-
880 kg/nr' air dry. Grain straight or slightly interlocked, texture moderately fine and 
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even. Sapwood usually is a distinctly lighter shade than the heartwood. The heartwood 
is yellow-white (Beilschmiedia), yellow brown or red-brown in most species of 
Cinnamomum, Cryptocarya and Endiandra, olive green in species of Litsea, 
Actinodaphne, Alseodaphne, Notaphoebe, Phoebe, and dark olive green-brown in 
Dehaasia (Wood  et al., 1958). 
 The family of Lauraceae provided many useful economic products. Most of the 
economically important species other than sources of excellent wood are spices or 
flavoring agent. For example avocado (Persea) is one of important tropical fruit 
(Bannister et al. 2012; Okuda et al., 2003). 
 
1.2  Lauraceae: Distribution and Habitat 
 Lauraceae is one of the major families of plants. Lauraceae or Laurel family is 
known as “Medang” or “Tejur” in Malay, comprises a group of flowering plants 
included in the order Laurales; The family consists about 55 genera and over 2500 
(perhaps as many as 4000) species world-wide and about 16 genera and 213 species 
were found in Malaysia. The tree of Lauraceae are usually evergreen, shrubs, and 
without buttresses. 
  Ecology of Lauraceae is dependent on type of the lands, whether lowlands or 
highlands. In the lowlands, Lauraceae are typically small trees except for a few species 
which may reach 30 m tall. In the highlands, Lauraceae like Fagaceae, becoming more 
abundant reaches the top layer of the forest, which lies at 1200-1600 m. such as Oak-
Laurel Forest which is a feature of the mountains of tropical Asia from Himalayas to 
New Guinea (Corner et al.,  1988).     
 
 
 
42 
 
1.3 Classification of Tribe and Lauraceae Classification 
 There are many primitive and archaic features, which characterize the Lauraceae 
family. The determination is dependent on a combination of characters. Scheme 1.1 
illustrated the classification proposed by ( Keng et al ., 1978). There are over 30 genera, 
mainly tropical and sub-tropical Asia and America, about 16 are found in Malaysia. 
This classification is according to Malayan seed plants . 
 The classification of Lauraceae included 63 genera, mainly in Southeast Asia 
and Latin America that can be illustrated in the list below: 
 
Kingdom: Plantae              Divison: Magnoliophyta              Class: Magnoliopsida  
Order: Laurales                   Family: Lauraceae (Wilson.,  2010 ) 
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Genera: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.1: Classification of Lauraceae Family 
 
 
 
1. Actinodaphne 
 
 
 
34. Mezilaurus 
2. Adenodaphne 35. Mochinnodaphne 
3. Aiouea 36. Mutisiopersea 
4. Alseodaphne 37. Nectandra 
5. Anaueria 38. Nocinnamomum 
6. Aniba 39. Neolitsea 
7. Apollonias 40. Nothaphoebe 
8. Aspidostemon 41.ocotea 
9. Beilschmiedia 42. Paraia 
10. Brassiodendhron 43. Parasassaras 
11. Caryodaphnops 44. Persea 
12. Cassytha 45. Phoebe 
 
 
13. Chlorocardium 46.Phyllostemonodaphne 
 
 
 
 
14. Cinnadenia 47.Pleurothyrium 
15. Cinnamomum 
 
 
 
 
 
48.Potameia 
16. Cryptocarya 
 
49.Potoxylon 
 
 
17.Dahlgrenodendrone 50.Povedadaphne 
 
18.Dehaasia 
 
 
51.Ravensara 
19.Dicypellium 52.Rhodostemonodaphne 
 
 
 
20.Dodecadenia 53.Sassafras 
21.Endiandra 54.Sextonia 
22.Endlicheria 55.Sinosassafras 
23.Eusideroxylon 56.Syndiclis 
24.Gamanthera 57.Triadodaphne 
25.Hexapora 58.Umbellularia 
 
26.Hypodaphnis 
 
59.Urbanodendron 
27.Iteadaphne 
 
60.Williamodendron 
28.Kubitzkia 
 
61.Yushunia 
 
29.Laurus 
 
62.Clinostemon 
30.Licaria 63.Cryptocarya 
31. Lindera  
32. Litsea  
33. Machilus  
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1.4  The Genus Lindera 
  Lindera is a genus of evergreen trees belongs to the Lauraceae family. The 
genus of  Lindera includes about 80-100 species of flowering plants in the family 
Lauraceae (Durtsche), mostly located in eastern Asia  and eastern North America 
(Suzuki et al. 1971)  and can be seen as shrubs and small trees. The examples of 
Linderaspecies are L. aggregata, L.reticulosa, L. chienii,  L.benzoin,  L.obtusiloba,  
L.lucida, L .melissifolia, L. wrayi, L. akoensis,  L. angustifolia, L. communis,  L. 
doniana, L. erythrocarpa, L. flavinervia, L. floribunda, L. glauca, L. gracilipes, L. 
guangxiensis, L. kariensis, L. kwangtungensis, L. latifolia, L. limprichtii, L. 
longipedunculata, L. metcalfiana, L. monghaiensis,  L. motuoensis,  L. oxyphylla, L. 
nacusua , L. neesiana, L. praecox, L. prattii , L. pulcherrima, L. reflexa, L. robusta, L. 
rubronervia, L. strychnifolia , L. supracostata, L. thomsonii,L. tienchuanensis, L. 
tonkinensis, L. umbellataand L. villipes. The leaves can be either deciduous or 
evergreen depending on species, and are alternate, entire or three-lobed, and strongly 
spicy-aromatic. The flowers are small, yellowish, with six tepals arranged in a star 
shape. The fruit is  small red, purple or black drupe containing a single seed. 
Lindera oxyphylla (KL 5359) 
  Lindera oxiphylla (KL 5359) was collected at Hutan Simpan Ulu Muda, Baling, 
Kedah. It is a medium size tree up to 30 m tall, 80 cm girth. Bark is brown, smooth  
reticulately  fissured to cracked. The inner barks are reddish brown. Leaves are alternate 
simple, thinly coriaceous, lanceolate apex acuminate acute. 
 Base cuneate, 7.5-15.0 x 3-5 cm shining dark green above, glaucous below, 
young leaves pinkish brown secondary nerves 7-11 pairs, raised belown faint. Tertiary  
nerves and reticulations visible beneath faint above. Petioles 1-1.5 cm long, in flowers 
cence in axillary olusters of umbellules or on the leaf less twigs flower buds rusty 
brown tomentose opening greenish, silky hairy. 
45 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: The Leaf and Bark of Lindera 
oxyphylla (KL 5359) 
 
1.5  The Genus Litsea 
 The genus Litsea evergreen belonging to the large family Lauraceae comprises 
nearly 200 to 400 species, which are spreaded abundant throughout tropical and 
subtropical Asia, North and South America. In Malaysia, it’s found widely in Penang, 
Perak, Pahang, Selangor, Negeri Sembilan and Johor. Litsea is represented by 72 
species and mostly growing in the south and south western parts of  Malaysia (Institute 
of Botany., 1982).  In Indonesia, it’s represented about 22 species (Henry et al., 1999). 
 The species that can be found in Peninsular Malaysia are L. johorensis, L. 
trunciflora, L. magnifica, L. tomentosa, L.grandis, L. artocarpifolia, L. firma, L. 
gracilis, L. amara, L. polyantha, L. wrayi, L. cordata, L. glabrifolia, L. angulata, L. 
quercina, L. perakensis, L. machilifolia, L. panamonja ,L. robusta and also L. costalis. 
 Litsea species are normally trees or shrubs. The leaves are usually alternate or 
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opposite or sub-opposite. The wood of Litsea is soft to moderately hard and the color 
generally grey. The seeds of Litsea contain oils and are used for burning and soap-
making. The flowers are shortly pedicelled or sessile. The perianth tube in males was 
small or none while in females it is funnel shaped and have 6 lobes. The fruits were 
globose ovoid, ellipsoid or cylindric on the perianth tube enlarged in a cup, usually 
large and often thick (Ridley et al., 1924).       
Litsea costalis (Nees) Kosterm (KL 5410) 
 Litsea costalis was collected from Hutan Simpan Piah, Lasah, Sg. Siput and 
Perak. It is a medium size tree up to 3 m tall, 6 cm girth. Bark is dark grey, inner bark 
yellow green, smooth reticulately fissured to crack. Leaves spirally simple, Thinly coria 
ceous, from elliptic oblong to ablong obovate in Apex minutely tipped base narrowed 
acute, 26.5-57cm x 15-23 cm  dark green above, glaucous below, margin entire, midrib 
sunken above, secondary nerves 8-12 pairs, tertiary  nerves and reticulations  faint on 
both surfaoesa, petioles  up to 4.5  cm long, in flowers cence in axillary, terminal 
recemes flowers yellowish green to creamy white . 
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 Figure 1.3:  The Bark and Flowers of Litsea costalis (Nees) Kosterm 
 
 
 
 
 
 
 
 
 
Figure 1.4: The Leaf of Litsea costalis (Nees) Kosterm 
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1.6  Objectives of study 
 The objectives of the study are: 
1. To extract and isolate the chemical constituents from the leaves and stem 
barks of Lindera oxyphylla and Litsea costalis (Nees) Kosterm using n-
hexane, dichloromethane and methanol as solvents. 
2. To elucidate the structure of isolated compounds using spectroscopic methods 
such as UV, IR, MS, 1D-NMR (
1
H, 
13
C, DEPT, NOE) and 2D NMR (COSY, 
NOESY, HMQC, HMBC). 
3. To study the biological activities such as antioxidant (DPPH,  FRAP, FIC) 
and anti cancer activities for selected compounds on various cancer cell lines, 
A375 human melanoma, HT-29 colon adenocarcinoma, MCF-7 human breast 
adenocarcinoma , WRL-68 normal hepatic cells, A549 non-small cell lung 
cancer  and PC-3 prostate adenocarcinoma, MDA-MA231 human breast 
adenocarcinoma, CEM-ss flagelliforme tuber on human T4 lymphoblastoid, 
HepG2 Hepatocellular carcinoma human, CCD841 human normal colonic cell 
line and Jurkat which are an immortalized line of T lymphocyte cells that are 
used to study acute T cell leukemia. 
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GENERAL CHEMICAL ASPECTS 
  
2.1  Introduction   
 Plants have been explored by chemists for their chemical compounds of their 
medicinal value. The studies have been aimed on compounds that are of the 
pharmaceutical interest in the scope of medicinal importance. Plants play an important 
role as medicine to human.  
 Lauraceous plants consists non-alkaloid (e.g. carbohydrates, lipids, amino acids 
and proteins, polyphenol, essential oils, terpenes and aromatic compounds) and alkaloid 
constituents and studies have been made on it (Fischer et al. 1999; Kochummen, 1997). 
 
Sources of Natural Products. 
 Natural products are derived from four classic sources (Dewick, 2009): 
 Microbial sources : For example, Cefprozil 
 
  
 
   Cefprozil (Cephalosporin) 
 Plant Sources: Several important drugs such as: Quinine 
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    Quinine  
 Marine Sources: first time separated in  1950 such as spongouridine 
 
 
 
    Spongouridine 
 Animal Sources: Epibatidine, obtained from the skin of an Ecuadorian poison 
frog 
 
   
      
    Epibatidine 
 
2.2 Aromatic Compounds: Phenolics 
 Phenolic compounds are the compounds that have one or more hydroxyl groups 
attached directly to the aromatic ring. The natural phenolic compounds are derived from  
the pentose phosphate, shikimate and phenylpropanoid pathways in plants  (Randhir et 
al., 2004).  
The phenolic compounds can be classified in a number of ways:  
 Harborne and Simmonds have classified these compounds into groups based on 
the number of carbons in the molecule  (Table 2.1) (Barton., 1999). 
 Swain and Bate-Smith category these compounds in common and less common . 
 Ribereau-Gayon has classified phenolic compounds into three families  
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Table 2.1: Category of phenolic compounds in plants. 
 
 
 
2.2.1 The C6 simple phenol compounds.      
 Phenols 8 and benzoquinones 9 are phenolic compounds consisting of a 
hydroxyl functional group (-OH) attached to an aromatic hydrocarbon group.  
 
 
                                 
                                     8                                      9 
 
Number of C- atoms Basic skeleton                     Families of Phenols 
6 C6 Simple phenol 8 and benzoquinone 9 
7 C6-C1 Gallic acid 10 and protocatechuic acid 11 
8 C6-C2 2-Hydroxyacetophenone12 
9 C6-C3 Cinnamic acids 13 and isocoumarins  14 
15 C15 Kaemferol 15, quercetin 16 and myricetin 17 
15 C15 Isoflavonoid 18 and neoflavonoid 19 
15 C15 epicatechin 20 and 3′-O-methylepicatechin 21 
15 C15 Flavanone 22 
15 C15 Flavanol 23 
15 C15 Chalcones 24 and dihydrochalcone 25     
15 C15 Aurones 26 
13,14 C6-C1-C6,C6-C2-C6 Benzophenone 27, xanthone  28 and stilbens 29 
N Lignans,neolignans (+)-Pinoresinol 30 and (+)-sesamin 31 
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2.2.2  The C6-C1 phenolic acids and related compounds 
 The  C6-C1 phenolic acid usually designates phenols that possess one carboxylic 
acid functionality (Robbins et al.,  2003; Haig et al.,  2000). Phenolic acid can be found 
in many plants especially in dried fruits. 
 
 
 
       Gallic acid 10  Protocatechuic acid 11 
 2.2.3 The C6-C2 acetophenones and phenyl acetic acids 
 The C6-C2  phenolic compounds  consist of C2 side chain such as acetophenone  
(Lamola et al., 1967)  and phenyl acetic acid   (Amir  et al.,  2004). Another is 2-
hydroxyacetophenone 12 (Dakternieks et al.,  1998). 
 
                                                                        
                                                           12         
2.2.4 The C6-C3 Cinnamic acids and related compounds 
 This group includes cinnamic acid 13  (Beavis et al.,  1989) and isocoumarin 14. 
   
           
                                  13                                     14                    
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 2.3 The C15 Flavonoids.  
 Flavonoid compounds are the main group of plant phenolics  and they can be 
found in all part of plants such as fruit, flower, leaves, root and stem (Henning et al., 
2004; Mulder et al., 2005).  The name of flavonoid was derived from Latin word flavus 
which means yellow. Flavonoids have small molecular weight consisting of fifteen 
carbon atoms, arranged in a C6–C3–C6 configuration. Essentially the structure of 
flavonoid  consists of two aromatic rings A and B, joined by a 3-carbon bridge, usually 
in the form of a heterocyclic ring (Bohm et al., 1998; Merke et al.,  2000). The aromatic 
ring A is derived from the acetate/malonate pathway, while ring B is derived from 
phenylalanine through the shikimate pathway. 
 
                                                                           
  
  Flavonoid  
  
 Depending on the degree of oxidation of the central ring C, they can be  
subdivided into several classes : flavones, flavonols, flavanones, isoflavones, flavans, 
flavanols, and anthocyanins  (Pietta et al., 2000).  The pyran ring can be opened 
(chalcones) and recyclized into a furan  ring (aurones) (Pharmacognosie et al., 1999).    
The most widely distributed flavones in nature are kaemferol (5, 7, 4′ -
trihydroxyflavone) 15, quercetin (5, 7, 3′, 4′ -tetrahydroxyflavone) 16 and myricetin (5, 
7, 3′, 4′, 5′ -pentahydroxy flavone 17.  
 
 
 
54 
 
 
 
 
 
                                
       
           15                                               16                                             17 
 
 Isoflavonoid (Graham et al., 1991) is flavonoid with aromatic ring at position C-
3,  for example 5, 7, 4'-trihydroxyisoflavone 18. When aromatic ring attached at 
position C-4 in the flavonoid skeleton, this compound is called neoflavonoid, for 
example 4-phenylcoumarins 19.  
 
                    
               
                              18                19 
 
 Flavonol  ( Li et al.,  1997) has a hydroxyl group at position C-3 and a double 
bond at C-2.  They are present in a wide variety of fruits and vegetables, for examples 
epicatechin 20 and 3'-O-methylepicatechin 21.  
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                            20                                                                21 
 Flavanone 22 (Fabre et al., 2001) has carbonyl group at position C-4 and it can 
form various derivatives including hydroxyl and methoxyl groups.  
 
 
                     
               22 
 Flavanol 23 (Schroeter et al., 2006)  has hydroxyl group at position C-3 and 
there is no double bond in ring C. 
 
 
 
23  
 Chalcone 24 (Napoli et al.,  1990) and dihydrochalcone 25  (Horowitz et al., 
1963) have a linear C3-chain connecting the two rings. The C3-chain of chalcone 
contains a double bond whereas the C3-chain of dihydrochalcones is saturated. 
 
                           
  24                                                                           25      
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Aurone 26  ( Ono et al., 2006) has furan ring in the molecule. 
 
 
                                                         
             26 
 
2.4 Benzophenones, xanthones, stilbenes    
 Benzophenone 27  (Dorman  et al.,  1994) and xanthone 28 (Qin et al., 2010) 
have C6-C1-C6 and stilbene 29 (Tao et al.,  2001)  has C6-C2- C6. 
 
 
 
 
                 27                                            28                                                 29  
 
2.5  Lignan and Neolignans  
 In 1927 Robinson  (Proc et al., 1927) found that  a common feature of many 
natural products have a C6-C3 unit (propylbenzene skeleton) which perhaps derived 
from cinnamyl units.  Haworth (Rep et al., 1936)    suggested   the class of compounds 
derived from two C6-C3 units and has β, β'-linked which could be called lignans. 
Lignans are a class of secondary metabolites produced by oxidative dimerization of two 
phenylpropanoid units consist of two phenylpropane (C6-C3) units, lignans show huge 
structural diversity (Mohan et al., 2012). The nomenclature of the diverse range of 
structures classified as lignans depended largely on slight names and if necessary the 
correct numbering derived from the systematic name. For example, 3, 3' –neolignan 30. 
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                     30                    
 Lignans are dimers or oligomers that product from the coupling of monolignols; 
p-coumaryl alcohol, sinapyl alcohol and coniferyl alcohol, with coniferyl alcohol being 
the most common  monolignol used in lignan biosynthesis. Lignans are nearby in ferns, 
angiosperms and gymnosperms. They are localized in woody stems and in seeds and 
play a role as insect deterrents. Some of these compounds have medicinal properties. 
                           
                             31                                                    32                
 
 The monolignol radicals, in this example derived from p-coumaryl alcohol, are 
generated enzymatically by activated cell-wall bound peroxidases, which eliminate the 
proton on the para-hydroxyl-group of the phenol. Most lignans are optically active, and 
typically only one enantiomer is found in a given species. Examples of lignans include 
(+)-pinoresinol 31 (Katayama et al., 1992) and (+)-sesamin 32 (Orito et al., 1991).  
 As the range of lignoids and their plant sources has widened so the distinction 
between lignans and neolignans has become less significant. Thus the neolignans were 
long - identified as more typical of plants of the family Lauraceae, but in recent years 
they have been  isolated from the Piperacae (Jensen et al., 1993), Magnoliaceae ( Li et 
al.,  2005), Brassica fruticulosa (Cutillo et al., 2003) and Callicarpa japonica Thunb 
(Ono et al., 2009) and  other plants. 
58 
 
2.6 Alkaloids     
 Alkaloids are among the first natural products to be isolated from medicinal 
plants. When they were first obtained from plant material in the early years of the 19th 
century, it was found that they were nitrogen containing bases which formed salts with 
acids. For this reason, they were known as the vegetable alkalis or alkaloids (Thomson 
et al.,  1993). The alkaloids have ability to be in the form of salts and make complex 
with metal ions and it helped their isolation and recognition in the period of time before 
chromatography techniques.The word alkaloid has been firstly drawn from the word 
‘vegetable alkali’ and was used to express the basicity or alkalinity of a number of 
initial alkaloidal segregations. And also, the word of alkaloid meant simply, alkali like 
(Middle English alcaly, from Medeval Latin alkali, from Arabic “alqaliy = ashes of 
stalwart, from qualey, to fry) (Cave et al., 1987). Name ‘alkaloid derives from the word 
‘alkaline’, which means a water soluble base (Cordell et al., 1989). 
 An “alkaloid” is a substance with nitrogen in the molecule, connected to at least 
two carbon atoms and must have at least one ring, but not necessarily heterocyclic. 
Alkaloids are grouped in three main categories based on knowledge and speculation 
about their biogenesis (Lee et al., 2000). It has been estimated that in excess of 6000 
compounds with the alkaloid-like properties are known, comprises the largest single 
class of secondary plant substance (Schiff  et al.,  1991). 
 The majority of the alkaloids are heterocyclic (compound containing a closed 
ring of atoms of which at least one is not a carbon atom) in nature. But there can be in 
other types like mescaline 33, ephedrine 34 and hordenine 35 that are non-cyclic. These 
are often known as ‘protoalkaloids’. 
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                        33                                             34                                       35 
2.6.1 Classification of the Alkaloids    
 Alkaloids have been classified to three main groups by Hegnauer which based 
on speculation of biogenetic pathways (Cordell et al., 1981) . 
2.6.1.1 True Alkaloid 
 The compounds which the nitrogen-containing heterocyclic system is derived 
from a biogenetic amine and produced by decarboxylation from amino acid were 
named true alkaloids. They are usually found as salts in plant such as liriodenine 36 ( 
Buchanan et al.,  1960), codeine 37 (Sindrup et al.,  1995) and  morphine 38 ( Cordell 
et al., 1981). 
                           
 
 
 
           36                                                        37 
                                                        
                         
              
 
                                        38                          
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2.6.1.2 Pseudo Alkaloid 
 Pseudo alkaloids  are in fact unrelated to amino acid (Schmidt et al.,  2003). The 
pseudo alkaloids are nitrogen-containing molecules but they have carbon skeletons 
derived from monoterpenes, other acetate derivatives and aliphatic polyketo acids such 
as coniine 39. It also known as heterocyclic containing nitrogen and derived from 
terpenoids such as actinidine 40. 
                                                               
                         39                                                       40                                                                         
2.6.1.3 Proto Alkaloids 
        These compound  like true alkaloids, that derived from amino acid or biogenetic 
amines but they do not contain any heterocyclic system (Piettre  et al., 1990). They are 
represented in nature by biogenetic amine themselves and their methylated derivatives 
such as serotonins 41.They are derived also from amino acid such as serotonine 42 and 
cathinone 43.  
 
 
                                 
                       41                                                             42                             
                                            
 
                          
                                                  43                  
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2.7 Chemical Constituents of Lindera Species 
 Table 2.2 showed the list of some selected compounds from Lindera species. All 
of these compounds have never been found in Lindera oxyphylla. 
 
 Table 2.2: Chemical constituents isolated from Lindera species 
 
NO. 
 
Lindera species 
Type of 
Compounds 
 
Examples 
 
Ref. 
 
1 
 
Lindera fruticosa 
 
Phenolic 
compound 
 
2-methoxy-3, 4-methylene 
dioxybenzophenone 44 
 
( Song et al., 2006) 
 
2 
 
Lindera fruticosa 
 
Benzophenone 
 
2, 3-dimethoxy-4-hydroxy 
benzophenone 45 
 
 
(Song t al., 2007) 
 
 
 
3 
 
Lindera aggregata 
 
 
Flovonoid 
 
quercetin-3-O-L-rhamnoside 
46 
 
 
 
 
(Xiao et al., 2011) 
 
4 
Lindera 
Obtusiloba blume 
 
Lignan 
 
pluviatilol 47 
 
 
(Kwon et al., 1999) 
 
5 
 
Lindera chunii 
 
Alkaloid 
 
lindechunine B 48 
 
(Zhang et al., 2002) 
 
 
 
 
                                      
 
                          44                                                                                 45 
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                                               46                                47 
    
 
 
                              
                                       48             
 
2.8 Chemical Constituents of Litsea Species. 
 Listed some selected chemicals of Litsea species, here again no investigation has 
been found on Litsea costalis (Table 2.3). 
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Table 2.3: Chemical constituents isolated from Litsea species 
 
NO. 
 
Litsea species 
Type of 
Compounds 
 
Examples 
 
Ref. 
 
1 
 
Litsea decanensis 
gamble 
 
Heterocyclic 
compound 
 
3,5dihydroxy-6-
methyl-2H-pyran-
4(3H)-one 49 and 5-
hydroxyfuran-2-
carbaldehyde 50 
 
 
(Kumara et al., 2000) 
 
2 
 
TwelveLitsea and 
neolitse 
 
Flavonoid 
 
2(3,4-dihydroxy phenyl)-
5,7-dihydroxy-3-
(((2S,4S,5R)-3,4,5-
trihydroxy tetrahydro-
2H-pyran-2-yl)oxy) 
hroman-4-one 51 
 
 
(Tsai  et al.,  2011) 
 
3 
 
Litsea rubescens and 
Litsea pedunculata 
 
Flovonoid 
 
Litseaone A 52 
Litseaone B 53 
 
( Li et al., 2011) 
 
4 
 
Litsea pedunculata 
 
Lignan 
 
Aryltetralone 54 
 
 
( Wang et al., 2009) 
 
5 
 
Litsea glutinosa 
 
Alkaloid 
 
Aporphine 55 
 
(Yang et al., 2005) 
 
6 
 
Litsea lancifolia 
 
Alkaloid 
 
Bisbenzylisoquinoline 
56 
 
( Sulaiman et al., 2011) 
 
 
 
                        49                                                                  50 
                                                                         
 
 
 
 
  
                                                                        51 
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                                  54                                                                   55    
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RESULTS AND DISCUSSION 
 
 
  3.0 Introduction  
 In recent years, chemists are interested in isolation of natural compounds from 
plants due to their pharmacological activities, they can be used as a source of 
therapeutics. In this course of studies the plants from the family Lauraceae, namely 
Lindera oxyphylla and Litsea costalis have been studied for their chemical 
constituents. 
 The cold extraction with n-hexane, followed by dichloromethane and 
methanol has been used for extracting the natural compounds from the bark and 
also the leaves. The isolation of the pure compounds from crude extract was carried 
out using chromatographic technique such as column chromatography (CC), 
preparative thin layer chromatography (PTLC) and higher performance liquid 
chromatography (HPLC). The structural elucidation was established through 
spectroscopic methods such as  UV, IR, MS, 1D (
1
H-NMR and 
13
C-NMR , DEPT) 
and 2D-NMR (COSY,  HMQC, HSQC , HMBC and NOESY), as well as X-ray 
reflection technique. The known compounds were identified by comparison their 
spectroscopic data with the literature data. 
 
3.1 Chemical constituents from bark and leaves of Lindera oxyphylla 
 The bark and leaves of Lindera oxyphylla were investigated for their chemical 
constituents.  The plant sample was soaked with n-hexane followed by dichloromethane 
and methanol to extract its compounds. The compounds from crude n-hexane, 
dichloromethane and methanol extracts were seperated using chromatographic 
technique  and the structural elucidation of isolated compounds were done using 
spectroscopic method. A total of six compounds were isolated from the bark of Lindera 
oxyphylla and those compounds were (+)-onysilin LOB4 and linderone LOB28 which 
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were isolated from n-hexane extract, (+)-pinostrobin LOB7, flavokawain B LOB15 and 
linderone A LOB25 were isolated from dichloromethane extract and (+)-pinocembrin 
LOB2 was isolated from methanol extract. A total of seven compounds were isolated 
from the leaves and those compounds were 1-methyllinderone LOL34 which was 
isolated from n-hexane extract, (+)-laurotetanine LOL20,  N-methyllaurotetanine 
LOL35, (+)-norboldine LOL50, (+)-N-methylhernovine LOL63 and (+)-norisoboldine 
LOL65 which were isolated from dichloromethane extract and  kaempferol LOL5 
isolated from methanol extract. The percentage yields of the isolated compounds are 
shown in Table 3.1 and Table 3.2. 
 
 Table 3.1: Chemical constituents from the bark of Lindera oxyphylla 
 
Compounds 
 
Types 
 
Part 
 
%Yield 
 
(S)-5-hydroxy-6,7-dimethoxy-2-
phenylchroman-4-one, (+)-onysilin 
LOB4 
 
 
Flavanone 
 
 
 
bark 
 
 
 
0.04 
(E)-2-(1-hydroxy-3-henylallylidene)-
4,5-dimethoxycyclopent-4-ene-1,3-
dione LOB28 
 
 
Linderone 
 
bark 
 
0.7 
(E)-1-(2-hydroxy-4,6-
dimethoxyphenyl)-3-phenylprop-2-
en-1-one, flavokawain B LOB15 
 
Chalcone 
 
bark 
 
0. 5 
2-cinnamoyl-3-hydroxy-4,5-
dimethoxycyclopenta-2,4-dienone 
LOB25 
 
 
Linderone A 
 
bark 
 
1.0 
5,7-dihydroxy -2(S)-phenyl chroman 
-4H-one , (+)-pinocenbrin 
LOB2 
 
Flavanone 
 
bark 
 
0.5 
5-Hydroxy-7-methoxy-2-phenyl 
chroman -4H-one, (+)- pinostrobin 
LOB7 
 
Flavanone 
 
Bark 
 
0.5 
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     Table 3.2: Chemical Constituents of leaves Lindera oxyphylla  
 
 
Compounds 
 
Types 
 
Part 
 
%Yield 
 
(E)-2-(1-methoxy-3-phenylprop-2-
en-1-ylidene)-4, 5-
dimethoxycyclopent-4-ene-1,3-
dione LOL34 
 
Methyllinderone 
 
 
Leaf 
 
 
0.1 
3, 5, 7-trihydroxy-2-(4-hydroxy 
phenyl)-4H-chromen-4-one 
 (Kaempferol)LOL5 
 
Flavanone 
 
Leaf 
 
0.01 
 
(+)-Laurotetanine  
LOL20 
 
Alkaloid 
 
Leaf 
 
0.05 
 
N-methyllaurotetanine 
LOL35 
 
Alkaloid 
 
Leaf 
 
0.25 
 
(+)-Norboldine  
LOL50 
 
Alkaloid 
 
Leaf 
 
0.05 
 
(+)-N-methylhernovine  
LOL63 
 
Alkaloid 
 
Leaf 
 
0.05 
 
(+)-Norisoboldine  
LOL65 
 
Alkaloid 
 
Leaf 
 
0.25 
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3.1. 1 Flavanone LOB4: (+) – Onysilin  
  
                                                   
 LOB4 
 Flavanone LOB4, (+)–Onysilin with IUPAC name [(2S)-5-hydroxy -6, 7-
dimethoxy-2-phenyl chroman-4H-one] (Garo et al., 1996) was isolated as  yellow 
amorphous solid with  25D = +3.1 (2.00×10
-4 
g/100 mL, MeOH). In the UV spectrum, 
absorption maxima were observed at max (MeOH) nm (log Ɛ) 293 (4.00) and 349 (1.43) 
which indicated the existence of the conjugated double bond system. Its IR spectrum 
showed absorption bands at υmax  3446 cm
-1
 due to hydroxyl group and 1644 cm
-1
 for 
conjugated  carbonyl group. The LC-MS (positive mode) spectrum showed an intense 
pseudomolecular ion peak, [M+H] at m/z 301.0824 corresponding to the molecular 
formula of C17H16O5 (Chantrapromma et l., 1997 ).                                
         
 
 
 
 
 
Figure 3.1: LC-MS Spectrum of (+) – Onysilin LOB4 
  
[M+1]
+
 
[ M+1]
+
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The 
1
H NMR spectrum (Table 3.3, Figure 3.2) exhibited two methoxyl groups at 
δ 3.83and 3.87 as a singlet corresponding to C7-OMe and C6-OMe, respectively. The C-
8 proton was observed as a singlet at δ 6.02 and sp3 methine group at C-2 appeared at δ 
5.41 as doublet of doublet. Two up filed signals appeared as doublet of doublet at δ 2.83 
and 3.19 and these signals belong to methylene group at H-3 and H-3β and the two 
methyl group were not equivalent. Furthermore one singlet signal appeared at δ 11.76 
was assigned to OH group and this OH group formed hydrogen bond with carbonyl 
group at C-4.  The aromatic protons gave a multiplet between δ 7.31 and 7.44 attributed 
to H2', H3ꞌ, H4ꞌ, H5ꞌ and H6ꞌ. The above observations were supported by COSY (Table 
3.3, Figure 3.3) spectrum which showed cross peaks between H-2/H-3, H-2/H-3β, and 
H-3/H-3β.The 
13
C NMR and DEPT spectra (Table 3.3, Figure 3.4) established the 
resonances of seventeen carbon signals including two methyl signals at δ 61.9 for C6-
OCH3 and  δ 56.1 for C7-OCH3, one sp
3
 methylene at δ 43.3 for C-3, seven methines 
resonated at δ 79.5 for sp3 C-2, δ 91.6 (C-8) , δ126.9 (C-2ꞌ ,C-6ꞌ), δ128.9 (C-3',C-4',C-
5') and seven quaternary carbon signals at δ196.3 (C-4), δ154.9 (C-8a), δ103.1(C-4a), 
δ150.4 (C-5), δ 130.5 (C-6), δ160.9  (C-7) and  δ 138.2 (C-1ꞌ) consistent with the 
proposed structure (Kamperdick et al,. 2002). 
 In the HMBC spectrum (Table 3.3,  Figure 3.5)  the cross-peaks were observed 
between H-2 to C-1ꞌ, C-2ꞌ, C-6ꞌ, H-3α to C-4 ,  H-3β to C-4 ,  H-3 to C-2, C-1' ,  H-8 to 
C-7, C-4, C-6, C-4a,  6-OMe to C-7 , 7-OMe to C-6, OH to C-5, C-4a, C-6 ,  H-Ar to C-
Ar, C-1'.  
Finally, by comparison of the spectroscopic data obtained with the data from literature 
values, it was deduced that compound LBO4 was (+)-onysilin ( Mukhtar et al., 2000;  
Sulaiman et al., 2003), which existed widely among the family of Annonaceae, 
Monimiaceae, and Lauraceae ( Achenbach et al., 1982; Fischer et al.,  1999). 
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Table 3.3: 
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral  data of (+) – onysilin LOB4 
 
 
 
 
 
 
 
 
Position 
1
H-NMR(   J in HZ) 
13
C-NMR 
(   
 
1 
 
- 
 
- 
 
2 
 
5.41(1H, dd, 13.4, 3.5) 
 
79.5 
 
3 
 
2.83 (1H, dd, 17.3, 3.1, Hα-3) 
 
3.19 (1H, dd, 17.3, 13.5, Hβ-3) 
 
 
43.3 
 
4 
 
- 
 
196.3 
 
4a 
 
- 
 
103.1 
 
5 
 
- 
 
158.6 
 
6 
 
- 
 
130.5 
 
7 
 
- 
 
160.9 
 
8 
 
6.05 (1H, s, H-8) 
 
91.6 
 
8a 
 
- 
 
154.9 
 
1ꞌ 
 
- 
 
138.2 
 
2ꞌ, 6ꞌ 
 
7.31-7.44 (2H, m) 
 
126.9 
 
3ꞌ,4ꞌ,5ꞌ 
 
7.31-7.44 (3H, m) 
 
128.9 
 
6-OCH3 
 
3.87 (3H, s) 
 
61.9 
 
7-OCH3 
 
3. 83 (3H, s) 
 
56.1 
 
5-OH 
 
11.76 (1H, s) 
 
- 
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3.1. 2 Flavanone LOB7: (+)-Pinostrobin 
                                                                         
 
                                
     
     LOB7 
 Flavanone LOB7: (+)-pinostrobin with IUPAC name [(S)-5-hydroxy - 7-
methoxy-2-phenyl chroman-4H-one) (Garo et al., 1996) was isolated as  yellow 
amorphous solid with  25D = +1.52 (2.00×10
-4
 g/100 mL, MeOH). The structure of 
compound LOB7 has the same skeleton and substituents with compound LOB4 except 
the lack of methoxyl group at C-6 and the spectroscopic data will also be the same 
except the lack of one methoxyl group. In the UV spectrum, absorption maxima were 
observed at   max (MeOH) nm (log Ɛ) 306 (1.273) and 223 (2.316)  (Jayaprakasam et al. 
1999) which indicated the existence of the conjugated double bond system. Its IR 
spectrum showed absorption bands at υmax 3429 cm
-1
 due to hydroxyl group, 1642 cm
-1
 
assigned for conjugated carbonyl group. The LC-MS (positive mode) spectrum showed 
an intense pseudomolecular ion peak, [MH] at m/z 271.088 corresponding to the 
molecular formula of C16H14O4 (Cuong et al.,  1996). 
 
   
 
 
 
 
              
Figure 3.6: LC-MS Spectrum of (+)-pinostrobin LOB7 
[M-1]
+
=271 
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 The 
1
H NMR spectrum of (Table 3.4, Figure 3.7) exhibited one group 
methoxyl signal at δ 3.88 which was positioned at C-7. A two proton singlet at δ 6.15 
was observed in the spectrum, confirming that H-6 and H-8 were unsubstituted. The 
downfield signal appeared as doublet and doublet at δ 5.42 was assigned to H-2 and two 
up filed signals appeared as doublet and doublet at δ 2.81 and 3.11 was assigned to H-
3α and H-3β respectively. Furthermore one downfield signal appeared as singlet at δ 
11.68 was assigned to OH group.  The aromatic protons gave a multiplet signal between 
δ 7.38 and 7.49 attributed to H-2ꞌ, H-3ꞌ, H-4ꞌ, H-5ꞌ and H-6ꞌ. The above observations 
were reinforced by COSY (Table 3.4, Figure 3.8) experiment which displayed 
correlations of H-2/H-3a, H-3b and H-3a/H-3b (Kulmagambetova et al., 2003; Tran  et 
al.,  2011). 
 The 
13
C NMR  and DEPT spectra (Table  3.4, Figure 3.9) established the 
resonances of sixteen carbons; one methoxyl appeared at δ 55.7 (C-7 -OCH3), one 
methylene at δ 43.4 (C-3) , eight methines at δ 79.3 (C-2), 94.3 (C-8), 95.2 (C-6), 126.2 
(C-2',6') and 128.9 (C-3ꞌ,4ꞌ,5ꞌ)  and six quaternary carbons at δ 162.9 (C-8a), 102.1(C-
4a), 164.2 (C-5), 168.0 (C-7),  138.5 (C-1ꞌ) and 195.8 (C-4) consistent with the 
proposed structure. 
 Based on the spectroscopic data of LOB7 and comparison with the literature 
values, it was confirmed that compound LOB7 was (+)-pinostrobin (Kulmagambetova 
et al., 2002; Passador et al., 1997) .  
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Table 3.4 
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of (+)-pinostrobin LOB7 
 
Position  1H-NMR(   J in HZ) 
13
C-NMR 
 c 
 
1 
 
- 
 
- 
 
2 
 
5.42 (1H, dd, 13, 3.2) 
 
79.3 
 
3 
 
2.81 (2H, dd, 17.2,  3.4, H-3α) 
 
3.11 (2H, dd, 17.4, 13, H-3β) 
 
43.4 
 
4 
 
- 
 
195.8 
 
4a 
 
- 
 
102.8 
 
5 
 
- 
 
164.2 
 
6 
 
6.15 (1H, s) 
 
95.2 
 
7 
 
- 
 
168.0 
 
8 
 
6.15 (1H, s) 
 
94.3 
 
8a 
 
- 
 
162.9 
 
1ꞌ 
 
- 
 
138.5 
 
2ꞌ, 6ꞌ 
 
7.38,7.49 (2H, m) 
 
126.2 
 
3ꞌ,4ꞌ,5ꞌ 
 
7.38,7.49 (3H, m) 
 
128.9 
 
7-OCH3 
 
3. 88 (3H, s) 
 
55.7 
 
OH 
 
11.86 (1H, s) 
 
- 
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3.1.3 Chalcone LOB15: Flavokawain B  
                 
                                        
 
 
LOB15 
  Flavonoid LOB15, Flavokawain B with IUPAC name (E)-1-(2-hydroxy-4, 6-
dimethoxyphenyl)-3-phenylprop-2-en-1-one was afforded as a red ctystal with  25D = 
+12.3 (2. 00×10
-4
 g/100 mL, MeOH). In the UV spectrum, absorption maxima, max 
(MeOH) nm (log Ɛ) at 241 (1.297) and 336 (1.860) indicated the presence of conjugated 
double bond system. Its IR spectrum showed absorption bands at υmax 3436 cm
-1 
for 
hydroxyl group and 1634 cm
-1
 for conjugated carbonyl group. The ESIMS (negative 
mode) spectrum showed an intense pseudomolecular ion peak, [M-H] at m/z 283.7380                         
corresponding to the molecular formula of   C17H16O4. 
                        
 
 
 
 
 
Figure 3.10: LC-MS Spectrum of Flavokawain B LOB15 
 
 
[M-H] 
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 The 
1
HNMR spectrum (Table 3.5, Figure 3.11) exhibited two distinct methoxyl 
signals at δ 3.84 and δ 3.91 which were most probably positioned at H-4 and H-6. A one 
proton singlet appeared at δ 6.09 was assigned to H-5 proton and a one proton signal at 
δ  6.91 was observed which belongs to H-3. Two downfield signals appeared as doublet 
of doublet at δ 8.14 and δ 7.87 assigned to H-α and H-β respectively. The aromatic 
protons gave a multiplate signal between δ 7.38 and δ 7.43 attributed to H-3ꞌ, H-4ꞌ, H-5ꞌ 
and δ 7.62-7.65 attributed H-2' and H-6'. The above observations were reinforced by 
COSY (Table 3.5, Figure 3.12) experiment which displayed correlations of H-α/H-β and 
H-Ar/H-Ar. 
 The 
13
C NMR and DEPT spectra (Table 3.5, Figure 3.13) established the total of 
seventeen carbon resonances; two methoxyls at δ 57.1 (C-4) and δ 62.5 (C-6), nine 
methines at δ  93.9 (C-3) ,  93.9 (C-5) , 144.5 (C-α), 129.7 (C-β    130.5 (C-2ꞌ ,C-6ꞌ)  and 
131.4 (C-3ꞌ,4ꞌ,5ꞌ). Six quaternary carbons appeared at  δ 105.4 (C-1), 152.1 (C-2), 164.2 
(C-4), 159.5 (C-6), 136.5 (C-1ꞌ) and 193.5 (C-) consistent with the structure proposed 
(Koorbanally et al., 2003). 
 HSQC spectrum (Table 3.5, Figure 3.14) showed the connectivity between 
proton and carbon: H-α/C-α, H-β/C-β, H-3/C- 3, H-5/C-5, H-Ar/C-Ar, H-4'/C-4 ꞌ, H-
4OMe/C-4OMe, H-6OMe/C-6OMe. 
  In the HMBC spectrum (Table 3.5,  Figure 3.16) the cross-peak were observed 
between  H- to C-, C-1',  H-β to C-, C-1' , C-, H-2' to C-3', C- 4', C-α, H-3' to C-
2',C-4' , H-4' to C-3',C-6' and H-5' to C-6', H-3 to C-1, C-4, C-2, H-5 to C-1, C-4, C-6, 
H-4 OMe to C-4OMe and  H-6-OMe to C-6-OMe. 
 Comparison of the empirical data with the literature values of the known 
compound, it was confirmed that compound LOB15 was flavokawain B, chalcone.      
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Table 3.5: 
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of flavokawain B  
      LOB15    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Position 
1
H-NMR(   J in HZ) 13C-NMR(  c) 
 
1 
 
- 
 
105.4 
 
2 
 
- 
 
152.1 
 
3 
 
6.91 (1H, s) 
 
93.9 
 
4 
 
- 
 
164.2 
 
5 
 
6.09 (1H, s) 
 
93.9 
 
6 
 
- 
 
159.5 
 
1ꞌ 
 
- 
 
136.5 
 
3ꞌ,4,5ꞌ 
 
7.38-7.43 (3H, m) 
 
131.7 
 
2′,6′ 
 
7.62-7.65 (2H, m) 
 
130.7 
 
β 
 
 
7.87(1H, d,15.2) 
 
129.7 
 
α 
 
8.14 (1H, d,15.6) 
 
144.5 
 
 
 
- 
 
193.5 
 
4-OMe 
 
3.84 (3H, s) 
 
57.1 
 
6-OMe 
 
 
3.91(3H, s) 
 
 
62.5 
 
 
OH 11.96 (1H, s) - 
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 3.1.4     Flavanone LOB2: (+)-Pinocembrin  
   
                                            
                                            
                                                               
LOB2 
 Flavonoid LOB2, (+)-pinocembrin with IUPAC name 5, 7-dihydroxy -2(S)-
phenyl chroman-4H-one was afforded as a yellow amorphous solid with [α]D
25
=+2.81 
(2. 00×10
-4
 g/100 mL, MeOH). The structure of LOB2 has the same skeleton with 
LOB4 and LOB7 which have been discussed before. In the UV spectrum, the 
absorption maxima at max (MeOH) nm (log Ɛ) 241 (1.519) and 290 (2.783) 
(Jayaprakasam et al., 1999). Its IR spectrum showed absorption bands at υmax 3417 cm
-1
 
for hydroxyl group and 1640 cm
-1
 assigned for chelated α, β unsaturated carbonyl. The 
molecular formula of LOB2 was established as C15H12O4 on the basis of ESI-MS 
(negative mode): m/z 255.0475 [M - H]
-
. MS/MS: m/z (relative abundance) 256.07 
(Neacsu et al.,  2007).                        
 
 
 
 
 
 
 
 
Figure 3.16: LC-MS Spectrum of (+)-Pinocembrin LOB2 
 
  
 
  
3ꞌ,4ꞌ,5ꞌ 
3 
5 
 
[M-1]
+
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The 
1
H NMR spectrum (Table 3.6, Figure 3.17) and 
13
C NMR spectrum 
(Table3.6, Figure 3.18) assembled the data for compound LOB7 except the hydroxyl 
group at C-7 appeared at δ 11.8 as a singlet which was overlapped with OH group at C-
5 in the 
1
H NMR and the C-7 resonated at δ 165.7 in 13C NMR.  
 Based on the spectroscopic data of LOB2 and comparison with the literature 
values, it was confirmed that compound LOB2 was (+)-pinocembrin (Bick et al ., 1972; 
Geoigina N et al.,  2009; Yenjai et al., 2009). 
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Table 3.6: 
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data od (+)-Pinocembrin 
      LOB2 
   
 
 
 
 
 
Postion 
 
1
H-NMR(   J in HZ) 
 
 
 
13
C-NMR   c) 
 
1 
 
- 
 
- 
 
2 
 
5.33 (1H, dd, 13.6, 3.5) 
 
79.0 
 
3 
 
2.62 (1H, dd, 17.4, 3.2, H-3α) 
3.01(1H, dd, 17.3, 13.5, H-3β) 
 
43.2 
 
4 
-  
195.6 
 
4a 
-  
102.8 
 
5 
-  
164.2 
 
6 
 
5.33 (1H ,d, 2.2) 
 
96.8 
 
7 
-  
165.7 
 
8 
 
5.94 (1H, d, 2.2) 
 
95.6 
 
 
8a 
-  
163.0 
 
1ꞌ 
-  
138.3 
 
2ꞌ,6ꞌ 
 
7.31-7.45 (2H, m) 
 
126.2 
3',4',5' 7.31-7.45(3H, m) 128.8 
 
5-OH 
 
11.81(1H, s) 
 
- 
 
7-OH 
 
11.81(1H, s) 
 
- 
92 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
93 
 
  
 
 
94 
 
3.1 .5 Linderone LOB28: Linderone 
 
 
   
 
     LOB28 
 Linderone LOB28 with IUPAC name (E)-2-(1-hydroxy-3-phenylprop-2-en-1-
ylidene)-4,5-dimethoxycyclopent-4-ene-1,3-dione was afforded as a yellow crystal with 
m.p 92 
o
C (Oh et al., 2005). In UV spectrum, absorption maxima was observed at max 
(MeOH) nm (log Ɛ) 246 (1.529) and 364 (1.631). Its IR spectrum showed absorption 
bands at υmax 3435 cm
-1
 assigned for hydroxyl group and 1632 cm
-1
 for conjugated 
carbonyl groups. The LC-MS (positive mode) spectrum showed an intense 
pseudomolecular ion peak, [M+H] at m/z 287.0677 corresponding to the molecular 
formula of C16H14O5. 
 
 
 
 
 
 
 
Figure 3.19: LC-MS Spectrum of Linderone LOB28 
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The 
1
H NMR spectrum of linderone LOB28 (Table 3.7, Figure 3.20) exhibited 
two distinct methoxyl signals at δ 3.91 and δ 4.08  which were most probably positioned 
at C-4 and C-5. The aromatic protons gave a three signal at  7.41 (H-3′, H-5′), 7.61 
attributed to (H-2′, 6′) and  7.72 belongs to H-4′. One signal appeared as a singlet at  
11.51 was assigned for OH group. The above observations were reinforced by COSY 
(Table 3.7, Figure 3.21) experiment which displayed correlations of H-3′/H-4', H-5'/H-
6’.  
 The 
13
C NMR and DEPT spectra (Table 3.7, Figure 3.22) established the total of 
sixteen carbon signals; two methoxyls at δ 60.0 (C-4) and δ 59.9 (C-5). Seven methines 
at δ 117.7 (C-β),  141.5 (C-),  128.9 (C-3ꞌ|), 128.9 (C-5ꞌ) ,  128.5 (C-2'), 128.5 (C-6') 
and  130.4 (C-4'), seven quaternary carbons resonated at δ 193.3 (C-1),  101.8 (C-2), 
184.8 (C-3), 148.2 (C-4), 145.3 (C-5),  164.6 (C-α)  ad 135.0 (C-1′). 
 In HSQC (Table 3.7, Figure 3.23) spectrum showed the correlation between 
hydrogen and carbon  such as H-2'/C-2', H-6'/C-6', H-3'/C-3', H-4'/C-4',H-5'/C-5', H-
4/C-4OMe and H-5/C-5OMe (Hiok-Huang et al.  1990).  
 In the HMBC spectrum (Table 3.7, Figure 3.24) the cross-peak were observed 
between H-2ꞌ to C-3', H-2' t0 C-4', C-1', H-6' to C-5', H-6' to C-4', H-4' to C-3', C-5, H-
4OMe to C-4OMe, H-5OMe/C-5OMe. 
 Based on the spectroscopic data of LOB28 and comparison with the literature 
values, it was confirmed that compound LOB28 was (E)-2-(1-hydroxy-3-phenylprop-2-
en-1-ylidene)-4,5-dimethoxycyclopent-4-ene-1,3-dione or linderone (Haibo Tan et al. 
2011). The structure of compound LOB28 was also confirmed by x-ray crystallography 
and this x-ray structure was the first time reported (see Figures 3.25 and 3.26). 
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Table 3.7: 
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data  of linderone LOB28 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Position 
 
 
 
1
H-NMR( J in HZ) 
 
13
C-NMR 
(c) 
 
1 
 
- 
 
193.3 
 
2 
 
- 
 
 
101.8 
 
3 
 
- 
 
184.8 
 
 4 
 
- 
 
148.2 
 
   5 
 
- 
 
145.3 
 
α 
 
- 
 
164.6 
 
β 
 
- 
 
117.7 
 
γ 
 
- 
 
141.5 
 
1ꞌ 
 
- 
 
135.0 
 
2ꞌ,6ꞌ 
 
7.61(2H, m) 
 
128.5 
 
3ꞌ,5ꞌ 
 
7.41(2H, m) 
 
128.9 
 
4ꞌ 
 
7.41(1H, m) 
 
130.4 
 
4-OMe 
 
3.91(3H, s) 
 
60.0 
 
5-OMe 
 
4.08 (3H, s) 
 
59.9 
 
OH 
 
11.51(1H, s) 
 
- 
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Figure 3.25: X-ray Crystallographic Structure monoclinic of LOB28 
(Hosseinzadeh, et al., 2011) 
  
Empirical formula 
 
C16H14O5 
Formula weight 
 
Mr = 286.27 
Crystal system 
 
Monoclinic 
Space group 
 
P 21/c 
a (Å) 7.3195 (5) Å 
b (Å) 9.8635 (7) Å 
c (Å) 18.6724 (11) Å 
β () 96.586 (6)° 
  
Volume (Å
3
) 
 
1339.17 (15) Å
3
 
Z value 
 
4 
Calculated density, Dcalc (Mg/m
3
) 
 
1.420 Mg m
−3
 
Absorption coefficient, µ (mm
-1
) 
 
 0.71073 Å 
Crystal size (mm) 
 
0.20 × 0.20 × 0.10 mm 
Cell determination, 2θ range () 
 
Cell parameters from 4706 reflections 
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Figure 3.26: X-ray Crystallographic Structure Triclinic of LOB28 
( Hosseinzadeh, et al., 2011) 
Empirical formula 
 
C16H14O5 
Formula weight 
 
Mr = 286.27 
Crystal system 
 
Triclinic 
Space group 
 
P 21/c 
a (Å) 5.4055 (2) Å 
b (Å) 11.2731 (3) Å 
c (Å) 11.6441 (3) Å 
α () 72.070 (1)° 
β () 83.088 (1)° 
γ () 77.760 (1)° 
  
Volume (Å
3
) 
 
77.760 (1)° 
Z value 
 
2 
Calculated density, Dcalc (Mg/m
3
) 
 
1.444 Mg m
−3
 
Absorption coefficient, µ (mm
-1
) 
 
0.71073 Å 
Crystal size (mm) 
 
0.26 × 0.19 × 0.11 mm 
Cell determination, 2θ range () 
 
Cell parameters from 2073 reflections 
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3.1.6 Linderone LOB25: Linderone A 
                                        
 
       
LOB 25 
 Linderone A LOB25 with IUPAC name 2-cinnamoyl-3-hydroxy-4,5-
dimethoxycyclopenta-2,4-dienone was afforded as a yellow amorphous solid.  The UV 
spectrum showed the absorption peak at max (MeOH) nm (log Ɛ) 246 (1.291) and 309 
(1.580) indicated the presence of conjugated carbon-carbon double bond and carbonyl 
group. Its IR spectrum showed absorption bands at υmax 3431 hydroxyl group, 1639, 
carbonyl group. The LC-MS (positive mode) spectrum showed an intense 
pseudomolecular ion peak, [M+H] at m/z 287.0677 corresponding to the molecular 
formula of C16H14O5. 
 
     
 
 
 
 
 
Figure 3.27: IR Spectrum of Linderone A LOB25 
 
    
H-2ꞌ,6ꞌ/C-  
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 Figure 3.28: LC-MS Spectrum of Linderone A LOB25 
 
 The 
1
H NMR spectrum (Table 3.8, Figure 3.29) exhibited one signal appeared as 
singlet at δ 4.15 coresponding to two methoxyl groups positioned at C-4 and C-5. A 
peak at δ 7.25 was observed as a doublet which was assigned for H-β and at δ 8.04 for 
H-. The aromatic protons gave a doublet signal  7.57 attributed to H-2ꞌ and H-6ꞌ and 
multiplate signal at  7.55 for H-3ꞌ, H-5ꞌ and one signal appeared as singlet at δ 7.41 
coresponding for H-4ꞌ. The above observations were reinforced by COSY (Table 3.8, 
Figure 3.30) experiment which displayed correlations of H-β/H- and H-2ꞌ/H-3ꞌ, H-3'/H-
4ꞌ, H-4 ꞌ /H-5ꞌ, H-5'/H-6ꞌ. 
 The 
13
C NMR and DEPT spectra (Table 3.8, Figure 3.31) established the 
resonances of seventeen carbons; two methoxyls at δ 60.1 coressponding to methyl 
group at C-4 and C-5. Seven sp
2
 methines appeared at δ 120.2 (C-β), 136.7 (C-), 128.1 
(C-3ꞌ), 128.1 (C-5ꞌ), 129.1 (C-2′), 129.1 (C- 6′) and  130.0 (C-4′). seven quaternary 
carbons resonated at δ 97.1 (C-2), 187.8 (C-3), 145.1 (C-4), 145.1 (C-5) and  135.2 (C-
1′) and two carbonyl signals appeared at  191.5 (C-1) and  153.4 (C-α).  
 The HMQC spectrum (Table 3.8, Figure 3.32) showed the correlation between 
hydrogen to their respective carbon atoms; H-/C-, H-β/C-β, H-2/ C-2, H-3/ C-3, H-
[M+1]
+
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4/ C-4, H-5/ C-5 and H-6/ C-6. 
 In the HMBC spectrum (Table 3.8, Figure 3.33) the cross-peak were observed 
between H-2ꞌ to C-4, C-3', H-γ to C-α, C-1', H-β to C-α,  H-3ꞌ to C-4, C-2', H-4OMe to 
C-4-OMe and H-5OMe to C-5-OMe. 
 Based on the spectroscopic data of LOB25, it was confirmed that compound 
LOB25 is a new compound and has never been reported before. This compound named 
as 2-cinnamoyl-3-hydroxy-4,5-dimethoxycyclopenta-2, 4-dienone or linderone A. 
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 Table 3.8: 1D (
1
H and 
13
C ) and 2D (COSY and HMBC) NMR spectral data of Linderone A 
       LOB25 
 
 
 
 
 
 
  
 
 
 
 
Position 
 
1
H-NMR(   J in HZ) 
 
13
C-NMR 
  c) 
 
COSY 
 
HMQC 
 
HMBC 
 
 
1 
 
- 
 
 
191.5 
- - - 
 
2 
-  
97.1 
- - - 
 
3 
-  
187.8 
- - - 
 
4 
-  
145.1 
- - - 
 
5 
-  
145.1 
- - - 
 
 
α 
-  
153.4 
- - 
 
- 
 
β 
 
7.25 (1H, d, 17.7) 
 
120.2 
 
H- 
 
H-   
 
α 
 
 
 
8.04 (1H, d, 17.7) 
 
136.7 
 
H-β 
 
H- 
 
1,α 
 
1ꞌ 
-  
135.2 
- - 
 
- 
 
 
2ꞌ,6ꞌ 
 
7.57 (2H, m) 
 
129.1 
 
H-3ꞌ,5ꞌ 
 
H-2’,6’ 
 
4’, 
 
3ꞌ ,5ꞌ 
 
7.55 (2H, m) 
 
128.1 
 
H-2ꞌ,6ꞌ,4 ꞌ 
 
H-3’,5’ 
 
4 
 
4ꞌ 
 
7.41 (H, m) 
 
130.0 
 
H-3ꞌ,5ꞌ 
 
H-4’ 
- 
 
 
4-OMe 
 
4.15 (3H, s) 
 
60.1 
 
H-OMe 
 
H-4OMe 
 
5-OMe 
 
5-OMe 
 
4.15 (3H, s) 
 
60.1 
 
H-OMe 
 
H-5OMe 
 
4-OMe 
108 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
109 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
110 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
111 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
112 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                         
 
 
 
 
 
 
 
 
 
 
113 
 
3.1.7       Linderone LOL34: Methyllinderone  
                                        
 
 
LOL34 
 Linderone LOL34 with IUPAC name (E)-2-(1-methoxy-3-phenylprop-2-en-1-
ylidene)-4, 5-dimethoxycyclopent-4-ene-1, 3-dione was isolated as a yellow amorphous 
solid.  The UV spectrum exhibited absorption maxima at max (MeOH) nm (log Ɛ) 241 
(0.908) and 357 (1.158). Its IR spectrum showed absorption bands at υmax 1702 cm
-1
 
indicated  the presence of carbonyl group. The LC-MS (positive mode) spectrum 
showed an intense pseudomolecular ion peak, [M] at m/z 300.88 corresponding to the 
molecular formula of C17H16O5 (Oh et al., 2005). 
  
 
     
 
 
 
 
Figure 3.34: LC-MS Spectrum of methyllinderone LOL34 
 
  The  
1
H NMR ( Table 3.9, Figure 3.35), 
13
C-NMR, COSY, HMQC and 
HMBCspectra showed the same pattern with that of linderone LOB28 except for the  
 
[M]
+
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hydroxyl group in LOB28 was replaced by methoxyl group in LOL34. The methoxyl 
group at C-α appeared at  4.32 in 1H-NMR and  64.4 in 13C-NMR (Table 3.9, Figure 
3.36) (oh  et al ., 2005).Based on the spectroscopic data of  LOL34 and comparison 
with the literature values, it was confirmed that compound LOL34 was (E)-2-(1-
methoxy-3-phenylprop-2-en-1-ylidene)-4, 5-dimethoxycyclopent-4-ene-1, 3-dione or 
methyllinderone.     
 Table 3.9: 
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of Methyllinderone 
       LOL34 
                                    
 
    
 
 
Position 
 
1
H-NMR(, J in HZ) 
 
13
C-NMR 
(C) 
 
1 - 
188.7 
 
 
2 
-  
110.1 
 
3 
-  
185.9 
 
4 
-  
150.2 
 
5 
-  
148.4 
α -  
165.3 
 
β 
 
7.52 (1H, d, 17.5) 
 
120.2 
 
 
 
7.95 (1H, d, 15.8) 
 
142.5 
 
1ꞌ 
-  
135.7 
 
2ꞌ,6ꞌ 
 
7.58 (2H, m) 
 
129.1 
 
3ꞌ,5ꞌ 
 
7.52 (2H, m) 
 
128.5 
 
4ꞌ 
 
7.52 (H, m) 
 
131.4 
 
4,5-OMe 
 
4.21(3H, s) 
 
60.0 
 
-OMe 
 
4.32 (3H, s) 
 
64.4 
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  3.1.8 Flavonol LOL5: Kaempferol  
 
 
 
 
LOL5 
 Flavonol LOL5 with IUPAC name 3, 5, 7-trihydroxy-2-(4-hydroxy phenyl)-4H-
chromen-4-one) was afforded as pale yellow amorphous solid. The UV spectrum 
exhibited absorption maxima at max (MeOH) nm (log Ɛ) 253 (0.434) and 364(0.616). 
The IR spectrum showed absorption bands at υmax 3431 cm
-1
 indicated the presence of 
hydroxyl group and 1646 cm
-1
 for carbonyl group stretching. The LC-MS (negative 
mode) spectrum showed an intense pseudomolecular ion peak, [M-1] at m/z 285.04 
corresponding to the molecular formula of C15H10O6. 
 
 
 
 
 
 
 
 
Figure 3.37: LC-MS Spectrum of Kaempferol LOL5 
  
 
 
 
  
 
 
[M-1] 
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The 
1H NMR spectrum (Table 3.10, Figure 3.38) showed a one proton singlet at δ 6.15 
which was assigned for aromatic proton at H-6 and one proton singlet δ 6.41 for 
aromatic proton at H-8. Furthermore, the peak with two protons at δ 6.91 appeared as 
doublet of doublet was assigned to H-2' and H-6'. Another doublet of doublet peak with 
two protons at   8.00 was assigned for H-5' and H-3'. The COSY spectrum (Table 3.10, 
Figure 3.39) showed the proton-proton correlation for H-2'/H-3' and H-5'/H-6'.  
 The 
13
C NMR spectrum (Table 3.10, Figure 3.40) established the resonances of 
fifteen carbon atoms.  Six sp
2
 methines appeared at δ 92.1 (C-6), 95.3 (C-8), 114.2 (C-
3', 5'), 131.8 (2ꞌ,6ꞌ)  and nine quaternary carbons resonated at  δ 110.4 (C-4a), 125.5 (C-
1'), 135.4 (C-3), 142. 7 (C-2), 142.7 (C-4'), 152.1 (C-8a), 155.8 (C-5), 161.2 (C-7) and 
198.5 (C-4).  
 Based on the spectroscopic data of  LOL5 and comparison with the literature 
values, it was confirmed that compound  LOL5 was kaemferol (Kim et al., 2006; Raoa 
et al., 2009). 
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Table 3.10: 
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral daata of Kaempferol LOL5 
 
 
 
Position 
 
1
H-NMR( J in HZ) 
 
13
C-NMR 
(c) 
 
1 
- - 
 
2 
- 
 
 
142.7 
 
3 
- 
 
 
135.4 
 
4 
-  
198.5 
 
4a 
-  
110.4 
 
5 
-  
155.8 
 
6 
 
6.15 (1H, s) 
 
92.1 
 
7 
-  
161.2 
 
8 
 
6.41(1H, s) 
 
95.3 
 
 
8a 
-  
152.1 
 
1ꞌ 
-  
125.5 
 
2ꞌ,6ꞌ 
 
8.00 (2H, dd, 8.5) 
 
131.8 
 
3’,5’ 
 
6.91(2H, dd, 8.6) 
 
114.2 
 
4’ 
 
- 
 
142.7 
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3.1.9 Alkaloid LOL20: (+)-laurotetanine  
 
                                                            
  
 
LOL 20 
 Alkaloid LOL20 laurotetanine with IUPAC name 4H-dibenzoquinolin-9-ol, 5, 6, 
6a,7-tetrahydro-1,2,10-trimethoxy with   25D = +29.4º (2.00×10
-4
 g/100 mL, MeOH) 
was afforded as a dark brown amorphous solid (Govindachari et al.,  1977). The UV 
spectrum showed absorptions at max (MeOH) nm (log Ɛ), 217 (2.345) and 242 (3.098) 
nm thus suggesting a 1, 2, 9, 10-tetrasubstituted aporphine skeleton. The IR spectrum 
showed absorption peak at 3429 cm
-1
 indicated presence of NH group and also hydroxyl 
group(Guinaudeau et al.,  1994). The LC-MS spectrum showed an intense 
pseudomolecular ion peak, [M+H]
+
 at m/z 328.1566 corresponding to the molecular 
formula of C19H21NO4.            
 
 
  
 
 
 
                       
Figure 3.41: LC-MS Spectrum of (+)-laurotetanine LOL20 
 
  
 
 [M+H]
+
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The 
1
H-NMR spectrum of LOL20 (Table 3.11, Figure 3.42) exhibited three 
distinct methoxyl groups which were observed as singlets at δ 3.64, δ 3.87 and δ 3.89 
corresponding to  C1-OMe, C2-OMe and C10-OMe respectively. Seven aliphatic protons 
were observed at a high field region between δ 2.71- 3.81 corresponding to H-4, H-5, H-
6a and H-7.  One proton singlet observed at δ 6.57 which was assigned to H-3 
confirming the subtitutions at  C-1 and C-2. Furthermore, the singlet at δ 6.77 was 
attributed to H-8. This value is typical of that  9, 10-substitution pattern ( Guinaudeau et 
al.,  1975; Johns et al., 1970). It was clear that, the low field signal of H-11 at δ 8.06 
suggested that C-10 was substituted by a methoxyl group. 
 The 
13
C-NMR and DEPT spectra (Table 3.11, Figure 3.43) established the 
resonances of nineteen carbons three methoxyls resonated at  δ 60.2 (C-1), 56.1 (C-2) 
and 55.9 (C-10) , three methylenes at δ 29.0 (C-4), 43.1 (C-5) and 36.5 (C-7),  four 
methines at δ 110.8 (C-3), 53.7 (C-6a), 113.9 (C-8) and 111.3 (C-11)  and nine 
quaternary carbons at  δ 144.3 (C-1), 152.2 (C-2) , 129.0 (C-3a), 126.8 (C-1a), 127.4 (C-
1b), 124.0 (C-11a),  129.7 (C-7a), 144.9 (C-10) and   145.3 (C-9).  
 The HMQC spectrum (Table 3.11, Figure 3.44) showed the connectivity 
between proton and carbon:  H-3/C-3, H-4/C-4, H-7/C-7, H-6a/C-6a, H-5/C-5, H-8/C-8, 
H-1OMe/C-1OMe, H-2OMe/C-2OMe, H-10OMe/C-10OMe and H-11/C-11.  
 In the HMBC spectrum (Table 3.11, Figure 3.45) the cross-peaks were observed 
between H-3 to C-4, C-1b, C-1, C-2, H-4 to C6a, C1b, H-5 to C-6a, C-3a, H-7 to C-6a, 
C-8, C-1b, C-11, H-8 to C-10, C-11a, C-7, H-11 to C-7a, C-9, 10-OCH3 to C-10, 2-
OCH3 to C-2 and 1-OCH3/C-1. 
 The structural elucidation was completed by the help of the 2D experiment. 
according to  comparison of the spectroscopic data obtained with the literature values, it 
was confirmed that alkaloid LOL20 was laurotetanine ( Mukhtar et al.,  2003). 
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Table 3.11: 
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of   (+)-laurotetanine 
         LOL20 
 
 
 
 
 
 
 
Position 
 
1
H-NMR( J in HZ) 
 
13
C-NMR 
(c) 
1 - 144.3 
1a   - 126.8 
1b - 127.4 
2    - 152.2 
3 6.57(1H, s ) 110.8 
3a   - 129.0 
4 2.74 (2H, dd,  13.6, 4.6) 29.0 
5 3.01 (2H, dd, 12.9, 4.1) 
3.6, m 
43.1 
6a   3.80 (1H, dd, 4.4, 13.2) 53.7  
7   2.64 (2H, d, 13.6) 36.5 
7a   - 129.7 
8    6.77 (1H, s ) 113.9 
9 - 145.3 
10 - 144.9 
11 8.06 (1H, s) 111.3 
11a - 124.0                     
1-OCH3  3.64 (3H, s) 60.2 
2-OCH3  3.86 (3H, s) 56.1 
10-OCH3 3.87(3H, s) 55.9 
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3.1.10 AlkaloidLOL35: N-Methyllaurotetanine 
                                          
 
 
 
 
LOL 35 
 Alkaloid LOL35 N-methyllaurotetanine with  25D =+15.0 (2. 00×10
-4
 g/100 mL 
, MeOH)  was isolated as a brown amorphous solid and its UV spectrum showed 
absorptions at   max (MeOH) nm (log Ɛ)   222 (2.098), 280 (1.987) and 320 (3.564) nm 
(Goodwin et al.,  1958) indicated the aporphine substituted at positions C-1, C-2, C-9 
and C-10 (Shamma et al., 1964). The IR spectrum showed a broad band of hydroxyl 
absorption at 3391 cm
-1
. The LC-MS revealed the precence a pseudomolecular ion peak, 
[M]
+
 at m/z 401.1625 consistent with the molecular formula of C24H35NO4. 
                   
 
 
 
     
   
Figure 3.46: LC-MS Spectrum of N-methyllaurotetanine LOL35 
 The 
1
H and 
13
C NMR spectrum (Table 3.12, Figure 3.47) of LOL35 have 
similar structure as (+)-laurotetanine LOL20 except that compound LOL35 has N-
methyl substitution (Wu et al. 1980).  
   [M]
+
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 Based on the spectroscopic data of LOL35 and comparison with the literature 
values, it was confirmed that compound LOL35 was known N-methyllaurotetanine. 
Table 3.12: 
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data   of N-methyl      
         laurotetanine LOL35 
   
 
 
 
 
 
 
Position 1H-NMR( J in HZ) 
13
C-NMR 
(c) 
1 - 144.2 
1a - 127.1 
1b - 127.2 
2 - 152.1 
3 6.58 (1H, s) 110.3 
3a - 128.9 
4 2.68 (2H,  d, 3 .6, 3.1) 29.2 
5 2.51 (2H,  d, 3.6, 3.0 ( dd, 5.9, 11.9) 53.3 
6a 2.99 (1H, m).2.6 ( 2H,  d, 3.2) 62.6 
7 2.95 (2H,  d,  2.12) 34.3 
7a - 130.1 
8 6.82 (1H, s) 113.9 
9 - 144.8 
10 - 145.3 
11 8.06 (1H, s) 111.2 
11a - 124.0 
1-OMe 3.65 (3H, s) 60.2 
2-OMe 3.88 (3H, s) 55.8 
10- OMe 3.90 (3H, s) 56.1 
N-CH3 2.54 (3H, s) 44.0 
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3.1.11 Alkaloid LOL50: (+)-Norboldine           
                    
                 
 
 
LOL50 
 Alkaloid LOL50, Norboldine with  
25
D = +9.87 (2. 00×10
-4
 g/100 mL, 
MeOH), was isolated as a brown amorphous solid (Pachler et al., 1965). The UV 
spectrum showed absorptions max (MeOH) nm (log Ɛ)  at 276 (3.765) and 317 (2.987) 
nm (Sangster et al., 1965).
 
The IR spectrum showed broad band at 3432 cm
-1
 due to the 
presence of OH and NH functional groups. The LC-MS revealed a pseudomolecular ion 
peak, [M+H]
+
 at m/z 314.1397 suggesting a molecular formula of C18H19NO4 
(Guinaudeau et al., 1994). 
             
  
 
 
 
 
                          Figure 3.49: LC-MS Spectrum of (+)-norboldine LOL50 
 The 
1
H and 
13
C NMR spectra (Table 3.13, Figure 3.50) and (Table 3.13, Figure 
3.51) of compound LOL50 have the same pattern as LOL20 except that the C-2 in 
LOL50 bearing the OH group (Weber et al., 1986).   
    [M+H]
+
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 Based on the spectroscopic data of  LOL50 and comparison with the literature 
values, it was confirmed that compound LOL50 was (+)- norboldine. 
 Table 3.13: 
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral  data of (+) - Norboldine 
         LOL50  
 
 
 
 
Position 
1
H-NMR(   J in HZ) 
       
13
C-NMR 
  c) 
1 - 148.1 
1a - 125.6 
1b - 128.0 
2 - 141.9 
3 6.58 (1H, s) 113.7 
3a - 130.2 
 
4 
 2.68 (1H, m, Hα)  
 2.91(1H, m, Hβ)  
 
29.0 
 
5 
 2.94 (1H, m , Hα) 
  3.29 (1H, m ,Hβ) 
 
43.3 
6a 3.72 (1H, dd, 4.2, 13.1) 53.8 
7   2.60 (2H, m ) 36.7 
7a - 130.1 
8 6.74 (1H, s) 114.1 
9 - 145.1 
10 - 145.6 
11 7.84 (1H, s) 110.2 
11a - 123.7 
1-OCH3 3.29 (3H, s) 60.4 
10-OCH3 3.72 (3H, s) 56.2 
101 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
102 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
103 
 
3.1.12 Alkaloid LOL63: (+)-10-O-Methy-N-methyllhernovine    
                                                    
                                                  
 
 
LOL63 
 Alkaloid LOL63, (+)-10-O-Methyl-N-methylhernovine with  25D =+4.50
 
(2.00×10
-4 
g/100mL, MeOH)
 
was afforded as a brownish amorphous powder 
(Buchanan, et al.,  2007). The UV spectrum showed absorptions  at max (MeOH) nm 
(log Ɛ) 244 (1.65) and 276 (2.76) nm, a characteristic values for 1, 2, 10, 11-
tetrasubstituted aporphine. The IR spectrum showed absorption peak at 3390 cm
-1
 
indicated the presence of hydroxyl group in the structure (Guinaudeau et al., 1994).The 
LC-MS spectrum showed an intense pseudomolecular ion peak at m/z 328.20 [M+H]
+
 
corresponding to the molecular formula of C19H21NO4. 
 
 
 
 
 
 
 
Figure 3.52: LC-MS Spectrum of (+)-10-O-Methyl-N-methylhernovine LOL63 
  
 The 
1
H-NMR spectra (Table 3.14, Figure 3.53) exhibited the same spectra 
pattern with compound LOL50 except the position C-11 in LOL63 was substituted 
with methoxyl group and C-9 was unsubstituted.  
 Based on the spectroscopic data of  LOL63 and comparison with the literature 
[M+H]
+
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values, it was confirmed that compound LOL63 was (+)-O10-N-methylhernovine 
(Shamma  et al.,  1964). 
 
Table 3.14: 
1
H NMR (400 MHz) spectral data of (+)-10-O-Methyl-N-methylhernovine    
        LOL63 
 
 
 
 
 
 
 
Position 
 
1
H-NMR(   J in HZ) 
1 - 
1a - 
1b - 
2 - 
3 6.66 (1H, s ) 
3a - 
4 2.68 (2H, dd, 14.0, 4.1) 
 
5 
2.82 (2H, dd, 12.0, 4.1) 
3.42(2H, m ) 
6a 3.58 (1H, dd, 4.4, 13.4) 
7 2.70 (2H, d, 13.2) 
7a - 
8 7.45(1H, d, 7.8) 
9 6.80(1H, d, 7.8) 
10 - 
11 - 
11a - 
1-OCH3 3.58 (3H, s) 
10-OCH3 3.85 (3H, s) 
11-OCH3 3.85 (3H, s) 
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3.1.13 Alkaloid LOL65: (+)-Norisoboldine 
 
                
LOL 65 
 Alkaloid LOL65, (+)-norisoboldine with  25D =+11.52
 
(2.00×10
-4 
g/100 mL, 
MeOH)
 
was afforded as a brown amorphous solid. The UV spectrum showed 
absorptions at max (MeOH) nm (log Ɛ)   241 (1.87), 250 (1.98) and 270 (2.98) nm, a 
characteristic values for 1, 2, 9, 10-tetrasubstituted aporphine. The IR spectrum showed 
absorption peak at 3436 cm
-1
 indicated  the presence of hydroxyl group in the structure 
(Guinaudeau et al., 1994).The LC-MS spectrum showed an intense pseudomolecular ion 
peak [M+H]
+
 at m/z 314.1399 corresponding to the molecular formula of C18H19NO4. 
 
 
 
 
 
 
 
                                
Figure 3.54: LC-MS Spectrum of (+)- Norisoboldine LOL65 
   
 The 
1
H and 
13
C NMR spectra (Table 3.15, Figure 3.55) of LOL65 shared the 
same characteristics  with that of LOL50 but the only difference was the substitution 
     [M+H]
+
=314.1399 
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pattern at ring A. The position C-1 and C-2 in LOL50 were subtituted with methoxyl 
and hydroxyl group, respectively, where as in LOB65 these positions were substituted 
with hydroxyl and methoxyl group, respectively.  
 Based on the spectroscopic data of  LOL65 and comparison with the literature 
values, it was confirmed that compound  LOL65 was (+)-norisoboldine (Marsaioli et 
al., 1979) 
Table 3.15: 
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of  (+)- Norisoboldine 
         LOL65 
 
 
 
Position 
 
1
H-NMR( J in HZ) 
13
C-NMR 
(c) 
1 - 148.0 
1a - 124.9 
1b - 128.1 
2 - 142.0 
3 6.53(1H,  s) 113.2 
3a - 130.6 
4 2.68 (1H, m, Hα)  2.90 (1H, m , Hβ) 30.1 
5 2.85 (1H, m, Hα)  3.25 (1H, m , Hβ) 43.6 
6a 3.70 (1H, dd, 4.7, 13.6) 54.0 
7 2.85 (2H, m ) 36.1 
7a - 130.0 
8 6.7 9 (1H, s) 114.1 
9 - 145.6 
10 - 145.9 
11 7.98 (1H, s) 111.4 
11a - 124.0 
2-OCH3 3.88 (3H, s) 60.4 
10-OCH3 3.90 (3H,s) 57.0 
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3.2 Chemical constituents from bark and leaves Litsea costalis (Nee) Kosterm 
 The extraction, isolation, purification and structural elucidation of the 
compounds from the bark and leaves of Litsea costalis have been performed and the 
procedure used was the same with the compounds isolated from Lindera oxyphylla. 
Eight compounds were isolated from the bark of Litsea costalis and these compounds 
are 3,4-dimethoxycinnamaldehyde LCB7, 2-hydroxy-5-methoxybenzaldehyde LCB11, 
2, 5-dimethoxybenzaldehyde LCB15, 4,4'-diallyl-5,5'-dimethoxy-[1,1'-biphenyl]-2,2'-
diol LCB3, 4,4'-diallyl-6,6'-dimethoxy-[1,1'-biphenyl]-2,2'-diol LCB9,2,2'-oxybis(4-
allyl-1-methoxybenzene) LCB10, 1,2-bis(5-allyl-2-methoxyphenyl)hydrazine 
LCB17, (E)-4(4-hydroxy-1,1-dimethoxybut-2-en-1-yl) benzene-1, 2-diol LCB4 and 
(E)-4-styrylphenol  LCB58.  Seven compounds were isolated from the leaves of Litsea 
costalis and these compounds are cinnamide LCL4, 2,4-dimethoxybenzamide  LCL2, 
3,4-dimethoxybenzamide LCL5, 2S,4S-2-(3',4'-methylenedioxyphenyl)-5,7-
dimethoxychroman-4-ol LCL7, (+)-pinostrobin LCL9, (+)-onysilin LCL13, (+)-
pinocenbrin LCL14 , 4-allyl-1,2-dimethoxybenzene LCL15 and 4-allyl -
2methoxyphenol LCL17. The percentage yields of the isolated compounds were shown 
in (Table 3.16 and 3.17). 
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   Table 3.16: Chemical Constituents of  Bark  Litsea Costalis  
 
 
Compounds 
 
Types 
 
%Yield 
 
3, 4-Dimethoxycinnamaldehyde LCB7 
 
Aldehyde 
 
0.35 
 
2-Hydroxy-5-methoxybenzaldehyde    LCB11 
 
Aldehyde 
 
 
0.04 
 
2, 5-Dimethoxybenzaldehyde LCB15 
 
Aldehyde 
 
0. 1 
4,4'-Diallyl-5,5'-dimethoxy-[1,1'-biphenyl]-
2,2'-diol 
 
LCB3 
 
Neolignan 
 
0.05 
4,4'-Diallyl-5,5'-dimethoxy-[1,1'-biphenyl]-
2,2'-diol 
 
LCB9 
 
Neolignan 
 
0.05 
 
2,2'-Oxybis(4-allyl-1-methoxybenzene 
LCB10 
Biphenyl ether Lignan 30 
1,2-Bis(5-allyl-2-methoxyphenyl)hydrazine 
LCB17 
Phenyl hydrazine 
 
30 
(E)-4(4-hydroxy-1, 1-dimethoxybut-2-en-1-yl) 
benzene-1, 2-diol 
LCB4 
Phenolic compound 0.05 
(E)-4-styrylphenol 
 
LCB58 
 
Stilbene 
2.5 
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Table3.17: Chemical Constituents of  Leaves Litsea costalis  
 
 
Compounds 
 
Types 
 
%Yield 
 
3, 4-Dimethoxycinnamaldehyde LCL4 
 
Aldehyde 
 
0.6 
 
2,4- Dimethoxybenzamide   LCL2 
 
Amide 
 
0.3 
 
3,4- Dimethox benzamide   LCL5 
 
Amide 
 
 
2.33 
2S,4S-2-(3',4'-methylenedioxyphenyl)-5,7-
dimethoxychroman-4-ol 
LCL7 
 
Flavonoid 
 
2.5 
 
(+)-Pinostrobin LCL9 
 
Flavonoid 
 
1.0 
 
(+)- Onysilin LCL13 
 
Flavonoid 
 
 
2.5 
 
(+)-Pinocembrin   LCL14 
 
Flavonoid 
 
1.5 
 
4-allyl-1,2-dimethoxybenzene LCL15 
 
Lignan 
 
1.5 
 
4-allyl-2-methoxyphenol LCL17 
 
Lignan 
 
1.5 
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3.2.1 Aldehyde LCB7:  3', 4-Dimethoxycinnamaldehyde 
                            
                                       
 
 
LCB 7 
 Compound LCB7, 3', 4'-Dimethoxycinnamaldehyde was obtained as brown oil. 
The UV spectrum showed absorption bands at  max (MeOH) nm (log Ɛ) 306 (1.847) 
and 326 (1.876) nm indicating a highly unsaturated chromophoric system. The IR 
spectrum showed the presence of conjugated carbonyl at νmax 1668 cm
-1
 and C-H 
stretching of aldehyde group at νmax 2848 cm
-1
. The LC-MS spectrum showed an intense 
pseudomolecular ion peak, [M-H] at m/z 191.0499 corresponding to the molecular 
formula of C11H12O3.       
 
 
 
 
                                                            
 
 
Figure 3.57: LC-MS Spectrum of 3',4'-Dimethoxycinnamaldehyde LCB7 
 
       
 
[M-H] 
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 The 
1
H-NMR spectrum (Table 3.18, Figure 3.58) showed the existence of an 
aldehyde group at δ 9.65. A peak at δ 3.95 appeared as a singlet with six protons were 
assigned for two methoxyls at positions C-3' and C-4'.   The aromatic proton at C-5' was 
resonated at  δ 6.97 as a doublet and the peak at δ 7.24 appeared as doublet of doublet 
with J values of 7.8 and 1.8 Hz belongs to proton at C-6' due to meta coupling with H-
2'. The aromatic proton at position C-2' was resonated at δ 7.06 as doublet with J value 
1.8 Hz due to meta coupling with H-6'. The COSY spectrum (Table 3.18, Figure 3.59) 
showed the correlations of H-2/H-3 and H-6ꞌ/H-5ꞌ. 
 The 
13
C-NMR and DEPT spectra (Table 3.18, Figure 3.60) showed 10 carbon 
signals consist of one carbonyl group, five methine groups and four quaternary carbons. 
The carbonyl group  resonated at δ 193.5 and two methoxyls resonated at δ 56.1 (C-3ꞌ 
and C-4ꞌ). Five methines were observed at δ 127.2 (C-2), 152.1 (C-3), 109.4 (C-2ꞌ), 
111.7 (C-5ꞌ) and 124.6 (C-6ꞌ), and four quaternary carbons resonated  at δ 193.5 (C-1), 
127.4 (C-1ꞌ), 147.8 (C-3ꞌ) and 149.5 (C-4ꞌ). The HMQC  data was tabulated in (Table 
3.18, Figure 3. 61 ) which showed the connectivity between proton to their respective 
and carbon atoms:  H-2/C-2, H-6/C-6, H-3/C-3, H-2/C-2,  H-5/C-5,  H-4OMe/C-
4OMe and H-3OMe/C-3OMe and  the HMBC spectrum (Table 3.18,  Figure 3.62) 
showed  the cross-peak  between H-1 to C-2, H-3 to C-2ꞌ, C-6ꞌ, C-1ꞌ, C-1, H-6ꞌ to C-2ꞌ, 
C-4ꞌ, H-2ꞌ to C-6ꞌ, C-4ꞌ, C-3ꞌ, H-5ꞌ to C-2, C-3ꞌ, H-3ꞌ,4ꞌOMe to C-3ꞌ, 4ꞌOMe. 
 Based on the spectroscopic data of  LCB7 and comparison with the literature 
values (Herath  et al., 1998), it was confirmed that compound  LCB7 was 3', 4'-
dimethoxycinnamaldehyde (Banwell et al.,  2004). 
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Table 3.18:
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of 3',4'-Dimethoxy 
         Cinnamaldehde  LCB7 
 
 
 
Position 
 
 
 
 
1
H-NMR(   J in HZ) 
 
13
C-NMR 
  c) 
 
1 
 
9.65 (1H ,d, 7.7) 
 
 
193.5 
 
2 
 
6.63 (1H, dd,15.8,7.7) 
 
127.2 
 
3 
 
7.45 (1H, d,16.0) 
 
152.1 
 
1ꞌ 
-  
127.2 
 
2ꞌ 
 
7.06 (1H, d, 1.8) 
 
109.4 
 
3 
-  
147.8 
 
4 
- 
 
 
149.5 
 
5 
 
6.97(1H, d, 7.8) 
 
111.7 
 
6ꞌ 
 
6.90 (1H, dd, 7.8, 1.8) 
 
124.2 
 
3ꞌ-OMe 
 
3.95 (1H, s) 
 
56.1 
 
4ꞌ-OMe 
 
3.95 (1H, s) 
 
56.1 
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3.2.2 Aldehyde LCB11:  Salicylaldehyde  
       
 
 
 
 
LCB11 
 Compound LCB11, 2-hydroxy-5-methoxybenzaldehyde was obtained as light 
yellow amorphous solid. The IR spectrum showed the presence of hydroxyl group at 
νmax 3431 cm
-1
 and aldehyde group at 1669 cm
-1
. The UV spectrum showed absorption 
bands at max (MeOH) nm (log Ɛ) 306 (1.845) and 231(1.723) nm. The LC-MS 
spectrum displayed pseudomolecular ion peak, [M+H]
+
 at m/z 153.0504 corresponding 
to the molecular formula of C8H8O3. 
 
 
 
 
 
 
     
Figure 3.63: LC-MS Spectrum of salicylaldehyde LCB11 
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1
H-NMR spectrum (Table 3.19, Figure 3.64) showed the existence of an 
aldehyde group which resonated at δ 9.61 as a singlet, one methoxy group was observed 
at δ 3.95 as a singlet and  a broad one proton peak appeared at δ 6.21 which was asigned 
for a hydroxyl group position at C-2. The aromatic protons were observed at δ 7.05 (C-
3), δ 7.40 (C-6) and δ 7.41 (C-4). The COSY (Table 3.19, Figure 3.65) showed only one 
proton-proton connectivity which displayed correlations of H-4/H-3 (Wang et al.,  
2000). 
 
13
C NMR and DEPT spectra (Table 3.19, Figure 3.66) showed 8 carbon signals 
of which three signals were due to the methine groups, one carbonyl, one methoy group 
and three quarternary carbons. The methoxyl group was observed at δ 56.2 (C-5), 
carbonyl group was resonated at  191.0, three methines were resonated at δ 108.8 (C-
3), 114.4 (C-4) and 127.6 (C-6). Three quaternary carbon were observed at δ 129.9 (C-
1), 151.7 (C-2) and 147.2 (C-5). 
 The HMQC and HMBC data were tabulated in (Table 3.19, Figure 3.67 and 
3.68), respectively (Alarcón et al.,  1994).  
 Based on the spectroscopic data of  LCB11 and comparison with the literature 
values, it was confirmed that compound  LCB11 was salicylaldehyde (Chang et al., 
1998). 
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Table 3.19: 
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral  data of salicylaldehyde 
        LCB11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Position 
 
 
 
 
1
H-NMR(   J in HZ) 
 
13
C-NMR 
  c) 
 
1 
 
- 
 
129.9 
 
2 
 
- 
 
151.8 
 
3 
 
7.05 (1H, d, 8.2) 
 
108.8 
 
4 
 
7.40(1H, dd, 8.2 ,1.8) 
 
127.6 
 
5 
- 
 
 
147.2 
 
6 
 
7.43 (1H, d, 1.8) 
 
114.4 
 
1' 
 
9.65 (1H, s) 
 
191.0 
2-OMe 
 
3.95 (3H, s) 
 
56.2 
   OH 6.21(1H, s) - 
124 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
125 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
126 
 
 
 
 
 
 
 
 
 
 
 
 
 
127 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
128 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
129 
 
3.2.3 Benzaldehyde LCB15: 2, 5-Dimethoxybenzaldehyde  
 
 
 
 
LCB 15 
Compound LCB15 2, 5-dimethoxybenzaldehyde was obtained as light yellow solid . 
The IR spectrum showed the absorption peak at  2848 cm
-1
  which assigned for C-H 
stretching of CHO group and  1669 cm
-1
 indicated the presence of C=O . The UV 
spectrum showed absorption bands at max (MeOH) nm (log Ɛ) 306 (2.703) and 234 
(2.531) nm indicating the presence of conjugated carbonyl group.  The LC-MS 
spectrum displayed pseudomolecular ion peak [M+H]
+
 at m/z 167.064, gave molecular 
formula of C9H10O3. 
      
 
 
 
 
 
                
 
Figure 3.69: LC-MS Spectrum of 2, 5-Dimethoxybenzaldehyde LCB15 
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 The 
1
H and 
13
C- NMR spectra (Table 3.20, Figure 3.70) and (Table 3.20, Figure 
3.71)  of  LCB15  resembled  the spectra assignments of LCB11 and the only  
difference was the substitution at position C-2 in LCB15 that was subtituted with 
methoxyl instead of  hydroxyl group.  Based on the spectroscopic data of LCB15 and 
comparison with the literature values, it was confirmed that compound LCB15 was 2, 
5-dimethoxybenzaldehyde  (Chang  et al., 1998) (Natiello et al., 1983).  
   
Table 3.20: 
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of 2,5-dimethoxy 
         benzaldehyde   LCB15 
 
 
 
 
 
 
 
 
 
 
 
Position 
 
 
 
 
1
H-NMR( ,J in HZ) 
 
13
C-NMR 
(c) 
 
1 
 
- 
 
129.5 
 
2 
 
- 
 
152.8 
 
3 
 
7.05 (1H, d, 8.8) 
 
108.8 
 
4 
 
7.44 (1H, dd,8.8, 1.2 ) 
 
127.6 
 
5 
- 
 
 
147.6 
 
6 
 
7.43 (1H, s) 
 
114.4 
 
1 
 
9.65 (1H, s) 
 
191.0 
 
2,5-OMe 
 
3.95 (6H, s) 
 
56.2 
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3.2.4 Neolignan LCB3: Biseugenol  A 
  
 
 
 
LCB 3 
 Neolignan LCB3 with IUPAC name of 4, 4-diallyl-5, 5-dimethoxy-(1, 1-
biphenyl)-2, 2-diol was afforded as brown oil. The UV spectrum showed absorptions at 
max (MeOH) nm (log Ɛ) 247 (3.121), 291 (2.214) and 306 (1.462). The IR spectrum 
showed absorptions at 3427 cm
-1
  due to the stretching of O-H,  and 1642 cm
-1
 indicated 
the existing of C=C group in the structure. LC-MS (negative mode) showed the 
pseudomolecular ion peak at  m/z 325.1394 corresponding to the molecular formula of 
C20H22O4. 
                             
                                 
 
 
 
 
 
 
 
 
Figure 3.72:  IR Spectrum of  biseugenol  A LCB3 
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Figure 3.73: LC-MS spectrum of biseugenol  A LCB3 
 
 The 
1
H-NMR (Table 3.21, Figure 3.74) analysis exhibited the presence of two 
methoxyl groups which resonated at  δ 3.81 as a singlet and these methoxyl groups were 
positioned at C-5 and C-5'. The two hydroxyl group were oberved at  5.91 as a singlet. 
Two sp
3 
methylene groups were resonated at δ 3.34 which was at lower field due to the 
deshielding effect of carbon-carbon double bond. Two sp
2
 methylene protons in the 
allyl groups were observed at δ 5.04 appeared as a doublet of doublet and the sp2 
methine groups were resonated at δ 5.95 as a multiplet.  The aromatic proton peaks were 
observed  at δ 6.73 ( C-3) and δ 6.74 ( C-6) (Nam et al., 1992). The COSY spectrum 
(Table 3.21, Figure 3.75) displayed only the correlations of H-  H-β, H-α/H-β. 
 The 
13
C NMR and DEPT spectra (Table 3.21, Figure 3.76) showed 20 carbon 
signals which consist of two methoxyls, four methylenes, six methines and eight 
quarternary cabons. The two methoxyls were observed at δ 56.1 as a singlet and these 
methoxyls positioned at C-5 and C-5'. Two sp
3
 methylenes were resonated at δ 39.9 (C-
α, α) and two sp2 methylene peaks appeared at δ 115.7 (C-,).  Two methines in the 
allyl group were observed at 137.6 (C- β, β) and four aromatic protons appeared at δ 
123.1 (C-3, 3') and 110.6 (C-6, 6'). Eight quaternary carbon peaks appeared at δ 
[M-H]
+
 = 325.1394 
[M-H]
+
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124.4(C-1, 1'), 140.8 (C-2, 2), 147.2 (C-5, 5') and 131.9 (C-4,4') (Delogu et al., 2004; 
Fujisawa et al., 1999; Suarez et al., 1983). The HMQC spectrum (Table 3.21,  Figure 
3.77) showed the connectivity between proton and carbon: H-β/ C- β, H-/C-, H-α/C-
α,H-3/ C-3 , H-6/C-6 and H-OCH3/C-OCH3 (Kawanishi et al., 1981). 
 The HMBC spectrum (Table 3.21, Figure 3.78) the cross-peaks were observed 
between H- to C-6,6', C-,', C-3,3', C-4,4', C-β,β';  OH to C-3,3', C-2,2', C-5,5'; OCH3 
to C-5,5'; H-3 to C-α, C-6,6', C-2,2', C-3,3' ; H-6 to C-α,α',  C-3,3', C-2,2', C-4,4', C-
5,5'; H- β to C-4,4' , C-,α'  and  H- to C-, C- β.  
 Based on the observed data it is confirmed that the compound LCB3 was 4, 4-
diallyl-5, 5'-dimethoxy-[1, 1'-biphennyl]-2, 2'-diol LCB3 and this compound is a new 
neolignan and has never been isolated from any plant species before. We named this 
compound as biseugenol A. The structure of biseugenol A has the similar skeleton with 
biseugenol which has been reported before  and the different was only the position of 
hydroxyl and methoxyl groups attached to the ring. 
  
  
 
 
 
 
 
 
 
 
 
136 
 
 
Table 3.21: 1D (
1
H and 
13
C)  and 2D (COSY, HMQC and HMBC ) NMR spectra data of    
        biseugenol A LCB3 
 
Position 
 
1
H-NMR( , J in HZ) 
 
13
C-NMR 
(c) 
  
 
COSY 
 
HMQC 
 
HMBC 
1,1' - 
 
124.4 - - - 
 
2,2' - 
 
140.8 
- 
 
- 
 
- 
 
 
3,3' 
 
6.73 (2H, s) 
 
123.1 
- 
 
 
H-3/C-3 
 
6,3,2,α 
 
4,4' 
- 131.9 - - - 
 
5,5' 
 
- 
 
147.2 
- 
 
- 
 
- 
 
 
6,6' 
 
6.74 (2H ,s) 
 
110.6 
-  
H-6/C-6 
 
2,3,4,5,α 
 
α 
 
3.3 (4H, d, 6.7) 
 
39.9 
 
H-/H-β 
 
H-/C- 
 
4,6,β,,3 
 
β 
 
 
5.91-5.95 (2H, m) 
 
 
137.6 
 
 
H-/H-β 
 
H-β/C-β 
 
 
4,α 
 
 
 
 
5.04 (4H, dd, 17,1, 
13.4) 
 
115.7 
-  
H-/C- 
 
α,β 
 
5-OMe 
 
3.81(6H, s) 
 
 
56.1 
 
- H-OMe/C-
5OMe 
 
 
5 
 
 
2-OH 
 
5.91(1H, s) 
- - -  
5,3,2 
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  3.2.5  Neolignan LCB9: Biseugenol  
 
 
 
  
LCB9 
 Neolignan LCB9 with IUPAC name of 4, 4-diallyl-6, 6-dimethoxy-[1, 1'-
biphennyl]-2, 2-diol was afforded as brown oil.the same Biseugenol A just different in 
the HMBC spectrum. The HMBC spectrum (Table 3.22, Figure 3.79) the cross-peaks 
were observed between H-/C-6,6', C-,', C-3,3', C-4,4', C-β,β';  OH/C-3,3', C-2,2', C-
5,5'; OCH3/C-5,5'; H-3/C-α, C-6,6', C-2,2', C-3,3' ; H-6/C-α,α',  C-3,3', C-2,2', C-4,4', C-
5,5'; H- β / C-4,4' , C-,α'  and  H-/C-, C- β.  
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Table 3.22: 1D (
1
H and 
13
C)  and 2D (COSY, HMQC and HMBC ) NMR spectra data of    
         biseugenol LCB9 
 
 
 
 
 
 
 
 
 
Position 
 
1
H-NMR( , J in HZ) 
 
13
C-NMR 
(c) 
  
 
COSY 
 
HMQC 
 
HMBC 
1,1' - 
 
124.4 - - - 
 
2,2' - 
 
140.8 
- 
 
- 
 
- 
 
 
3,3' 
 
6.73 (2H, s) 
 
123.1 
- 
 
 
H-3/C-3 
 
6,3,2,α 
 
4,4' 
-  
131.9 
- 
 
- 
 
- 
 
 
5,5' 
 
6.74 (2H ,s) 
 
110.6 
- 
 
 
H-5/C-5 
- 
 
 
6,6' 
 
- 
 
142.2 
- - 
 
 
2,3,4,5,α 
 
α 
 
3.3 (4H, d, 6.7) 
 
39.9 
 
H-/H-β 
 
H-/C- 
 
4,5,β,,3 
 
β 
 
 
5.91-5.95 (2H, m) 
 
 
137.6 
 
 
H-/H-β 
 
H-β/C-β 
 
 
4,α 
 
 
 
 
5.04 (4H, dd, 17,1, 
13.4) 
 
115.7 
-  
H-/C- 
 
α,β 
 
6-OMe 
 
3.81(6H, s) 
 
 
56.1 
 
- H-OMe/C-
6OMe 
 
 
5 
 
 
2-OH 
 
5.91(1H, s) 
- - -  
5,3,2 
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3.2.6 Oxyneolignan LCB 10: Biseugenol B 
 
 
 
 
      
LCB10 
 
 Compound LCB10 with IUPAC name 2, 2-oxybis (4-allyl-1-methoxybenzene) 
was afforded as yellow brown oil. The UV spectrum showed absorptions at max 
(MeOH) nm (log Ɛ) 278 (2.337) and 239 (2.767) indicating the presence of unsaturated 
carbon-carbon bond. The IR spectrum  showed  an absorption peak at 1591 cm
-1
 
assigned for the  aromatic characteristics and allyl group was absorpted at 1638 cm
-1
 
(Iio et al.,  1982). LC-MS showed the pseudomolecular ion peak [M-1]
-
 at m/z 309.20 
corresponding to the molecular formula of C20H22O3. 
 
         
 
 
 
 
 
 
                                Figure 3.80: IR Spectrum biseugenol B LCB10 
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Figure 3.81: LC-MS spectrum of biseugenol B LCB10 
  
 The 
1
H-NMR spectrum (Table 3.23, Figure 3.82) exhibited two methoxyls 
resonated at δ 3.81 as a singlet and these methoxyls positioned at C-1 and C-1'. One sp3 
methylene group was observed at δ 3.31 as a doublet and sp2 methylene group was 
resonated at δ 5.05 as a doublet of doublet. The sp2 methine was observed at δ 5.04 as a 
multiplet. The aromatic proton were resonated at δ 6.81 (C-5), δ 6.31 (C-6) and δ 6.72 
(C-3). The above observations were reinforced by COSY (Table 3.23, Figure 3.83) 
experiment which displayed correlations of H-5/H-6, H-α/H-β and H-β/H-. 
 The 
13
C NMR and DEPT spectrum (Table 3.23, Figure 3.84) established 20 
carbon signals which consist of two methoxyls, two sp
2
 methylene, two sp
3
 methylene, 
eight methines and six quarternary carbons. The two methoxyl groups positioned at C-1 
and C-1' were resonated at δ 56.0. Two sp3 methylenes were observed at δ 39.8 (C-α, 
α), two sp2 methylenes appeared at δ 115.6 (C-,). Two methines in allyl group were 
observed at δ 137.7 (C-β, β') and six aromatic protons appeared at δ 111.3 (C-6, 6'), 
111.9 (C-3, 3') and 120.4 (C-5, 5').  Six quaternary carbons were resonated at δ 132.7 
(C-4,4'),  148.9  (C-1,1') and  147.4 (C-2,2'). HMQC spectrum (Table 3.23, Figure 3.85) 
showed the connectivity between proton and carbon: H-β/C- β, H-/C-, H-α/C-, H-
3/C-3, H-5/C-5, H-6/C-6 and H-OMe/C-OCH3). In the HMBC spectrum (Table 3.23, 
Figure 3.86) the cross-peaks were observed between H-3 to C-6, C-5,C-2,C-, H-6 to 
[M+1]
+
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C-2, H-5 to C-4, C-5, C-2, C-, H- to C-5,  C-, C-β , C-4, C-3, H- β to C-4, /C-α, H-
OMe to C-2,  H- to C-β (Kwak et al., 2008). 
 Based on the observed spectral data of LCB10 it was confirmed that compound 
LCB10 was   2, 2 -oxybis (4-allyl-1-methoxybenzene). This is a new compound and 
has never been reported before. This compound has the same skeleton with eugenol and 
related to compound LCB3. This compound was named as biseugenol B. 
 
Table 3.23. 1D (
1
H and 
13
C)  and 2D (COSY, HMQC and HMBC ) NMR spectra data of   
        biseugenol B LCB10 
 
 
 
Position 
 
1
H-NMR(   J in HZ) 
 
13
C-NMR 
  c) 
 
 
COSY 
 
HMQC 
 
HMBC 
1,1’ 
- 
148.9 - - - 
 
2,2’ - 
 
147.4 
 
- 
- - 
 
 
3,3’ 
 
6.72(2H, s) 
 
111.9 
 
- 
 
H-3/C-3 
 
2,5,6,α 
 
4,4’ 
 
- 
 
132.7 
 
- 
 
- 
 
 
- 
 
 
5,5’ 
 
6.8 1(2H, d, 7.9) 
 
120.4 
 
H-5/H-6 
 
H-5/C-5 
 
2,4,5,α 
 
6,6’ 
 
6.31 (2H, d, 7.9) 
 
111.3 
 
H-6/H-5 
 
H-6/C-6 
 
2 
 
α 
 
3.31(4H, d, 6.8) 
 
39.8 
 
β 
- 
 
 
β,,3,5,4 
 
β 
 
 
5.09 (2H, m) 
 
 
137.7 
 
 
γ 
 
 
 
H-β/C-β 
 
 
4,α 
 
 
 
 
5.01-5.09( 4H, dd, 17.1 
,12.4) 
 
115.6 
-  
H-/C- 
 
Β, α 
 
1-OMe 
 
 
3.81(3H ,s) 
 
 
56.0 
 
- H-OMe/C-
1OMe 
 
 
2 
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3.2.7 4-Allyl-1, 2-dimethoxybenzene 
 
 
 
 
 
 
 
 
 
 
LCL15 
 
      Compound LCL15 with IUPAC name 4-allyl-1,2-dimethoxy benzene was afforded 
as yellow brown oil. The UV spectrum showed absorptions at max (MeOH) nm (log Ɛ) 
278 (2.337) and 239 (2.767) indicating the presence of unsaturated carbon-carbon bond. 
The IR spectrum  showed  an absorption peak at 1591 cm
-1
 assigned for the  aromatic 
characteristics and allyl group was absorpted at 1638 cm
-1
 (Iio et al.,  1982). LC-MS 
showed the pseudomolecular ion peak [M - H]
-
 ion peak at m/z 177.084 corresponding 
to the molecular formula of C11H14O2. 
 
 
 
 
 
 
Figure 3.87: LC-MAS Spectrum of 4-allyl-1,2-dimethoxybenzene LCL15 
 
 
H-/C- 
H-β/C- 
H-5/C-4 
H-4/C- H-6/C- 
H-/C-6 
H-/C- 
H-/C-5 
H-5/C-5 
H-6/C-2 
[M - H]
-
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 The 
1
H NMR spectra of LCB15 showed the presence of 1, 2, 4-trisubstituted 
benzene. The presence of one C3 units and two methoxyl groups suggesting that LCB15 
is a lignan.  The 
1
H NMR spectrum of LCL15  showed sets of ABX-type hyrdrogen 
aromatic signals, [δ 6.72 (1H, d, J=2.0Hz, H-3) ,  δ 6.81 (1H, d, J= 7.93, H-5) and  6.73 
(1H, d, J=7.93, H-6)] , an allyl group, [δ 3.31 (2H, d, J= 6.84 HZ, H-7),  5.04 (1H, d, 
J=10.4 HZ, Ha-9), 5.08 (1H, d, J=17.2 HZ, Hb-9)  and 5.95( 1H, ddt, J=17.2, 10.4, 6.8 
Hz, H-8)] and two methoxy groups, [δ 3.81, 3H, s] (Figure 3.88).  
Based on the observed data it was confirmed that LCL15 was 4-allyl-1,2-
dimethoxybenzene and it was a simple aromatic compound. 
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3.2.8 Biphenylydrazine LCB17:  Biseugenol C 
 
 
 
 
 
LCB 17 
  Compound LCB17 with IUPAC name 1, 2-bis (5-allyl-2-methoxyphenyl) 
hydrazine was afforded as yellow oil . The UV spectrum showed absorptions at max 
(MeOH) nm (log Ɛ) 225 (2.413) and 239 (2.763)  indicating the presence of unsaturated 
carbon-carbon bond. The IR spectrum  showed absorption peak at 3517 cm
-1
 indicated 
the existing of NH, 1638 cm
-1
 for olefenic SP bond and 1513 cm
-1
 assigned for the  
aromatic characteristics. LC-MS showed the pseudomolecular ion peak [M+Na]
+
 at m/z 
348.8434 and  molecular ion peak [M
+
] at m/z  324.7967 corresponding to the molecular 
formula of C20H24N2O2. 
 
 
 
 
 
                      
Figure 3.89: IR Spectrum of biseugenol C LCB17 
H-6/C-3 H-5/C-1 
H-4/C-1 
H-/C-β 
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Figure 3.90: LC-MS Spectrum of biseugenol C LCB17  
  
 The 
1
H-NMR spectrum (Table 3.24, Figure 3.91) exhibited two methoxyls 
resonated at δ 3.81 as a singlet and these methoxyls positioned at C-6 and C-6'. One sp3 
methylene group was observed at δ 3.31 as a doublet and sp2 methylene group was 
resonated at  δ 5.05 as a doublet of doublet. The sp2 methine was observed at δ 5.95 as a 
multiplet. The aromatic proton were resonated at δ 6.73 (C-3 and C-4) and δ 6.89 (C-5). 
The above observations were reinforced by COSY (Table 3.24, Figure 3.92) experiment 
which displayed correlations of H-γ/H-β, H-α/H-β, H-4/H-5 and H-3/H-4. 
 The 
13
C NMR and DEPT spectra (Table 3.24, Figure 3.93) established 20 carbon 
signals which consist of two methoxyls, two sp
2
 methylene, two sp
3
 methylene, eight 
methines and six quarternary carbons. The two methoxyl groups positioned at C-6 and 
C-6' were resonated at δ 55.9. Two sp3 methylenes were observed at δ 39.8 (C-α, C-α'),  
two sp
2
 methylenes appeared at δ 115.5 (C-γ, C-γ'). Two methines in allyl group were 
observed at δ 137.8 (C-β, C-β') and six aromatic protons appeared at δ 111.2 (C-3, C-
3), 114 .2 (C-5, C-5), 121.1 (C-4, C-4).  Six quaternary SP carbons were resonated at 
δ143.8 (C-1, C-1'),  131.9 (C-2, C-2') and  146.4 (C-6, C-6').  HMQC spectrum (Table 
3.24, Figure 3.94) showed the connectivity between proton and carbon: H-β/C- β, H-
/C-, H-α/C-, H-3/C-3, H-4/C-4 and H-5/C-5. 
[M]
+
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 In the HMBC spectrum (Table 3.24, Figure 3.95)  the cross-peaks were observed 
between H- to C-3, C-β, C-, C-4, C-2; OMe to C-6,6'; H- β  to C-2, C-α ; NH to C-5, 
C-1, C-6; H- to C-, C- β;  H-4 to C-3, C-2, C-6;  H-3 to C-4, C-2, C-1, C-6;  H-5 to 
C-2, C-1, C-6. Based on the observed spectral data of LCB17  it was confirmed that 
compound LCB17 was   1, 1'-bis (2-allyl-6-methoxyphenyl) hydrazine. This is a new 
compound and  has  never been  reported before. Compound LCB17 was named as 
biseugenol C. The structure of this compound has similarity with biseugenol. 
 
Table 3.24: 1D (
1
H and 
13
C)  and 2D (COSY, HMQC and HMBC ) NMR spectra   data                          
              biseugenol  C LCB17 
 
 
Position 
 
1
H-NMR(   J in HZ) 
 
13
C-NMR 
  c) 
 
 
COSY
 
 
HMQC 
 
HMBC 
 
1,1’ - 
 
143.8 
 
- 
 
- 
 
- 
 
2,2’ 
- 
 
 
131.9 
- 
 
 
 
- 
 
- 
 
3,3’ 
 
6.73 (2H, d, 8.0) 
 
111.2 
 
H-3/H-4 
 
H-3/C-3 
 
1,2,4,6 
 
4,4' 
 
6.73 (2H, m) 
 
121.1 
 
H-4/H-5,3 
 
H-4/C-4 
 
3,6,2 
 
5,5' 
 
- 
 
146.4 
 
H-5/H-4 
 
H-5/C-5 
1,2,6 
6,6’ 
6.89 (2H, m, 8.2)- 
114.2 
 
- - 
- 
,’ 
 
3.31(4H, d, 7.1) 
 
39.8 H-/H-β 
 
H-/C- 
 2,3,4,γ, β 
β,β’ 
 
5.95 (2H, m) 
 
137.8 H- β /H- H-β/C-β 
 2,α 
,’ 
 
5.05 (4H, dd, 14.8, 12.4) 115.5 - - 
 ,β 
6,6’OMe 3.81 (6H, s) 55.9 - - 
6 
NH 5.51(1H, s) - - - 
1,5,6 
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Electrochemical investigation 
 As the biseugenol C as a phenylhydrazine-derivative is electrochemical active 
and soluble in aqueous solutions. For the electrochemical investigation of biseugenol C 
we used a carbon nanotubes paste electrode in the presence of 500 µM above compound 
in phosphate buffer solution (pH 6.0). As (Figure 3.96) shows, the cyclic 
voltammogram of biseugenol C exhibits an anodic and cathodic peak at the forward and 
reverse scans of the potential related to the oxidation and reduction of the NH-NH bond 
in biseugenol C, respectively (Beitollahi et al., 2008).  
 
Figure 3.96: (a) Cyclic voltammogram of carbon nanotube paste electrode in 0.1 M phosphate buffer 
solution (pH 6.0) in the presence of 500 biseugenol C at scan rate 50 mV s
-1
, (b) as a) in the absence of 
biseugenol C. 
 
A pair of reversible peaks observed at Epa=0.5 V and Epc=0.0 V. The half-wave 
potential (E1/2) and ΔEp were 0.5 and 0.25 V, respectively. The peak separation 
potential, ΔEp (= Epa-Epc), is greater than the (59/n) mV expected for a reversible 
system, which indicates a quasi-reversible behavior for the mediator in an aqueous 
medium. In addition, the effect of the scan rate of the potential on the electrochemical 
properties of the biseugenol C was studied in phosphate buffer solution by cyclic 
voltammetry. The plots of the anodic and cathodic peak currents were linearly 
dependent on the square root of scan rate (v
1/2
) (Not shown). This behavior indicates 
that the nature of the redox process is diffusion controlled (Afzali et al. 2011; Ensafi  
and Kanim et al.  2010). Double potential step chronoamperometry was used with 
165 
 
carbon nanotubes paste electrode to determine the diffusion coefficient of biseugenol C 
.We have determined the diffusion  coefficient, D, of biseugenol C using the Cottrell 
equation ( Bard et al.,  2001; Ensafi et al., 2011) . 
I =  nFAD
1/2
 Cbπ
-1/2
 t
-1/2
           (1) 
According above equation we calculated a diffusion coefficient of 7.5×10
−6
cm
2
 s
−1
 
for this compound. In addition, the effect of pH on biseugenol C peak potential and 
peak current was investigated by cyclic voltammetry using 0.1 mol L
−1
 buffer solutions 
at pH levels ranging from 4.0 to 9.0 with a scan rate of 50 mV s
−1
 (Figure.3.97). The 
results showed that the slope of E vs. pH was 67.1 mV pH
−1
 over a pH range of 4.0 to 
9.0, which is very close to the anticipated Nernstian value of 59.2 mV for a two electron 
and two-proton process. Results suggest oxidation of NH-NH group to N=N in  
biseugenol C with two electron and two-proton that can be confirm for structure of this 
compound. 
                 
Figure 3.97: Current–pH curve for electrooxidation of 500 μM biseugenol C at carbon nanotubes paste 
electrode with a scan rate of 50 mV s
−1
. Inset influence of pH on cyclic voltammograms of biseugenol Cat 
the surface of the modified electrode, (pH 4.0, 5.0, 6.0, 7.0, 8.0,  and 9.0. 
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3.2.9 Phenolic Compound LCB4: Litsin 
 
 
 
 
LCB4 
 Compound LCB4 with IUPAC name (E)-4-(4'-hydroxy-1',1'-dimethoxybut-2'-
en-1-yl)benzene-1,2-diol was afforded as white amorphous solid with [α]D
25
 = + 2.93     
( 2.00×10
-4 
g/100 mL, MeOH). The UV spectrum showed absorptions at  max (MeOH) 
nm (log Ɛ) 261 (2.486) and 223 (2.202)  indicating the presence of unsaturated carbon-
carbon bond. The IR spectrum showed absorption peak at 3434 cm
-1
 indicated the 
existing of hydroxyl group and 1640 cm
-1
 assigned for the alkene group. LC-MS 
showed the molecular ion peak [M
+
] at m/z 240.72 corresponding to the molecular 
formula of C12H16O5. 
   
 
 
 
 
                                                       
 
 
 
           
Figure 3.98: IR Spectrum of litsin LCB4 
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Figure 3.99: LC-MS Spectrum of litsin LCB4 
 The 
1
H-NMR spectrum (Table 3.25, Figure 3.100) displayed two methoxyl 
peaks at δ 3.88 as singlet and these methoxyl groups were positioned at C-1', one sp
3
 
methylene was  resonated further downfield as a doublet at δ 4.32 assigned to H-4'. One 
multiplet peak observed at δ 6.22 assigned to H- 3' and one doublet peak at δ 6.56 
assigned to H-2'. The aromatic protons were resonated at  6.94 as a doublet of doublet 
and was assigned for H-5,   6.90 as a doublet assigned to H- 6 and  6.93 as a doublet 
assigned to H-3. The COSY (Table 3.25, Figure 3.101) experiment which displayed 
correlations of H- H- , H-2'/H-3' and H-3'/H-4'. 
 The 
13
C-NMR and DEPT spectrum (Table 3.25, Figure 3.102) showed  12 
carbon signals in the molecule which consist of  one sp
3
 methylene at  δ 63.9 (C-4′), 
four quaternary carbon  exhibited at δ 114.0 (C-4), δ 129.7 (C-1′) and  δ 148.6 (C-1, C-
2) and three aromatic methines at δ 107.8 (C-5), δ 110.6 (C-6) and  δ 119.7 (C-3). The 
sp
2
 methines were observed at δ 132.2 (C-2′) and δ 126.3 (C-3′) and two methoxyl 
groups appeared at δ  55.9 (C-1' ). HMQC spectrum (Table 3.25, Figure 3.103) showed 
the connectivity between proton and carbon:  H-3/C-3, H-5/C-5, H-6/C-6, H-2'/C-2′ and  
two H-OMe/C-OMe. In the HMBC spectrum (Table 3.25 , Figure 3.104), the cross-
peaks were observed between H-5/C-1, C-2,  C-3, C-6;  H-OMe/C-2, H-3/C-1 , C-6, C-
[M]
+
 
168 
 
2;  H-6/C-1, C-1′, C-2 ; H-2′/C-4′, C-3;  H-4′/C-3′ and C-2′. 
Based on the observed spectral data, it was confirmed that LCB4 was litsin. 
Table 3.25: 1D (
1
H and 
13
C)  and 2D (COSY, HMQC and HMBC ) NMR spectra data of litsin 
        LCB4 
 
 
 
 
 
 
 
 
 
Position 
 
1
H-NMR(   J in HZ) 
 
13
C-NMR 
  c) 
 
 
COSY 
 
HMQC 
 
HMBC 
1 
- 
148.6 - - - 
 
2 - 
 
148.6 
 
- 
- 
 
 
- 
 
3 
 
6.93 (1H, d, 1.7) 
 
119.7 
 
- 
 
H-3/C-3 
 
1,2,6 
 
4 
- 
 
 
114.1 
 
- 
- 
 
 
- 
 
5 
 
6.94(1H,  dd, 8.0, 2.1) 
 
107.8 
 
H-5/H-6 
 
H-5/H-5 
 
6,3,1,2 
 
6 
 
6.90 (1H, d,  8.0  ) 
 
110.6 
 
H-6/H-5 
 
H-6/C-6 
 
1’,1,2 
 
1' 
 
- 
 
129.7 
-  
1’-OMe/C1’-
OMe 
 
- 
 
2’ 
 
6.56 (1H, d, 15.3) 
 
132.2 
- -  
4’,3 
3’ 
 
6.22 (1H, m) 
 
 
126.3 
 
- -  
 
4’ 
 
4.32 (2H,  d, 6.6) 
 
63.9 
-  
H-4’/C-4’ 
 
3’,2’ 
   
OMe 
 
3.88(9H, s) 
 
55.9 
- -  
2-OH 
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3.2.10 E-4-styrylphenol LCB5 
 
  
     
 
LCB5 
 (E)-4-Styrylphenol LCB5 was afforded as a brown amorphous solid with       
[α]  = -22.8 (2×10-4g/100 mL, MeOH). In the UV spectrum absorption maxima were 
observed at   max (MeOH) nm (log Ɛ) 306 (0.418) and 213 (0.424) which indicated the 
existence of the conjugated system. Its  IR spectrum showed absorption bands at υmax  
3425 cm
-1
 (hydroxyl), 1643cm
-1
 (C=C). The LCMS (positive mode) spectrum showed 
an intense pseudomolecular ion peak, [M+1] at m/z 196.0295 which was associated the 
molecular formula of C14H12O.                
 
 
 
 
 
 
  
                                  Figure 3.105: LC-MS Spectrum of stilbene LCB5 
 The 
1
H-NMR spectrum of E-4-styrylphenol (Table 3.26 , Figure 3.106) showed 
the presence of two protons peak at δ 8.15 appeared as a doublet which was assigned for 
H- 2' and H-6', the doublet signal appeared as a doublet at δ 7.80 was assigned to H-1′′, 
H-2''. One doublet peak with two protons at δ 7.42 was assigned to H-2 and H-6, one 
doublet of doublet peak at δ 7.60 was assigned to H-4′, one doublet  peak resonated at δ 
7.70 was assigned  to H-3′and H-5′ and one doublet   appeared at δ 7.50  belongs to H-3, 
[M+1]
+
=197.0295 
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H-5. The above observations were reinforced by COSY (Table 3.26, Figure 3.107) 
spectrum showed cross peaks between H-2′, 6′/H-3′,5′, H-1′′/H-2′′and  H-2,6/H-3,5 5 
(Sako et al., 2004). 
 The 
13
C-NMR spectrum (Table 3.26, Figure 3.108) of 4-hydroxystilbene 
revealed a total of 14 carbon atoms in the molecule. Three quarternary carbons 
exhibited at δ 154.8 (C-4) , 138.2 (C-1′)  and  δ 134.9 (C-1) and eleven sp2 methines 
resonated at δ 132.8 (C-1′′),  130.5 (C-2′′) ,  110.6 ( C-3’, C-5’), 132.2 (C-2,H-6),  129.7 
(C-3′,5′) ,  110.6 (C-4′) and  122.1 (C-3,C-5). 
Based on the spectroscopic data of LCB5 and comparison with the literature values, it 
was confirmed that compound LCB5 was (E)-4-styrylphenol. 
 
Table 3.26: 
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of stilbene LCB5 
 
 
 
Position 
 
 
 
 
 
1
H-NMR(   J in HZ) 
 
 
13
C-NMR 
  c) 
  
 
1 
-  
134.9 
 
2,6 
 
7.42 (2H, d, 7.7) 
 
128.9 
 
3,5 
 
7.50 (2H, d, 7.0) 
 
122.1 
 
4 
- 
 
 
154.8 
 
1’ 
- 
 
 
138.2 
 
2′,6′ 
 
8.15 (2H, d, 7.7 ) 
 
132.2 
 
  
3,5 
 
7.70 (2H, dd,7.9) 
 
129.7 
 
4′ 
 
7.60 (1H, dd, 7.1) 
 
 
110.6 
                     1′′ 
7.80 (1H, d,16.8) 
132.8 
2′′ 
 
7.80(1H, d, 16.8) 
 
130.5 
 
176 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
177 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
178 
 
  3.2.11 Cinnamide LCL4 
 
  
 
 
                             
LCL4 
Compound LCL4, cinnamide was afforded as a colorless crystalline needle (Zhang et 
al.,  2010). The UV spectrum showed the absorption bands at max (MeOH) nm (log Ɛ) 
at 223 (1.204) and 278 (0.875) nm. The IR spectrum of this amide showed absorption 
peaks at 3353 cm
-1
 and 1669 cm
-1
 indicated the presence of N-H group and amide 
carbonyl stretching vibrations, respectively (Balasubraman et al.,  2004) The LC-MS 
spectrum was relatively simple with a molecular ion peak, observed at m/z 148.30 
[M+H]
+
  suggesting a molecular formula of C9H9NO. 
 
 
 
 
 
 
 
                           
Figure 3.108: LC-MS Spectrum of cinnamide LCL4 
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 The 
1
H-NMR spectrum (Table3.27, Figure 3.109) showed five aromatic proton 
signals appeared at δ 7.49 (C-2, C-6) , δ 7.36 (C-3, C-5)  and δ 7.24 (C-4). The NH2 
group was resonated at δ 5.5 as a broad singlet.  
 The 
13
C-NMR spectrum showed only a total of 9 carbon sigals (Table 3.27, 
Figure 3.110) which consist of seven sp
2
 methines and two quaternary carbon. There are 
2 overlapping carbons appeared at the same chemical shift which has equivalent 
environment in the aromatic ring. These signals appeared at δ 134.4 (C-1), δ 128.10 (C-
2, C-6), δ 129.0 (C-3,C-5) and δ 130.2 (C-4). The carbonyl amide group was resonated 
at δ 168.4 (C-7). The signals appeared at δ 119.5 was assigned to C-8 and at δ 142.2  for 
C-9. 
 Based on the spectroscopic data of LCL4 and comparison with the literature 
values, it was confirmed that compound LCL4 was cinnamide. 
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Table 3.27: 
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of cinnamide LCL4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Position  1H-NMR( ,J in HZ) 
13
C-NMR 
(c) 
  
 
1 
 
 
- 
 
134.4 
2 7.49 (1H, dd,  9.3, 3.9 ) 128.1 
3 7.36 (1H, dd, 15.6, 7.5) 129.0 
4 7.24, (1H, m) 130.2 
5 7.36 (1H, dd, 15.6, 7.5) 129.0 
6 7.49 (1H, dd, 9.3,3.9) 128.1 
7 - 168.4 
8 6.45 (1H,  d,15.6) 119.5 
9 7.65 (1H, d, 15.6) 142.2 
NH2 5.5 (br, s) - 
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3. 2.12 2, 4 –Dimethoxybenzamide LCL2 
 
 
 
 
 
LCL2 
 Compound LCL2, 2, 4–dimethoxybenzamide was obtained as brown oil. The IR 
spectrum showed the absorption peak at 3448 cm
-1 
 indicated the presence of NH2 group 
and  1607 cm
-1
  showed amide carbonyl stretching vibrations. The UV spectrum showed 
absorption bands at max (MeOH) nm (log Ɛ) 261 (2.474) and 258 (2.486) nm. The LC-
MS spectrum displayed the ion peak [M]
+
 at m/z 181.044 which gave a molecular 
formula of C9H11NO3. 
 
 
 
 
 
 
 
 
 
                   
 
Figure 3.111: LC-MS spectrum of  2, 4 –dimethoxy benzamide LCL2 
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 The 
1
H-NMR spectrum (Table 3.28,  Figure 3.112) showed there aromatic 
proton signals appeared at δ 6.82 (H-3, d), δ 7.49 (H-5,s ) and δ 7.58 (H-6,d ) and  two 
methoxyl groups were resonated at δ 3.90 as a singlet. The NH2 amide group was 
resonated at δ 3.10 as abroad peak.  
 The 
13
C-NMR spectrum (Table 3.28, Figure 3.114) showed a total of nine 
carbon signals which consist of six aromatic carbon, two carbon methoxyls and one 
carbonyl amide. The aromatic carbons were resonated  at δ 112.2 (C-3), δ 114.3(C-6) 
and δ 124.5 (C-5), δ 150.7 (C-4), δ 146.37 (C-1) and δ 122.1(C-2). The carbonyl amide 
was resonated at δ 169.0 (C-1').  Two methoxyl groups  were resonated at δ 56.1 
(Schnyder et al., 2001).   
 HMQC spectrum (Table 3.28, Figure 3.115) showed the connectivity between 
proton and carbon:  H-3/C-3, H-5/C-5, H-6/C-6 and H-OMe/C-OMe.  
  In the HMBC spectrum (Table 3.28, Figure 3.116) the cross-peak were 
observed between H-6/C-2, C-1, C-4, H-3/C-4, C-5, C-1′, H-5/C-3, C-4, C-1', H-
OMe/C-1,C4. 
 Based on the spectroscopic data of LCL2 and comparison with the literature 
values, it was confirmed that compound LCL 2 was 2, 4 –dimethoxybenzamide (Zhang 
et al. , 2006). 
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Table 3.28: 
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of 2, 4 –dimethoxy 
         benzamide LCL2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Position 
 
 
 
1
H-NMR( , J in HZ) 
 
13
C-NMR 
(c) 
 
 
1 
-  
146.3 
 
2 
-  
122.1 
 
3 
 
6.82 (1H, d,  8.0 Hz, H-6) 
 
112.2 
 
4 
- 
 
 
150.7 
 
5 
 
7.45 (1H, s, H-5) 
 
124.5 
 
6 
 
7.58 (1H, d,  1.9 Hz, H-3) 
 
114.3 
 
1 
 
- 
 
169,0 
2,4-OMe 
 
3.95 (6H, s) 
 
 
56.2 
NH2 
 
3.10 (2H, br s) 
 
- 
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3.2.13 3,4-Dimethoxybenzamide LCL5 
 
 
  
 
 
LCL5 
 Compound LCL5, 3, 4 –Dimethoxy benzamide was obtained brown oil. The IR 
spectrum of at 3448 cm
-1
 indicated the presence of NH2 group and 1607 cm
-1
 showed 
amide carbonyl stretching vibrations,. The UV spectrum showed absorption bands at 
 max (MeOH) nm (log Ɛ), 261 (2.474) and 258 (2.486) nm.The LC-MS spectrum 
displayed ion peak [M]+ at m/z 181.044, gave molecular formula of C9H11NO3. 
 
  
 
 
 
 
                              
 
                   
Figure 3.116: LC-MS Spectrum of 3, 4 –dimethoxy benzamide LCL5 
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 The 
1
H and 
13
C N MR spectra (Table 3.29, Figure 3.117) and (Table 3.28 , 
Figure 3.118) exhibited the same spectra pattern with compound  LCL2 except the 
position C-3 in LCL5 was substituted with methoxyl group and C-2 was unsubstituted 
(Van Daele et al., 1991). The aromatic proton at C-5 appeared at  6.90 as a doublet, the 
C-6 proton resonated at   7.57 as a doublet and the C-2 proton signal appeared at  
7.58. 
 Based on the spectroscopic data of LCL5 and comparison with the literature 
values, it was confirmed that compound LCL5 was 3,4-dimethoxybenzamide. 
 
 Table 3.29: 1H NMR (400 MHz) and 13C NMR (100 MHz) spectral data  of 3, 4 –dimethoxy 
         benzamide LCL5 
 
 
 
 
 
 
 
Position 
 
 
 
1
H-NMR( , J in HZ) 
 
13
C-NMR 
(c) 
 
 
1 
-  
112.9 
 
2 
 
7.58 (1H,  d,  1.9 , H-2) 
 
116.6 
 
3 
- 
 
 
143.1 
 
4 
- 
 
 
148.6 
 
5 
 
 6.90 (1H, d, 8.0, H-5) 
 
114.9 
 
6 
 
7.57 (1H, d, 8.0 , H-6) 
 
123.8 
 
1 
 
- 
 
167.1 
3,4-OMe 3.96 (6H, s)  
52.1 
 
NH2 
 
6.15 (2H, br s) 
 
- 
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3.2.14 Flavonoid LCL7: Costalin 
 
 
 
 
 
LCL7 
 Compound LCL7 with IUPAC name (2S, 4S)–5,7-dimethoxy-3', 4'-
methylenedioxyflavanone was obtained as white amorphous solid. [α]D
25
 = + 12.1 ( 
2.00×10
-4 
g/100 mL, MeOH).  In the UV spectrum obsorption maxima were observed at  
 max nm (log Ɛ) 293 (4.00) and 349 (1.433) which suggested a flavan type of the 
compound (Jayaprakasam et al., 1999) . The IR spectrum of LCL7 indicated the 
presence of hydroxyl (3392 cm
-1
) and aromatic rings (1600 and 1454 cm
-1
). The LC-MS 
spectrum showed pseudomolecular ion peak [M+1]
 +
 at m/z 331.0867 and [M+Na]
+
 
peak at m/z 353.0665 corresponding to the molecular formula of C18H18O6. 
. 
  
 
 
 
 
 
 
                                      Figure 3.119: IR Spectrum of costalin LCL7 
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Figure 3.120: LC-MS Spectrum of costalin LCL7 
 
 Nine proton signals were observed in the 
1
H-NMR spectrum (Table 3.30, Figure 
3 .121)  and eighteen carbon signals were observed in the 
13
C-NMR spectrum (Table 
3.30, Figure 3 .122). The type of groups present were sorted by the DEPT experiment 
which showed the presence of two methoxyls, two methylenes, seven methines and 
seven quaternary carbons. The 
1
H NMR spectrum showed three sets of doublet triplet at 
δ 4.91(1H, dt J=14.6, 6.3 Hz, H-2), δ 2.88 (2H, m, H-3) and δ 4.24 (1H, dt, J=14.0, 
6.1Hz, H-4) of ring-C of a Flavanone moiety. It also showed signals for two  methoxyl 
groups at δ 3.76 and δ 3.78 which were assigned for C-5 and C-7 positions, 
respectively, as they showed 
3
J correlation with these carbons at  δ 155.2  and  δ 159.7 
in the HMBC spectrum.  The meta-coupled doublets at δ 6.10 (1H, d, J=2.3 HZ, H-8) 
and δ 6.16 (1H, d, J=2.6 HZ, H-6) , which correlated to carbons at δ 93.3  and δ 92.3, 
respectively, in the HSQC spectrum (Table 3.29, Figure 3 .124)  which were assigned to 
H-6 and H-8 of ring-A respectively. A sharp two-proton singlet at δ 5.96, correlation 
with the carbon at δ 101.2 in the HSQC spectrum of LCL7 indicated a methylenedioxyl 
group. HMBC (Table 3.30, Figure 3 .125) experiments also confirmed the ring-B have a 
methylenedioxyl group between C-3 (δ 148.0) and C-4 (δ 147.4) positions. The 
1
H 
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NMR spectrum also exhibited a typical AMX spectrum at δ 7.03 (1H, d, J=1.3 HZ, H-
2), δ 6.94 (1H, d, J=8.1 HZ, H-5) and δ 6.83 (1H, dd, J=8.1, 1.3 HZ, H-6) 
corresponding to three aromatic protons of ring-B (Mukherjee et al., 1994 ). The proton  
positioned at C-2 has connectivity with C-2, C-6 and C-1 and also it has correlation to 
C-3 and C-4 position. On the basis of these observations the methylenedioxyl group at δ 
5.96 was found to be located between C-3 and C-4 positions. The connectivity also 
observed between H-3 at δ 2.88 with C-2, C-4 and C-4a. H-4 at δ 4.24 has correlation 
with C-2, C-3 and C-4a. The configuration at C-2 and C-4 were found to be S as it 
showed in CD and in the NOESY (Table 3.29, Figure 3 .126 and 3.128)  spectrum  the 
H-2 at δ 4.91  can see H-4 at δ 4.24. Thus, the structure of compound LCL7 was 
established as (2S, 4S) – 5, -dimethoxy-3', 4'-methylenedioxyflavanone. This is the first 
time that flavonoid has hydroxyl group at the C-4 position has been isolated from leaves 
plant (Reddy et al., 2003). 
 Based on the observed data it was confirmed that the compound  LCL7 was (2S, 
4S) – 5, -dimethoxy-3', 4'-methylenedioxyflavanone.  This is a new compound and has 
never been reported  before and  this compound was named as costalin. 
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Table3.30: 1D (
1
H and 
13
C)  and 2D (COSY, HMQC and HMBC ) NMR spectra data of     
        costalin LCL7 
 
 
 
Position 
 
 
1
H-NMR( ,J in HZ) 
 
13
C-NMR 
(c) 
 
 
COSY 
 
HMBC 
 
NOESY 
 
1 
 
- 
 
- 
 
      - 
 
       - 
 
- 
 
2 
 
4.91 (1H, dt, 14.6, 6.3 ) 
 
78.5  
 
  
  
1′,2′,6′,3,4  
           
 
H-4, H-3 
 
3 
 
2.88 (2H, m ) 
 
 
 
28.2 
 
 
 
H-3/H-4 
 
       2,4,4a, 
 
H-2, H-4 
 
4 
 
4.24 (1H, dt, 14.0, 6.1 ) 
 
66.5 
 
H-4/H-3 
 
2,3,4a 
 
H-2, H-3 
 
4a 
 
- 
 
100.2 
- - - 
 
 
5 
 
- 
 
155.2 
- - - 
 
 
6 
 
6.18 ( 1H, d, 2.6) 
 
93.3 
-  
4a,5,8 
- 
 
 
7 
 
- 
 
159.7 
- - - 
 
 
8 
 
6.10 (1H, d, 2.3) 
 
92.3 
-  
4a,6,8a 
- 
 
 
8a 
 
- 
 
159.3 
- - - 
 
1ꞌ 
 
- 
 
132.2 
- - - 
 
 
2ꞌ 
 
 7.03 (1H, d, 1.3 ) 
 
119.8 
-  
2,3,4,6 
- 
 
 
3ꞌ 
 
- 
 
148.0 
- -  
- 
 
4′ 
 
- 
 
147.4 
- - - 
 
5′ 
 
 6.94 (1H, d, 8.1 ) 
 
107.2 
 
H-5′/H-6′ 
   
4′,1′,3 
 
 
- 
 
6′ 
  
6.83 (1H, dd, 8.1, 1.3) 
 
4.801 
 
 H-6′/H-5′ 
 
 
 
2 
- 
 
1′′ 
 
5.96 (2H, s) 
 
101.2 
-  
3′,4 
 
- 
 
5-OCH3 
 
3.76 (3H, s) 
 
55.4 
-  
7 
 
 
- 
 
7-OCH3 
 
3. 78 (3H, s) 
 
55.5 
-  
5 
 
- 
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Figure 3.127: 3D Structure  of costalin LCL7 
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Figure 3.128: CD Structure  of Costalin LCL 
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 3.2.15 Flavanone LCL9: (+)- pinostrobin 
 
 
 
 
 
LCL9 
 
  Flavanone LCL9: (+)-pinostrobin with IUPAC name [(S)-5-hydroxy - 7-
dimethoxy-2-phenyl chroman-4H-one. was afforded as a yellow amorphous solid with 
 25D = +1.52 (2. 00×10
-4
 g/100 mL, MeOH). The UV spectrum, absorption maxima 
were observed at    max (MeOH) nm (log Ɛ) 306 (1.273) and 223 (2.316) .Its IR 
spectrum showed absorption bands at υmax  3429  cm
-1
  assigned for bonded hydroxyl, 
1642 cm
-1
  assigned for carbonyl group. The LC-MS (positive mode) spectrum showed 
an intense pseudomolecular ion peak, [MH] at m/z 271.088 corresponding to the 
molecular formula of C16H14O4.  
1
H-NMR and 
13
C-NMR data were assemble to LCL9. 
In fact LCL9 is LOB7 and has been discussed in Section 3.1.2. (Please refer to page 
40-45). 
 
 
3.2.16  Flavonol LCL14: (+)-Pinocembrin 
 
 
 
 
 
 
 
 
LCL14 
 
 
 Flavonoid LCL14, (+)-Pinocembrin, was afforded as a yellow amorphous solid 
with  [ ]D
25
=+2.81 (2. 00×10
-4
 g/100 mL, MeOH). In the UV spectrum, the absorption 
maxima at  max (MeOH) nm (log Ɛ) 241 (1.519) and 290 (2.783). Its IR spectrum 
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showed absorption bands at υmax 3417 cm
-1
  for bonded hydroxyl and 1640 cm
-1
 
assigned for chelated    unsaturated carbonyl. The molecular formula of LCL14 was 
established as C15H12O4 on the basis of ESI-MS (negative mode): m/z 255.0475 [M - 
H]
-
. MS/MS: m/z (relative abundance) 256.07.
 1
H-NMR and 
13
C-NMR data were 
assemble to LCL14. In fact LCL14 is LOB2 and has been discussed in Section 3.1.4. 
(Please refer to page 54-58).               
 
3.2.17  Flavanone LCL13: (+)-Onysilin 
 
 
 
 
 
 
 
 
LCL13 
 
 
   Flavanone LCL13, (+)–Onysilin with IUPAC name [(2S)-5-hydroxy -6, 7-
dimethoxy-2-phenyl chroman-4-one] was afforded as a yellow amorphous solid with 
 25D = +3.1 (2.00 ×10
-4
g/100 mL, MeOH). In the UV spectrum, absorption maxima 
were observed at  max (MeOH) nm (log Ɛ) 293 (4.00) and 349 (1.43) which indicated 
the existence of the conjugated double bond system. Its IR spectrum showed absorption 
bands at υmax 3446 cm
-1
 assigned for bonded hydroxyl group and 1644 cm
-1
 for carbonyl 
group. The ESIMS (positive mode) spectrum showed an intense pseudomolecular ion 
peak, [M+H] at m/z 301.0824 corresponding to the molecular formula of C17H16O5.
1
H-
NMR and 
13
C-NMR data were assembled to LCL13. In fact LCL13 is LOB4 and has 
been discussed in Section 3.1.1. (Please refer to page 35-39).  
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3.2.18  Lignan LCL17: Eugenol 
 
              
                
 
 
 
 LCL17 
Compound LCL17 with IUPAC name 4-allyl-2methoxyphenol was afforded as yellow 
oil . The UV spectrum showed absorptions at max (MeOH) nm (log Ɛ) 225 (2.413) and 
239 (2.763) indicating the presence of unsaturated carbon-carbon bond. The IR 
spectrum showed absorption peak at 3517 cm
-1
 indicated the existing of OH, 1638 cm
-1
 
for olefenic SP bond and 1513 cm
-1
 assigned for the aromatic characteristics. LC-MS 
showed the pseudomolecular ion peak [M+1]
+
 at m/z 165.0855 and  molecular ion peak 
corresponding to the molecular formula of C10H12O2.  
 
 
 
 
 
 
 
 
Figure 3.129: LC-MS Spectrum of eugenol LCL17  
 
 
209 
 
       The 
1
H-NMR spectrum (Table 3.31, Figure 3.130) exhibited one methoxyls 
resonated at δ 3.81 as a singlet and these methoxyls positioned at C-2. One sp3 
methylene group was observed at δ 3.31 as a doublet and sp2 methylene group was 
resonated at  δ 5.05 as a doublet of doublet. The sp2 methine was observed at δ 5.95 as a 
multiplet. The aromatic proton were resonated at δ 6.69-6.71 (H-3 and H-5) and δ 6.85-
6.86 (C-6) .   
       The 
13
C NMR  spectrum (Table 3.31, Figure 3.131) established 10 carbon signals 
which consist of one methoxyl, sp
2
 methylene, sp
3
 methylene, four methines and three 
quarternary carbons. The one methoxyl group positioned at C-2 was resonated at δ 55.9. 
sp
3
 methylenes was observed at δ 39.8 (C-α), sp
2
 methylenes appeared at δ 115.5 (C-γ). 
Methines in allyl group were observed at δ 137.8 (C-β) and three aromatic protons 
appeared at δ 111.2 (C-3), δ114 .2 (C-5), δ121.1 (C-6).  Three quaternary SP carbons 
were resonated at δ143.8 (C-1), δ131.9 (C-4) and δ146.4 (C-2).   
 Based on the observed spectral data of LCL17 it was confirmed that compound 
LCL17 was   eugenol.  
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Table 3.31: 
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectral data of  eugenol   LCL17 
 
 
 
 
 
  
 
 
 
 
Position 
 
                    1
H-NMR(   J in HZ) 
 
13
C-NMR  c) 
 
 
1 - 
 
143.8 
 
2 
 
- 
 
131.9 
 
3 
 
6.69-6.71 (H, m) 
 
111.2 
 
  4 
 
- 
 
121.1 
 
   
 
6.69-6.71 (H, m) 
 
114.2 
 
6 
 
6.85-6.86(1H, d, 8.1) 
 
146.4 
 
 
 
 
 
3.31(2H, d, 7.1) 
 
39.8 
β 
 
 
5.95 (H, m) 
 
137.8 
 
 
 
5.05 (2H, dd, 14.8, 12.4) 
115.5 
’OMe  
3.81 (3H, s) 
55.9 
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BIOACTIVITY 
 
 4.1 Introduction 
 This chapter is about antioxidant and anticancer activities of some isolated 
compounds. The compounds were first isolated from plants followed by antioxidant 
assay by several methods such as free radical scavenging activity by means of 
DPPH, Ferric Reducing Assay (FRAP) and Metal Chelating Assay. 
 Free radicals are produced during oxidation process of damaging cells caused by 
diseases and these free radical scan contain one electron or more unpaired electrons. 
Examples of free radicals are hydroxyl (OH
.
), superoxide (O2
.-), nitric oxide (NO·) and 
peroxyl (RO2·). Antioxidants have ability to delay or prevent the oxidation of 
molecules. Antioxidant activity of plants function in several methods including free 
radical scavenging (DPPH), metal ion chelating (FIC) and FRAP performing as a 
substrate to absorb radicals such as superoxide and hydroxide. There are three 
mechanisms  to determine antioxidant activity of a plant extract based on hydrogen 
atom transfer (HAT) reactions and electron transfer (ET) (Huang et al., 2005). 1,1'-
Diphenyl- 2-picryl hydrazyl radical scavenging assay (DPPH) is one of a few stable and 
commercially available organic nitrogen radicals and has a UV-Vis absorption 
maximum at 517 nm (Miliauskas et al., 2004).  Polyphenolic compounds, such as 
flavonoids, phenolic acids and lignans in plants have been reported to have 
multiple biological effects, including antioxidant activity and anticancer  
(Kähkönen MP et al.,  1999). Phenolic compounds  are natural antioxidants in the 
plants showed  their antioxidant activity in several ways (Bombardelli et al.,  1993) . 
 Radical scavenging activity toward either reactive species  such as 
·
OH, O2
·-
 
functioning via hydrogen atom exchange or electron donation (Niki  et al., 2000). 
Phenolic compounds exhibit a wide range of bioactivly substances, such as anti-
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allergenic, anti-artherogenic (Benavente et al., 1997),  anti-inflammatory (Manach et al.,  
2005),  anti-microbial (Middleton  et al.,  2000) , antioxidant, anti-thrombotic (Heim et 
al.,  2002),  cardioprotective and vasodilatory effects (Cook.N.C, Samman, S. 1996). 
 
4.2  Antioxidant: Free radicals and oxidation 
 A free radical has high-energy and can be defined  as any element or compound 
that needs an electron to fill an unfilled molecular valence orbital .  They often “attack” 
and remove electrons from the molecule in closest proximity which  can be neutral, 
positively or negatively charged (Hughes et al., 1999). This mechanism indicates the 
oxidized molecule a free radical and may initiate a chain reaction which can pursue 
stability from a nearby molecule without discrimination.  
 Oxygen can become a reactive molecule when oxygen is expose  to a source of 
high energy , the energy is transferred to from singlet oxygen (Ardestani  et al., 2007). 
                                       O2 +    energy O2
. 
Normally, over 95% of the oxygen reduced to H2O by the electron transport system in 
the mitochondria: 
                                   O2
.
 + 4e
-
 + 4H       2H2O 
When molecule oxygen is reduced by one electron, formation superoxide radical: 
                                    O2 + e
-   
O2
.- 
After this added second electron at physiologic pH the formation two products of 
hydrogen peroxide (H2O2) and hydrogen peroxide: 
                                  2 O2
. - 
+ 2H
+  
        O2 +H2O2 
                                 O2
. - 
+ H2O2 + 4H
+  
O2 + H2O +HO
. 
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The formation of HO
.  
from H2O2 is catalyzed by transition metals, mostly iron and 
copper.  O2
. -
 , H2O2 and  HO
.
 are known as reactive oxygen species (ROS) and are 
continuously produced by aerobically growing cells (Castro et al.,  2001). 
 
4.3 Determination of antioxidant activity          
 We evaluated by using three different methods: 
 i) 1,1-diphenyl-2-picrylhydrazyl (DPPH) Radical Scavenging Activity Assay 
 ii) Ferric Reducing Power Assay (FRAP) 
 iii) Metal  Chelating Assay 
 
4.4 DPPH Radical Scavenging Activity Assay 
 The DPPH radical scavenging activity assay is an assay that can determine the 
activity of antioxidants to directly react with DPPH stable free radical by observing its 
absorbance at 517 nm with a spectrophotometer . The DPPH radical is a stable nitrogen 
centered free radical.  Purple coloured 1, 1-diphenyl-2-picrylhydrazyl (DPPH), a stable 
free radical which reduced to α, α- diphenyl- -picrylhydrazine. DPPH was observed 
yellow in colour if reacts with antioxidant. The decolorization of purple colour indicated 
the potential of antioxidants of the samples. When the more decolorization of purple 
colour occurred, the antioxidant concentration of the sample was higher. 
 The DPPH radical scavenging activity was used in the screening of the 
antioxidant properties of pure compounds and plant extracts. This method is simple and 
can be determined by using single read spectrophotometer. However, the disadvantage 
of the DPPH activity scavenging assay is the use of non physiologically relevant free 
radicals which resembled to free radicals that involved in the oxidation process in 
biological system (Adedapo et al.,  2008) (Miller et al., 2000). The relative radical-
scavenging abilities of  phenolic compounds through their properties as electron- or H-
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donating agents DPPH is discruded in  (scheme 4.1). 
 
        Scheme 4.1:  Radical-scavenging abilities of DPPH through H-donating agents 
 
4.4.1 Material 
 DPPH (1,1'diphenyl-2-picrylhydrazyl), trichloroacetic acid, sodium phosphate 
monobasic, and sodium phosphate dibasic were purchased from Sigma Chemical Co. 
(St. Louis, MO, USA). Ferric chloride, methanol and water (HPLC) were purchased 
from Chemolab Supplies (Kuala Lumpur, Malaysia). An ELISA reader (Sunrise, 
Switzerland) and UV-vis spectrophotometer-1700 (Shimadzu, Japan) were used for 
absorbance determinations. 
 
4.4.2 Preparations of solutions 
 A. Preparation of compounds 
         1.00 mg/mL concentration of compounds in methanol were prepared by dissolving 
1.00 mg of compound in 1.00 mL methanol (Ranilla et al., 2010). 
B. Preparation of Ascorbic acid. 
       Ascorbic acid was used as the positive standard reference in DPPH radical 
scavenging assay. Ascorbic acid standard, DPPH, and methanol were prepared as 
shown in (Table 4.1). Ascorbic acid was prepared at the concentration of 1000  g /mL. 
1.00 mg of ascorbic acid was dissolved in 1.00 mL methanol. The stock solution was 
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kept in flask which was wrapped in aluminium foil. 
C. Preparation of DPPH 
           A stock of DPPH in methanol was prepared at the concentration at 60 μM by 
dissolving 0.0024 g of DPPH stock in 100 mL methanol. The stock solution was kept in 
flask which was wrapped in aluminium foil (Ranilla et al., 2010). 
D. Determination of DPPH activity of compounds. 
    The scavenging activity of all compound and ascorbic acid were tested at different 
concentrations (1000 μg/mL, 500 μg/mL, 250 μg/mL, 125 μg/mL, 62.5 μg/mL, and 
31.25 μg/mL). Reaction mixtures containing DPPH and compounds or ascorbic were 
prepared according to Table 4.1. 
Assay was run by mixing 1250 µL of 60 µM DPPH solution with 250 µL of each crude 
compounds at various concentrations (31.25 to 1000 μg/ml) in 96-well microplate. This 
reaction can tolerate to stand at 25 
o
C for 30 min. After 30 min incubation in darkness, 
the absorbance at 517 nm was measured by using ELISA reader (Sunrise, Switzerland). 
E. Determination of percentage of inhibition of DPPH. 
DPPH Scavening effect activity was calculated by using the following formula:
DPPH Scavenging effect (%)= 
A0 (Control)-A1 (Sample)
A0 (Control)
x 100
 
Where; 
A0 control = absorbance value of control 
A1 sample = absorbance value of sample  
 Percentage inhibition for each sample for the active extract was calculated by using the 
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above formula. A graph of percentage of inhibition against concentration was plotted  in 
order to IC50 value can be determined. The IC50 value was the concentration (in µg/mL) 
at which 50% of DPPH radicals were inhibited. 
 The entire test was performed in triplicate and results were expressed as mean ± 
standard deviation (SD).  
Table 4.1: DPPH and different concentration of standard ascorbic acid                            
 
 
 
 
 
 
 
Concentration of  
compounds                
          
 
Volume  of  
methanol (     
 
Volume of  
compounds (     
 
Volume of DPPH solution 
(     
1000.0 
 
0.0 250.0 1250.0 
500.0 
 
500.0 250.0 1250.0 
250.0 
 
750.0 250.0 1250.0 
125.0 
 
875.0 250.0 1250.0 
62.5 
 
937.5 250.0 1250.0 
31.25 
 
968.75 250.0 1250.0 
Control 
 
250.00 - 1250.0 
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4.5 Ferric Reducing Power Assay (FRAP) 
 The Reducing Power Assay was one of the mechanism actions of antioxidants 
and it can be used to measure the electron-donating ability of antioxidants using the 
potassium ferricyanide reduction method. The ferric ion or ferricyanide complex was 
reduced by the antioxidants to the ferrous form and Perl
’
 s Prussian blue complex was 
observed. Fe(III) reduction was often used as an indicator of electron- donating activity 
and it can be strongly correlated with other antioxidant properties (Ozsoy et al., 2008) . 
 The yellow colour of the test solution can change to various blue and green 
colours depending on the reducing power potential of each extract. The reductions that 
present in the compounds  caused the Fe
3+
/Ferricyanide complex to be reduced to 
ferrous ion, Fe
2+
. When the Perl
’ 
s Prussian blue was formed in the reaction mixture, it 
indicated the presence of Fe
2+
. The more intense of blue colour showed the higher 
reducing power capability of the compounds and the increase of OD reading (700 nm) 
indicated the greater reducing power of the extract. Reducing power can evaluate the 
ability of extract to reduce from Fe
3+
 to Fe
2+
(Chang, et al., 2007).    
     
4.5.1 Material 
 Potassium ferricyanide K3[Fe(CN)6], trichloroacetic acid,  ferric chloride 
solution, sodium phosphate from Sigma Chemical Co. (St. Louis, MO, USA). methanol 
and water (HPLC) were purchased from Chemolab Supplies (Kuala Lumpur, Malaysia). 
An ELISA reader (Sunrise, Switzerland) and UV-vis spectrophotometer-1700 
(Shimadzu, Japan) were used for absorbance determination. 
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4.5.2 Preparations of solutions  
A. Preparation of 1% Potassium Ferricyanide K3 [Fe (CN)6]  
 A stock of potassium ferricyanide was prepared at the concentration of 10 
mg/mL. 0.6 g of potassium ferricyanide stock was dissolved in 60 mL distilled water. 
The stock solution was kept in flask wrapped with aluminium foil (Yu et al.,  2008).  
B. Preparation of 10% Trichloroacetic acid (TCA) 
     A stock of trichloroacetic acid was prepared at the concentration of 100 mg/mL. 6 g 
of trichloroacetic acid stock was dissolved in 60 mL distilled water.  The stock solution 
was kept in flask wrapped with aluminium foil.   
C. Preparation of 0.1% Ferric chloride solution  
 A stock of ferric chloride solution was prepared at the concentration of 1 
mg/mL. 0.01 g of ferric chloride  was dissolved in 10 mL distilled water .The stock 
solution was kept in flask wrapped with aluminium foil.   
 D. Preparation of 0.2 M , buffer solution 
 Sodium phosphate buffer were prepared according to published method 
 (Dawson et al. 1986). 
D.1 Preparation of 0.4 M sodium phosphate monobasic (NaH2PO4) stock 
 solution 
 To prepare 250 mL of 0.4 M stock solution, 12 g of sodium phosphate 
monobasic (MW=119.98 g/mole) was dissolved in 250 mL distilled water. The stock 
was kept in a flask prior to prepare 0.2 M sodium phosphate buffer.  
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D.2 Preparation of 0.4 M sodium phosphate dibasic (Na2HPO4) stock solution 
 To prepare 250 mL of 0.4 M stock solution, 14.2 g of sodium phosphate dibasic 
(MW=141.96 g/mole) was dissolved in 250 mL distilled water. The stock was kept in a 
flask prior to prepare 0.2 M sodium phosphate buffer. 
 To prepare 500 mL of 0.2 M sodium phosphate buffer solution (pH = 6.6), 
approximately 93.75 mL of sodium phosphate dibasic (Na2HPO4) stock solution was 
mixed with 156.25 mL of sodium phosphate monobasic (NaH2PO4) stock solution and it 
was diluted to 500 mL with distilled water. This solution can be stored in the 
refrigerator for several months. 
E. Determination of FRAP Assay 
      Generally, different amount of compounds were dissolved in 1 mL methanol and 
were vortexed until it mixed completely. 0.5 mL of prepared compounds was then 
added to 0.5 mL of 0.2 M Phosphate buffer (pH 6.6) and 0.5 mL of 1% (W/V) 
potassium ferricyanide. The mixtures were incubated in water bath at 50
o
C for 20 min.  
After incubation, 0.5 ml of 10% trichloroacetic acid (TCA) solution was added to each 
mixture and then centrifuged at 3000 rpm for approximately 10 minutes. The 
supernatant (0.5 mL) was mixed with 0.5 mL of distilled water and 0.1 mL of freshly 
prepared 0.1% ferric chloride solution. The absorbance was measured at 700 nm using 
UV spectrophotometer (Shimadzu, Japan). The BHA at different concentrations (16.62-
1000 μg/mL) was used as standard reference. Methanol was used as blank. All the tests 
were carried out triplicates and results were expressed as mean ± standard deviation 
(SD).  
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 4.6 Metal Chelating Activity Assay 
 The chelating activity of compounds was determined according to the method of 
(Dinis et al., 1994). The purpose of this assay is to evaluate the ability of compounds 
extract from plant to chelate ferrous ion and preventing the formation of ferrozine – Fe2+ 
complex. 
4.6.1 Material 
 Ferrozine,  EDTA,  ferric chloride from Sigma Chemical Co. (St. Louis, MO, 
USA). methanol and water (HPLC) were purchased from Chemolab Supplies (Kuala 
Lumpur, Malaysia). An ELISA reader (Sunrise, Switzerland) and UV-vis 
spectrophotometer-1700 (Shimadzu, Japan) were used for absorbance determinations. 
4.6.2 Preparation of  solution 
 A. Preparation of 5mM Ferrozine 
 0.0246 g ferrozine stock was dissolved in 10 mL deionized water. The stock was 
 kept in flask wrapped with aluminium foil. 
B. Preparation of 2mM Ferrous chloride (FeCl2) 
 0.004 g of FeCl2 stock was dissolved in 10 mL deionized water. The stock was 
 kept in flask wrapped with aluminium foil. 
C. Preparation of standard EDTA 
 Ethylenediamine tetraacetic acid (EDTA) was used as positive reference 
 standard in this assay. The tested compound was carried out in different 
 concentration of (62.5 -1000 μg/mL followed by treatment with ferric chloride 
 (FeCl3) and ferrozine respectively in centrifuge tubes according to (Table 4.2) . 
D. Determination of metal chelating activity of compounds 
 Compounds in different concentration of (62.5 -1000       was treated with 
 0.05 ml  ferric chloride (FeCl3 2 mM) and 0.2 ml ferrozine (5mM) respectively 
 in centrifuge tubes according to (Table 4.2). 
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 The reaction mixture was shaken and left incubated in the room temperature for 
 10 minutes. 1 ml of mixture was divided into 3 cuvettes each. The absorbance 
 was measured at 562 nm. Methanol is used as balank. All compounds were 
 tested in triplicates and the readings were averaged out  
E. Determination of percentage of inhibition of ferrozine  
 The percentage of metal chelating effect of ferrozine Fe
2+
 complex formation 
 was calculated using the formula below. 
                        Metal chelating effect  (%) = 
                      
           
     
 Where; 
 Abs control=absorbance reading of control 
 Abs sample= absorbance reading of sample  
 
Table4.2:Metal chelating of standard EDTA 
 
 
 
 
 
 
 
Concentration of EDTA  
and compound(mg/mL) 
 
Volume of 
methanol (mL) 
 
Volume of 
FeCl2/mM(mL) 
 
Volume of ferrozine 
5mM(mL) 
 
1000 
 
0 
 
0.05 
 
0.2 
 
500 
 
500 
 
0.05 
 
0.2 
 
250 
 
750 
 
0.05 
 
0.2 
 
125 
 
875 
 
0.05 
 
0.2 
 
62.5 
 
937.5 
 
0.05 
 
0.2 
 
Control 
 
1000 
 
0.05 
 
0.2 
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4.7 Results and Discussion 
 
4.7.1 DPPH Radical Scavenging Activity Assay 
 The percentage inhibition against DPPH radical of ascorbic acid (compound 1), 
(Table 4.5, Figure 4.1 ) at 1000  g/mL showed the inhibition activity range between 
83.98 ± 0.001 to 95.68 ± 0.003 at concentration of 31.5µg/mL and  IC50 value was 
determined as 4.62  µg/mL. The percentage inhibition of flavokawain B LOB15     
(compound 2) against DPPH radical  showed  inhibition activity ranging between 28.66 
± 0.004% to 92.68 ± 0.002% at concentration of 62.5 μg/mL and  IC50 = 8.5  g/mL 
(Table 4.6, Figure 4.2). The percentage inhibition of (+)-onysilin LOB4 (compound 3) 
against DPPH radical showed the inhibition activity ranging between 19.03 ± 0.02 to 
64.15 ± 0.006 and  IC50 = 78.97  g/mL (Table 4.7, Figure 4.3). The percentage 
inhibition of (+)-pinocenbrin LOB2 (compound 4) against DPPH showed the inhibition 
activity ranging between 25.14 ± 0.004 to 66.86 ± 0.02 and IC50  = 41.32  g/mL (Table 
4.8, Figure 4.4). The percentage inhibition of linderone LOB28 (compound 5) against 
DPPH radical showed  the inhibition activity between 8.94 ± 0.02 to 52.88 ± 0.04 and  
IC50 = 157.58  g/mL (Table 4.9, Figure 4.5). The percentage inhibition of Linderone A 
LOB25 (compound 6) against DPPH radical showed the inhibition activity ranging 
between 20.43 ± 0.007 to 55.76 ±0.002 and IC50 = 149.45  g/mL (Table 4.10,  Figure 
4.6). The percentage inhibition of biseugenol C LCB17 (compound 7) against DPPH 
radical showed  the inhibition activity ranging between 38.47 ± 0.01 to 81.96  ± 0.01 
and  IC50 = 16.34  g/mL (Table 4.11, Figure 4.7).  The percentage inhibition of 2, 5-
dimethoxybenzaldehyde LCB15 (compound 8) against DPPH radical showed the 
inhibition activity ranging between 8.75 ± 0.01 to 51.5 ± 0.01 IC50 = 161.81  g/mL 
(Table 4.12, Figure 4.8 ). The percentage inhibition of biseugenol B LCB10 (compound 
9) against DPPH radical showed the inhibition activity ranging between 12.15 ± 0.03 to 
59.72± 0.03 and  IC50 = 81.92  g/mL (Table 4.13, Figure 4.9). The percentage 
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inhibition of 2-hydroxy-5-methoxybenzaldehyde LCB11 (compound 10) against DPPH 
radical showed the inhibition activity ranging between 3.93 ± 0.03 to 84.46 ± 0.003 IC50 
= 81.92  g/mL (Table 4.14, Figure 4.10). The percentage inhibition of biseugenol A 
LCB3 (compound 11) against DPPH radical showed  the inhibition activity ranging 
between 54.52 ± 0.01 to 72.86 ± 0.01 and  IC50 = 4.77  g/mL (Table 4.15, Figure 4.11). 
The percentage inhibition of 3, 4-dimethoxycinnamaldehyde LCB7 (compound 12) 
against DPPH radical showed the inhibition activity range between 7.63 ± 0.01 to 65.27 
± 0.02 and  IC50 = 73.24  g/mL (Table 4.16, Figure 4.12). The percentage inhibition of 
Litsin LCB4 (compound 13) against DPPH radical showed the inhibition activity 
ranging between 16.45 ± 0.02 to 93.3 ± 0.003 and  IC50 = 26.69  g/mL (Table 4.17, 
Figure 4.13). The percentage inhibition of Costalin LCL7 (compound 14) against 
DPPH radical showed the inhibition activity ranging  between 14.75 ± 0.003 to 69.75 ± 
0.01 and  IC50 = 76.45 (Table 4.18, Figure 4.14).  
          The results showed that biseugenol A LCB3 with IC50 = 4.77  g/mL, C LCB17 
IC50 = 16.34  g/mL and flavokawain B LOB15 IC50 = 8.5  g/mL demonstrated very 
good radical scavenging activity using DPPH method compared to ascorbic acid with 
IC50 = 4.62  g/mL. Biseugenol A showed comparable acivity to that of  ascorbic acid, 
thus it is suitable as a potential  antioxidant. 
 The ability of neolignan and phenyl hydrazine to be better radical scavenger 
could be due to OH and NH groups to attached to the ring system. our results obtained 
from DPPH test validated some of previous studies on neolignan as antioxidant (Woo, 
S. L et al.,  2004). Generally Flavonoid has better antioxidant activity than their 
corresponding chalcones in vitro antioxidant assays because of their strong capacity to 
donate electrons or hydrogen atoms. 
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  4.7.2 Antioxidant of Lindera Species 
 From our literature review we have listed in (Table 4.3) some selected 
antioxidant prepertise of  Lindera species, here again no investigation has been found 
on Lindera oxyphylla. 
 Table 4.3: Antioxidant of some selected chemicals in species of Lindera 
 
 
4.7.3 Antioxidant of Litsea Species 
 From our literature review we have listed in Table 4.4 some selected antioxidant 
prepertise of Litsea species, here again no investigation has been found on Litsea 
costalis. 
   
 Table 4.4: Antioxidant of some selected chemicals in species of Litsea 
 
 
 
 
 
 
No. Lindera species Antioxidant RF 
1 Lindera pulcherrima (Nee) Benth Essential oil (Joshi  et al. 2012) 
2 Lindera strychnifolia Extracts (Yan, Peng,  et al. 2011) 
3 Lindera angustifolia Chen Alkaloids (Zhao et al. 2006) 
No. Litsea species Antioxidant RF 
1 Litsea coreana L Loying tea (Zhang et al 2000) 
2 Litsea monopetala Phenolic compounds (Arfan et al. 2008) 
3 Litsea akoensis Essential oil (Ho et al. 2011) 
4 Litsea cubeba Methanol extract (Hwang et al. 2005) 
5 Litsea japonica Ethanol extract (Yoon et al. 2010) 
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Table 4.5:  DPPH radical scavenging activity Ascorbic acid 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Graph of concentration (μg/mL) as % inhibition DPPH radical scavenging 
        activity of Ascorbic Acid. 
 
 
 
 
Concentration 
of Ascorbic 
acid 
( g/mL) 
 
Ascorbic acid  at 517  nm 
 
1                  2           3            
 
% 
Inhibition 
 
STDV 
 
Mean ± SD 
 
IC50 
(μg/mL) 
 
31.25 
 
0.078     0.079     0.076 
 
83.98 
 
0.001 
 
0.08 ± 0.001 
 
4.62 
 
62.5 
 
0.069   0.075      0.082 
 
84.59 
 
0.006 
 
0.07 ± 0.004 
 
 
125 
 
0.06     0.054      0.05 
 
88.91 
 
0.005 
 
0.05  ± 0.003 
 
 
250 
 
0.048   0.032       0.036 
 
92.19 
 
0.008 
 
0.04 ± 0.009 
 
 
500 
 
0.034    0.028      0.025 
 
94.04 
 
0.004 
 
0.03  ± 0.003 
 
 
1000 
 
0.027    0.02       0.017 
 
95.68 
 
0.005 
 
0.02 ±  0.003 
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               Table 4.6:  DPPH radical scavenging activity of flavokawain B LOB15 
 
 
 
 
 
Figure 4.2: Graph of concentration (μg/mL) as % inhibition DPPH radical scavenging 
        activity of Flavokawin B LOB15. 
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Concentration(g/mL) 
 
Concentration 
of compound 
( g/mL) 
 
Absorbance   at 517  nm 
 
1             2             3 
 
% 
Inhibition 
 
STDV 
 
Mean ± SD 
 
IC50 
(μg/mL) 
 
31.25 
 
 
0.691      0.684       0.686 
 
28.66 
 
0.004 
 
0.687 ± 0.002 
 
 
62.5 
 
0.332      0.346        0.34 
 
64.79 
 
0.007 
 
0.339  ± 0.004 
 
8.5 
 
125 
 
 
0.165      0.148      0.159 
 
0.009 
 
82.3 
 
0.157 ± 0.005 
 
 
250 
 
0.087     0.072     0.078 
 
91.1 
 
0.007 
 
0.079 ± 0.004 
 
 
500 
 
0.07      0.065       0.068 
 
92.45 
 
0.002 
 
0.07 ±  0.001 
 
 
1000 
 
0.068      0.065    0.064 
 
92.68 
 
0.002 
 
0.06 ±  0.001 
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Table 4.7: DPPH radical scavenging activity of (+) -Onysilin LOB4 
 
 
 
        
           
 
 
 
 
 
 
 
 
          
 
 
 
 
 
 
 
 
Figure 4.3: Graph of concentration (μg/mL) as % inhibition DPPH radical scavenging 
        activity of (+)-Onysilin LOB4 
 
 
 
 
 
Concentration 
of compound  
( g/mL) 
 
Absorbance at 517 
nm 
 1               2                3 
 
% 
Inhibition 
 
STDV 
 
Mean ±SD 
 
IC50 
( μg/mL) 
 
31.25 
 
  0.67           0.7             0.670 
 
19.03 
 
0.02 
 
0.7 ±  0.01 
 
 
62.5 
 
 
 0.551       0.550        0.587 
 
34.19 
 
0.05 
 
0.6  ± 0.03 
 
  
 
125 
 
0.486       0.420       0.443 
 
47.23 
 
0.03 
 
0.4 ± 0.02 
 
 
250 
 
 
0.465      0.412       0.413 
 
49.47 
 
0.03 
 
0.4  ± 0.01 
 
 
500 
 
 
0.423       0.398      0.387 
 
52.76 
 
0.003 
 
0.4 ± 0.001 
 
78.97 
 
1000 
 
 
0.320       0.307      0.288 
 
64.15 
 
0.006 
 
0.3 ± 0.004 
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Table 4.8: DPPH radical scavenging activity of (+)-Pinocembrin LOB2 
 
 
 
 
 
 
 
 
Figure 4. 4: Graph of concentration (μg/mL) as % inhibition DPPH radical scavenging 
         activity of (+)-pinocembrin LOB2 
. 
 
 
 
Concentration 
of compound 
( g/mL) 
 
Absorbance at 517 nm 
1                  2                3 
 
% 
Inhibition 
 
STDV 
 
Mean ±SD 
 
IC50 
( μg/mL) 
 
31.25 
 
 
0.620         0.687         0.604 
 
25.14 
 
0.04 
 
0.6 ± 0.02  
 
62.5 
 
 
0.550        0.560          0.565 
 
34.43 
 
0.008 
 
0.5 ± 0.004  
 
125 
 
 
0.473        0.490          0.489 
 
43.12 
 
0.01 
 
0.5 ± 0.005  
 
250 
 
 
0.412        0.426           0.430 
 
50.41 
 
0.01 
 
0.4 ± 0.005 
 
41.32 
 
500 
 
 
0.324        0.312           0.350 
 
61.45 
 
0.02 
 
0.3 ± 0.01 
 
 
 
1000 
 
0.301        0.256           0.289 
 
66.86 
 
0.02 
 
0.3 ± 0.01  
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Table 4.9: DPPH radical scavenging activity of Linderone LOB28 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5: Graph of concentration (μg/mL) as % inhibition DPPH radical scavenging 
        activity of Linderone LOB28. 
 
 
 
 
Concentration 
of compound  
(μg/mL) 
 
Absorbance at 517 nm 
1            2            3 
 
% 
Inhibition 
 
STDV 
 
Mean  ± SD 
 
IC50 
( μg/mL) 
31.25 
 
0.970     0.923     0.950 
 
8.94 
 
0.02 
 
0.9  ± 0.01  
 
62.5 
 
 
0.868      0.819       0.83 
 
 
19.23 
 
0.02 
 
0.8  ± 0.01 
 
125 
 
0.815      0.771        0.8 23.26 0.02 0.8  ± 0.01  
 
250 
 
0.742     0.667      0.752 
 
30.76 
 
0.05 
 
0.7  ±  0.03 
 
 
 
 
500 
 
 
0.604     0.597     0.611 
 
41.92 
 
0.007 
 
0.6  ± 0.004 
 
 
 
1000 
 
 
0.450      0.521        0.5 
 
52.88 
 
0.04 
 
0.5 ± 0.02 
 
157.58 
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Table 4.10: DPPH radical scavenging activity of Linderone A LOB25 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. 6: Graph of concentration (μg/mL) as % inhibition DPPH radical scavenging 
         activity of Linderone A LOB25. 
 
 
 
 
 
 
Concentration 
of compound 
( g/mL) 
 
Absorbance at 517 
nm 
1            2           3 
 
% 
Inhibition 
 
STDV 
 
Mean ± SD 
 
IC50 
(μg/mL) 
 
31.25 
 
 
0.549  0.537     0.550 
 
20.43 
 
0.007 
 
0.5 ± 0.004 
 
 
62.5 
 
 
0.485    0.536   0.568 
 
22.77 
 
0.004 
 
0.5 ± 0.02 
 
 
125 
 
 
0.431    0.451   0.448 
 
35.32 
 
0.01 
 
0.4  ± 0.006 
 
 
250 
 
 
0.35  0.414       0.389 
 
43.94 
 
0.03 
 
0.4 ± 0.02 
 
 
 
 
500 
 
0.311    0.387   0.379 
 
47.59 
 
0.03 
 
0.4  ± 0.02 
 
 
 
1000 
 
 
0.278   0.308    0.324 
 
55.76 
 
0.02 
 
0.3  ± 0.01 
 
149.45 
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Table 4.11: DPPH radical scavenging activity of biseugenol C LCB17 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7: Graph of concentration (μg/mL) as % inhibition DPPH radical scavenging 
activity of Biseugenol C LCB17.  
 
 
 
Concentration 
of compound 
( g/mL) 
 
Absorbance at 517 nm 
1            2           3 
 
% 
Inhibition 
 
STDV 
 
Mean ±SD 
 
IC50 
(μg/mL) 
 
31.25 
 
 
0.322    0.299   0.301 
 
38.47 
 
0.011 
 
0.3 ± 0.007 
 
 
62.5 
 
 
0.223    0.282   0.253 
 
49.49 
 
0.03 
 
0.3 ± 0.02 
 
 
125 
 
 
0.180  0.170     0.195 
 
63.72 
 
0.01 
 
0.2  ±0.007 
 
16.34 
 
 
250 
 
 
0.221    0.125   0.187 
 
64.52 
 
0.05 
 
0.2  ±  0.03 
 
 
 
500 
 
0.118   0.105    0.11 
 
77.95 
 
0.006 
 
0.1  ±0.004 
 
 
 
1000 
 
 
0.09   0.08    0.101 
 
81.96 
 
0.01 
 
0.1 ± 0.006 
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Table 4.12: DPPH radical scavenging activity of 2, 5-Dimethoxybenzaldehyde  LCB15 
 
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  4. 8: Graph of concentration (μg/mL) as % inhibition DPPH radical scavenging 
activity of 2,5-Dimethoxybenzaldehyde LCB15.  
 
 
 
Concentration 
of compound  
( g/mL) 
 
Absorbance at 517 
nm 
   1            2           3 
 
% 
Inhibition 
 
STD
V 
 
Mean ± SD 
 
IC50 
(μg/mL
) 
 
31.25 
 
 
0.355    0.368   0.373 
 
8.75 
 
0.01 
 
0.365  ±   0.005 
 
 
62.5 
 
 
0.309    0.397   0.345 
 
12.5 
 
0.04 
 
0.350  ±  0.03 
 
 
125 
 
 
0.272  0.299     0.354 
 
23 
 
0.04 
 
0.308  ± 0.02 
 
 
 
250 
 
 
0.250    0.280   0.291 
 
31.75 
 
0.02 
 
0.273 ±  0.01 
 
 
 
500 
 
0.233   0.243    0.225 
 
41.75 
 
0.009 
 
0.233 ±  0.005 
 
 
 
1000 
 
 
0.202   0.198    0.183 
 
51.5 
 
0.01 
 
0.194  ± 0.006 
 
161.81 
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Table 4.13: DPPH radical scavenging activity of biseugenol B LCB10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9: Graph of concentration (μg/mL) as % inhibition DPPH radical scavenging 
activity of Biseugenol B LCB10. 
 
 
 
 
 
Concentration 
of compound 
( g/mL) 
 
Absorbance at 517 nm 
   1            2           3 
 
% 
Inhibition 
 
STDV 
 
Mean ± 
SD 
 
IC50 
(μg/mL) 
 
31.25 
 
 
0.480   0.538   0.50 
 
12.15 
 
0.03 
 
0.5 ±   0.02 
 
 
62.5 
 
 
0.481    0.520   0.490 
 
13.71 
 
0.02 
 
0.5 ± 0.01 
 
 
125 
 
 
0.513  0.427     0.453 
 
19.44 
 
0.04 
 
0.5± 0.02 
 
 
 
250 
 
 
0.404    0.427   0.411 
 
28.12 
 
0.01 
 
0.4 ± 0.007 
 
 
 
500 
 
0.299     0.250    0.301 
 
50.86 
 
0.03 
 
0.3 ±  0.02 
 
81.92 
 
 
1000 
 
 
0.253    0.245    0.199 
 
59.72 
 
0.03 
 
0.2 ±  0.02 
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Table 4.14: DPPH radical scavenging activity of 2-hydroxy-5-methoxybenzaldehyde 
LCB11         
 
 
 
 
 
 
Figure 4.10: Graph of concentration (μg/mL) as % inhibition DPPH radical scavenging 
          activity of 2-hydroxy-5-dimethoxybenzaldehyde LCB11. 
 
 
  
 
Concentration 
of compound  
( g/mL) 
 
Absorbance at 517 nm 
   1            2           3 
 
% 
Inhibition 
 
STDV 
 
Mean ± SD 
 
IC50 
(μg/mL) 
 
31.25 
 
 
0.517   0.586   0.551 
 
3.93 
 
0.03 
 
0.6 ±   0.02 
 
 
62.5 
 
 
0.520    0.510   0.515 
 
10.11 
 
0.005 
 
0.5 ± 0.003 
 
 
125 
 
 
0.465  0.394    0.429 
 
25.11 
 
0.03 
 
0.4 ± 0.02 
 
 
 
250 
 
 
0.394    0.389  0.385 
 
32.11 
 
0.03 
 
0.4 ±  0.01 
 
 
 
500 
 
0.295    0.226    0.245 
 
55.49 
 
0.03 
 
0.2 ±  0.02 
 
81.92 
 
 
1000 
 
 
0.088     0.086    0.093 
 
84.46 
 
0.003 
 
0.09 ±  0.002 
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Table 4.15: DPPH radical scavenging activity of biseugenol A LCB3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11: Graph of concentration (μg/mL) as % inhibition DPPH radical scavenging 
          activity of Biseugenol A LCB3.  
 
 
 
 
Concentration 
of compound 
( g/mL) 
 
Absorbance at 517 nm 
   1            2           3 
 
%  
Inhibition 
 
STDV 
 
Mean ± SD 
 
IC50 
(μg/mL) 
 
31.25 
 
 
0.177   0.198   0.185 
 
54.52 
 
0.01 
 
0.2 ±   0.006 
 
4.77 
 
62.5 
 
 
0.160    0.163   0.159 
 
60.88 
 
0.002 
 
0.2 ± 0.001 
 
 
125 
 
 
0.133  0.145    0.150 
 
64.54 
 
0.01 
 
0.1 ± 0.007 
 
 
 
250 
 
 
0.142    0.140  0.138 
 
65.77 
 
0.002 
 
0.1 ±  0.001 
 
 
 
500 
 
0.117  0.128    0.112 
 
70.9 
 
0.008 
 
0.1 ±  0.004 
 
 
1000 
 
 
0.122   0.102    0.111 
 
72.86 
 
0.01 
 
0.1 ±  0.006 
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Table 4.16: DPPH radical scavenging activity of Cinnamaldehyde LCB7 
 
 
 
 
 
 
 
 
Figure 4.12: Graph of concentration (μg/mL) as % inhibition DPPH radical scavenging 
          activity of Cinnamaldehyde LCB7. 
 
 
 
 
 
 
Concentration 
of compound 
( g/mL) 
 
Absorbance at 517 nm 
   1            2           3 
 
% 
Inhibition 
 
STDV 
 
Mean    
 
IC50 
(μg/mL) 
 
31.25 
 
 
0.375   0.379   0.371 
 
7.63 
 
0.01 
 
0.4 ±   0.006 
 
 
 
62.5 
 
 
0.398    0.321   0.354 
 
12.06 
 
0.004 
 
0.4 ± 0.002 
 
 
125 
 
 
0.331  0.336    0.325 
 
18.71 
 
0.005 
 
0.3 ± 0.003 
 
 
 
250 
 
 
0.3    0.245  0.286 
 
31.77 
 
0.03 
 
0.3 ±  0.02 
 
 
 
500 
 
0.173  0.188    0.165 
 
56.89 
 
0.01 
 
0.2 ±  0.007 
 
73.24 
 
 
1000 
 
 
0.154   0.148    0.122 
 
65.27 
 
0.02 
 
0.1 ±  0.01 
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Table 4.17: DPPH radical scavenging activity of Litsin LCB4 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure 4.13: Graph of concentration (μg/mL) as % inhibition DPPH radical scavenging 
           activity of Litsin LCB4. 
 
 
 
 
Concentration 
of compound 
( g/mL) 
 
Absorbance at 517 nm 
   1            2           3 
 
%  
Inhibition 
 
STDV 
 
Mean    
 
IC50 
(μg/mL) 
 
31.25 
 
 
0.887   0.864   0.853 
 
16.45 
 
0.02 
 
0.9 ±   0.01 
 
 
 
62.5 
 
 
0.756    0.763   0.745 
 
26.79 
 
0.009 
 
0.7 ± 0.005 
 
 
125 
 
 
0.517  0.590    0.555 
 
46.21 
 
0.04 
 
0.5 ± 0.02 
 
 
 
250 
 
 
0.229    0.211  0.239 
 
78.05 
 
0.01 
 
0.2 ±  0.008 
 
26.69 
 
500 
 
0.087  0.108    0.093 
 
90.67 
 
0.01 
 
0.1  ±  0.006 
 
 
 
1000 
 
 
0.068   0.067    0.073 
 
93.30 
 
0.003 
 
0.07 ±  0.002 
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Table 4.18: DPPH radical scavenging activity of Costalin LCL7 
 
 
 
 
Figure 4.14: Graph of concentration (μg/mL) as % inhibition DPPH radical scavenging 
          activity of Costalin LCL7. 
 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
 
 
 
Concentration 
of compound  
( g/mL) 
 
Absorbance at 517 nm 
   1            2           3 
 
% 
Inhibition 
 
STDV 
 
Mean    
 
IC50 
(μg/mL) 
 
31.25 
 
 
0.367   0.311   0.345 
 
14.75 
 
0.003 
 
0.3 ±   0.02 
 
 
 
62.5 
 
 
0.321    0.301  0.298 
 
23.5 
 
0.01 
 
0.3 ± 0.007 
 
 
125 
 
 
0.258  0.273    0.296 
 
31.25 
 
0.02 
 
0.3 ± 0.01 
 
 
 
250 
 
 
0.211    0.198  0.235 
 
46.5 
 
0.02 
 
0.2 ±  0.01 
 
 
 
500 
 
0.188  0.176   0.184 
 
54.5 
 
0.006 
 
0.2  ±  0.003 
 
76.45 
 
 
1000 
 
 
0.109   0.121   0.134 
 
69.75 
 
0.01 
 
0.1 ±  0.007 
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4.7.4 FRAP (Ferric Reducing Power Assay) 
 The antioxidant activities of compounds from Lindera oxyphylla and Litsea 
costalis were determined by using reducing power assay. The reaction mixtures turned 
from yellow to green and Perl
 , 
s Prussian blue complex and it depending on the 
reducing power of each compounds used. The absorbance reading at 700 nm was taken. 
This assay was carried out in triplicates and average reading was recorded. 
 BHA (compound 1) (Table 4. 19, Figure 4. 15) showed the absorbance 1.0 ± 
0.05 at concentration of 1000 µg/mL. Flavokawain B LOB15 (compound 2) ,(Table 
4.20, Figure 4. 16) showed  the absorbance 1.0 ± 0.06 at concentration of 1000 µg/mL. 
(+)-Pinocenbrin LOB2 (compound 3), (Table 4.21,  Figure 4.17) showed    the 
absorbance 0.7 ± 0.02 at concentration of 1000 µg/mL. (+)-Onysilin  LOB4 (compound 
4), (Table 4.22, Figure 4.18) showed  the absorbance 0.6 ± 0.01 at concentration of 
1000 µg/mL. Linderone LOB28 (compound 5) ,(Table 4.23,  Figure 4. 19) showed the 
absorbance 0.6 ± 0.02 at concentration of 1000 µg/mL. Linderone  A LOB25 
(compound 6), (Table 4.24 , Figure 4.20) showed  the absorbance 0.6 ± 0.03 at 
concentration of 1000 µg/mL.  
The results showed that flavokawain B LOB15 the absorbance 1.0 ± 0.06, demonstrated 
very good FRAP method compared to BHA showed the absorbance 1.0 ± 0.05  
Flavonoid has better antioxidant activity than their corresponding chalcones in vitro 
antioxidant assays because of their strong capacity to donate electrons or hydrogen 
atoms. 
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Table 4.19:  FRAP of BHA standard    
 
 
 
                           Figure 4.15: Absorbance of BHA standard          
 
 
 
 
 
     
 
 
 
Concentration of BHA 
(μg/mL) 
Absorbance at 700 nm 
1                 2               3 
 
STDV 
 
Mean ± SD 
 
15.62 
 
0.594          0.733            0.662 
 
0.069 
 
0.7 ± 0.04 
 
31.25 
 
0.645           0.687           0.728 
 
0.041 
 
0.7 ± 0.02  
 
62.5 
 
0.689          0.723            0.786 
 
0.05 
 
0.7 ± 0.03  
 
125 
 
 
0.754          0.826             0.787 
 
0.036 
 
0.8 ± 0.02  
 
250 
 
 
0.865          0.898             0.923 
 
0.03 
 
0.9 ± 0.02  
 
500 
 
 
1.083          0.925            0.987 
 
0.08 
 
1.0 ± 0.05   
 
1000 
 
 
1.11            1.16              0.987 
 
0.09 
 
1.0 ± 0.05 
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Table 4.20:  FRAP of flavokawain B LOB25    
 
 
     
                                       
 
 
 
 
 
 
 
 
 
 
 
                                   Figure 4.16: Absorbance of  flavokawain B LOB25 
 
 
 
 
Concentration of 
compound (μg/mL) 
Absorbance at 700 nm 
1                 2               3 
 
STDV 
 
Mean ± SD 
 
15.62 
 
0.401          0.398            0.415 
 
0.01 
 
0.4 ± 0.005  
 
31.25 
 
0.446           0.414            0.422 
 
0.017 
 
0.4 ± 0.01   
 
62.5 
 
0.468          0.419             0.453 
 
0.025 
 
0.4 ± 0.01   
 
125 
 
 
0.541          0.655          0.648 
 
0.063 
 
0.6 ± 0.04  
 
250 
 
 
0.795           0.757          0.762 
 
0.02 
 
0.8 ± 0.01  
 
500 
 
 
0.798            0.812          0.856 
 
0.03 
 
0.8 ± 0.01  
 
1000 
 
 
1.121           0.978           0.912 
 
0.1 
 
1.0 ± 0.06  
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Table 4.21:  FRAP of (+)-Pinocenbrin LOB2 
 
 
 
 
                                             Figure 4.17: Absorbance  of (+)-Pinocenbrin LOB2 
 
 
 
 
 
Concentration of 
compound  (μg/mL) 
Absorbance at 700 nm 
1                 2               3 
 
STDV 
 
Mean ± SD 
 
15.62 
 
0.312            0.345           0.338                        
 
0.03
 
0.3 ± 0.01           
 
31.25 
 
0.380               0.326         0.373                       
 
0.03 
 
0.3 ± 0.02 
 
62.5 
 
0.450                 0.383        0.401                    
 
0.03                   
 
0.4 ± 0.02            
 
125 
 
 
0.527                 0.424        0.498                    
 
0.05                   
 
0.5 ± 0.03  
 
250 
 
 
0.504                 0.521        0.513                     
 
0.008                   
 
0.5 ± 0.005                     
 
500 
 
 
0.564                 0.589        0.612                    
 
0.024 
 
0.6  ± 0.01 
 
1000 
 
 
0.645                 0.678        0.713                    
 
0.03 
 
0.7  ±  0.02               
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Table 4.22:  FRAP of  (+)- Onysilin LOB4 
 
 
 
 
Figure 4.18: Absorbance  of (+)- Onysilin LOB4 
 
 
 
 
Concentration of 
compound   (μg/mL) 
Absorbance at 700 nm 
1                 2               3 
 
STDV 
 
Mean ± SD 
 
15.52 
  
    0.310                0.324           0.335 
 
0.01 
 
 
0.323 ± 0.001 
 
31.25 
 
     
      0.3                 0.352             0.343                             
 
0.02                     
 
0.335 ± 0.012 
 
61.5 
 
  
      0.352                0.365          0.378                             
 
0.01 
 
0.365 ± 0.008  
 
125 
 
    
          0.405            0.432          0.478                              
 
0.02                
   
  0.438 ± 0.02  
 
250 
 
 
   
       0.425              0.453           0.489                            
 
 
 
0.03  
 
 0.455 ± 0.02 
 
500 
 
  
       0.463                0.502           0.545                            
 
0.02                  
 
0.56 ± 0.02                  
 
1000 
 
  
        0.523                 0.547         0.669                               
 
0.02 
 
0.6 ± 0.01 
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Table 4.23:  FRAP  of Linderone LOB28 
 
 
 
 
                               Figure 4.19: Absorbance of Linderone   LOB28 
   
 
 
 
 
 
Concentration of 
compound (μg/mL) 
Absorbance at 700 nm 
1                 2               3 
 
STDV 
 
Mean ± SD
 
 
 
15.62 
 
 
0.3             0.301            0.312                      
 
0.01 
 
0.304 ± 0.005                                                                                       
 
31.25 
 
 
0.345             0.325           0.333                              
 
0.006
 
0.334 ± 0.003                    
 
62.5 
 
 
0.375             0.320            0.355                              
 
0.03           
 
0.35 ± 0.016  
 
125 
 
 
0.387             0.372            0.385                             
 
0.008             
 
0.381 ± 0.005 
 
250 
 
  
    0.419              0.369           0.401                            
   
0.02            
 
0.396 ± 0.014                 
 
500 
 
 
0.462             0.491            0.555                             
 
0.05
 
0.502 ± 0.027                       
 
1000 
 
 
0.534             0.564            0.601                              
 
0.03
 
0.566 ± 0.02   
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Table 4.24: FRAP of Linderone  A LOB25        
 
                                                                                                                                                                                                                        
 
 
Figure 4. 20: Absorbance of Linderone  A  LOB25 
 
                                                                                                                                                         
 
                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
 
 
Concentration of 
compound  (μg/mL) 
Absorbance at 700 nm 
1                 2               3 
 
STDV 
 
Mean
 
± SD 
 
15.62 
 
0.3             0.301            0.312                      
 
0.01
 
0.304 ± 0.005                                                                                     
 
31.25 
 
0.350           0.341             0.338                            
 
0.006
 
0.343 ± 0.003                 
 
62.5 
 
0.363          0.355              0.383                             
 
0.01         
 
0.367 ± 0.008 
 
125 
 
 
0.401          0.447               0.483                             
 
0.04          
 
0.443 ± 0.02 
 
250 
 
 
0.437          0.478              0.498                             
 
0.03         
 
0.471 ± 0.02 
 
500 
 
  
  0.474          0.494            0.589                            
 
0.06
 
0.519 ± 0.03                   
 
1000 
 
 
0.543           0.598               0.634                             
 
0.04
 
0.591 ± 0.03 
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4.7.5  Metal Chelating Assay 
 The antioxidant activities of compounds from Lindera oxyphylla and Litsea 
costalis were determined using metal chelating assay. It was based on the chelating 
effect of Fe
2+
 ions by ferrozine reagent.  Antioxidant from the test samples disturbed the 
formation of ferrozine-Fe
2+ 
complexes. The colour intensity of the reaction mixtures 
reduced. As the concentration of the samples and standard increased, the metal chelating 
activity  increased. This assay was also carried out in triplicates and the average reading 
was recorded. 
 Ethylenediaminetetraacetic acid (EDTA) was used as the standard in the metal 
chelating assay.  At the concentration 1000 μg/mL of EDTA (Table 4.25, Figure 4.21) 
the chelating activity was 99.08 ± 0.007. All  of the tested compounds  showed 
chelating activity less than 50% when it was tested at various concentrations of 61.5-
1000  μg/mL The chelating activity for flavokawain B LOB15  (Table 4.26, Figure 
4.22), (+)-pinocenbrin LOB2  (Table 4.27, Figure 4.23), (+)-onysilin LOB4  (Table 
4.28, Figure 4.24), linderone LOB28 (Table 4.29, Figure 4.25) and linderone A LOB25  
(Table 4.30, Figure 4.26) were 33.37 ± 0.01 , 26.11 ± 0.01 ,  25.69 ± 0.01% , 13.09 ± 
0.006  and 13.51 ± 0.01 ,respectively.  
In this study, the purple colour of reaction solutions did not change much in the 
presence of all compounds and their percentages of metal ion chelating effect were 
lower than the standard control EDTA . EDTA is a strong metal chelator (Gülçin, 
Berasvili & Gepdiremen, 2005), hence, it was used as standard metal chelator agent in 
this study. 
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Table 4.25: Metal Chelating Assay of EDTA 
 
 
 
 
 
 
 
 
 
 
 
                                   Figure 4.21: % Chelating activity of  EDTA         
 
 
 
 
 
 
 
Concentration 
EDTA ( g/mL) 
 
Absorbance at 517 nm 
   1            2           3 
 
Metal chelate 
effect 
(%) 
 
STDV 
 
Mean ± SD 
 
62.5 
 
 
0.141  0.094  0.107 
 
95.26 
 
0.02 
 
0.114  ±  0.01 
 
125 
 
 
0.055  0.062   0.06 
 
97.54 
 
0.003 
 
0.06  ±  0.002 
 
250 
 
 
0.063  0.053  0.047 
 
97.75 
 
0.008 
 
0.05  ±  0.005 
 
500 
 
 
0.043  0.031  0.049 
 
98.29 
 
0.009 
 
0.041  ±  0.005 
 
1000 
 
 
0.034 0.011   0.021 
 
99.08 
 
0.01 
 
0.022  ±  0.007 
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Table 4.26: Metal Chelating Assay of  flavokawain B LOB15 
 
 
 
 
                                  
 
 
 
 
                    Figure 4.22: % Chelating activity of flavokawain B LOB15  
 
 
 
 
 
 
Concentration of 
compound 
( g/mL) 
 
Absorbance at 517 nm 
   1            2           3 
 
Metal chelate 
effect 
(%) 
 
 
STDV 
 
Mean ± SD  
 
125 
 
 
2.279  2.288   2.301 
 
4.2 
 
0.01 
 
2.289  ± 0.006 
 
250 
 
 
2.109   2.123    2.112 
 
11.25 
 
0.007 
 
2.114  ±  0.004 
 
500 
 
 
2.098  1.897    1.965 
 
16.87 
 
0.1 
 
1.986  ±  0.06 
 
1000 
 
 
1.43   1.567     1.765 
 
33.37 
 
0.2 
 
1.587 ±  0.1 
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Table 4.27: Metal Chelating Assay of (+)-Pinocenbrin LOB2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.23: % Chelating activity of (+)-Pinocenbrin  LOB2 
 
 
 
 
 
 
 
 
Concentration 
of compound 
( g/mL) 
 
Absorbance at 517 nm 
   1            2           3 
 
Metal chelate 
effect 
(%) 
 
STDV 
 
Mean ± SD 
 
125 
 
 
2.345    2.232    2.211 
 
3.4 
 
0.07 
 
2.262  ±  0.04 
 
250 
 
 
2.243      2.257     2.276 
 
10.7 
 
0.02 
 
2.258  ±  0.01 
 
500 
 
 
2.234      2.211     2.225 
 
20.56 
 
0.01 
 
2.223  ±   0.007 
 
1000 
 
2.163     2.139     2.129 
 
26.11 
 
0.02 
 
2.142  ±  0.01 
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Table 4.28: Metal Chelating Assay of (+)-Onysilin LOB4 
 
                                               
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.24: % Chelating activity of (+)-Onysilin LOB4 
 
 
 
 
 
 
 
 
 
 
Concentration 
of compound  
( g/mL) 
 
Absorbance at 517 nm 
1            2           3 
 
Metal chelate 
effect 
(%) 
 
STDV 
 
Mean ± SD 
 
125 
 
 
2.332   2.289    2.291 
 
5.03 
 
0.02 
 
2.301 ± 0.01 
 
250 
 
 
2.253   2.278     2.229 
 
10.07 
 
0.02 
 
2.253 ±  0.01 
 
500 
 
 
2.247   2.217     2.223 
 
20.02 
 
0.01 
 
2.229 ±  0.009 
 
1000 
 
2.187   2.153    2.142 
 
25.69 
 
0.02 
 
2.16  ± 0.01 
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Table 4.29: Metal Chelating Assay of Linderone LOB28 
 
 
 
 
 
 
 
 
 
Figure 4. 25: % Chelating activity of  Linderone LOB28 
 
 
 
 
 
 
 
Concentration 
of compound 
( g/mL) 
 
Absorbance at 517 nm 
   1            2           3 
 
Metal chelate 
effect  
(%) 
 
STDV 
 
Mean ± SD 
 
125 
 
 
2.323   2.309    2.287 
 
3.19 
 
0.01 
 
2.366  ± 0.01 
 
250 
 
 
2.253     2.294     2.268 
 
4.65 
 
0.02 
 
2.271 ±  0.01 
 
500 
 
 
2.189     2.162     2.148 
 
9.06 
 
0.02 
 
2.166 ±  0.01 
 
1000 
 
2.065     2.039     2.084 
 
13.51 
 
0.02 
 
2.062  ± 0.01 
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Table 4.30: Metal Chelating Assay of Linderone A LOB25 
 
 
 
 
 
 
Figure 4. 26: % Chelating activity of  Linderone A LOB2                                                                                                                                 
                                                                                                                                                                                                                                       
 
 
 
 
 
Concentration 
of compound  
( g/mL) 
 
Absorbance at 517 nm 
1            2           3 
 
Metal chelate 
effect 
(%) 
 
STDV 
 
Mean ± SD 
 
125 
 
 
2.302   2.312    2.297 
 
3.31 
 
0.008 
 
2.303   ± 0.004 
 
250 
 
 
2.278    2.256     2.263 
 
4.91 
 
0.01 
 
2.265 ± 0.006 
 
500 
 
 
2.165    2.142     2.109 
 
10.24 
 
0.03 
 
2.138  ± 0.02 
 
1000 
 
2.065     2.087    2.074 
 
13.09 
 
0.01 
 
2.075  ± 0.006 
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4.8     Anticancer:  Cytotoxicity  Activity  
 Cancer is a wide group of several diseases. In cancer, cells divide and grow 
wildly, and invade nearby parts cells of the body. The cancer may also spread to more 
distant parts of the body through the lymphatic system or blood stream. do not all 
tumors are cancerous. Benign tumors do not grow uncontrollably, do not invade 
neighboring tissues, and do not spread throughout the body. Cancer is the second 
leading cause of death among children between the ages of one to fourteen and it is also 
responsible for 25% of all deaths today (Jemal et al.  2005). There were 10.9 million 
new cancer cases diagnosed in USA and 6.7 million deaths in 2002 (Tan et al.,  2006). 
Seventy-seven percent of all the cancers diagnosed were observed in people aged 55 
years or older ("Cancer facts and figures," 2002). These figures show that the death toll 
from cancer is going to increase with the aging of US population. In spite of the 
availability of a large number of anticancer drugs and various chemotherapy options, 
there is still an acute need for less toxic and more potent cancer drugs and continues be 
the concern. Cancer can be detected in a number of ways, counting the presence of 
certain signs and symptoms, screening tests, or medical imaging. Once a possible cancer 
is detected it is diagnosed by microscopic examination of a tissue sample. Cancer is 
usually treated with chemotherapy, radiation therapy and surgery. The risks of surviving 
the disease vary greatly by the type and location of the cancer and the extent of disease 
at the start of treatment. While cancer can affect people of all ages, and a few types of 
cancer are more showeded in children, the risk of developing cancer generally increases 
with age. In 2007, cancer produced about 13% of all human deaths worldwide 
(7.9 million). Rates are growing as more people live to an old age and as mass lifestyle 
changes occur in the developing world (Jemal  et al.  2011). Most of the drugs available 
are not selective to cancer cells and affect normal cells as well leading to severe side 
effects. However, these drugs are now the most effective means to fight cancer. The aim 
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of research in cancer drug development is to find new drugs that are specific to cancer 
cells, or to develop a method that alters the nature of the drug administered such that it 
acts only on the target cells and not the regular normal functioning cells, thereby 
reducing the side effects. 
        Several anticancer agents available in the market today derive from natural 
sources. One of the earliest compounds isolated as an anticancer agent was 
podophyllotoxin, a compound obtained from Podophyllum peltatum (Sweeney) in 1944 
(Imbert et al., 1998). It was initially used therapeutically as a purgative and in the 
treatment of venereal warts (Kaplan et al.,  1942). Later, in 1974, it was shown that it 
acts as an anticancer agent by binding irreversibly to tubulin (Wilson et al.,  1974). 
Etoposide and teniposide, the modified analogs of podophyllotoxin, can cause cell death 
by inhibition of topoisomerase II, thus preventing the cleavage of the enzyme- DNA 
complex and arresting the cell growth (Srivastava et al. 2005). Both these analogs are 
currently used in the treatment of various cancers (Odwyer et al., 1985). 
  Bioassays are crucial for the successful isolation of active compounds from 
various natural sources. The usual method for isolation of active components is the 
bioassay guided fractionation. Several bioassays are available to evaluate different types 
of bioactivities of different types of compounds. The assays can be chosen based on the 
nature and the type of activity that is desired to isolate. An ideal bioassay would be 
highly sensitive to small amounts of active material, selective to the specific bioactivity, 
cost effective and easy to run and maintain (Rahman et al.,  2003). 
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4.8.1 Anti cancer of Lindera Species 
 From our literature review we have listed in Table 4.31 some selected 
anticancer properties of Lindera species, and no investigation on cancer has been found 
on Lindera oxyphylla. 
Table 4.31: Anticancer activity of some selected species of Lindera 
 
No. Lindera species Type of compound Cell lines Refrence 
1 Lindera ommunis sesquiterpenoids HepG2 (Deng et al., 2011) 
2 Lindera trychnifolia LinerolideA-F RAW264.7 (Sumiokaet al., 2011) 
3 Lindera trychnifolia phenolic compound HepG2 (Yan et al., 2011) 
 
 4.8.2 Anticancer of Litsea Species 
 From our literature review we have listed in Table 4.32 some selected 
anticancer properties of Litsea species, no investigation on cancer has been found on 
Litsea costalis.         
   Table 4.32: Anticancer activity of some selected species of Litsea   
   
No. Litsea species Type of compound Cell lines Refrence 
 
1 
 
Litsea cubeba 
 
The leaf and fruit oils 
 
 
A549 
(Ho et al., 2010) 
2 Litsea coreanalevl Green tea AGS and HT-29 (Xin & Yan-fei, 2008) 
3 Litsea akoensis 
 
Compounds P-388, KB16, 
A549 and HT-29 
(Chen, Lai-Yaun, Duh, & 
Tsai, 1998 
 
4.8.3 Materials and Methods 
 4.8.3.1 Cell culture 
 All the cells that used in this study were obtained from American Type Cell 
Collection (ATCC) and maintained in a 37
°
C incubator with 5% CO2 saturation cell line 
A375 human melanoma, HT-29 human colon adenocarcinoma cells and WRL-68 
normal hepatic cells were maintained in Dulbecco’s modified Eagle’s medium 
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(DMEM). Whereas A549 non-small cell lung cancer cells and PC3 prostate 
adenocarcinoma cells were maintained in RPMI medium. Both medium were 
supplemented with 10% fetus calf serum (FCS), 100 units/mL penicillin, and 0.1 
mg/mL streptomycin.  
 4.8.3.2 Cellular viability assay 
 Different cell types from above were used to determine the inhibitory effect of 
compounds  on cell growth using the MTT assay. This colorimetric assay is based on 
the conversion of the yellow tetrazolium bromide (MTT) to the purple formazan 
derivatives by mitochondrial succinate dehydrogenase in viable cells. The MTT assay 
was modified as described by (Cheah et al., 2011) and (Friedman et al.,  2009). Briefly, 
cells were seeded at a density of 1 × 10
5
 cells/mL in a 96-well plate and incubated for 
24 hours at 37
o
C, 5% CO2. Next day, cells were treated with the compounds and 
incubated for another 24 hours. After 24 hours, MTT solution at 2 mg/mL was added 
for 1 hour. Absorbance at 570 nm were measured and recorded. Results were expressed 
as a percentage of control giving percentage cell viability after 24 hours exposure to test 
agent. The potency of cell growth inhibition for each test agent was expressed as an 
EC50 value, defined as the concentration that caused a 50% loss of cell growth. Viability 
was defined as the ratio (expressed as a percentage) of absorbance of treated cells to 
untreated cells. 
 4.8.3.3 Statistical Analyses 
 Each experiment was performed at least three times. Results are expressed as the 
mean value ± standard deviation (SD). Log EC50 calculations were performed using the 
built-in algorithms for dose-response curves with variable slope using Graphpad Prism 
software (version 4.0; GraphPad Software Inc., San Diego, CA). A fixed maximum 
value of the dose-response curve was set to the maximum obtained value for each drug. 
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  4.8.4   Results  
 To evaluate the cytotoxic activity, compound was tested with a series of 
different doses on MTT, (Figures 4.27 ). After 24 hours, cell viability was determined 
by the MTT assay. Test agents induced cell cytotoxicity in a concentration dependent 
manner. These dose titration curves allowed determination of  EC50 for the test agents 
towards different cell lines (Tables 4.33 and Table 4.34 ).  
 In Table 4.33 showed mild cytotoxicity of selected compounds against various 
cancer cell lines; MCF-7 was 79.57 µg/mL for flavokawain B  LOB15 , PC3 was 30.12 
µg/mL, A549 was 65.03 µg/mL  and MCF-7 was 47.67 µg/mL for (+)-Onysilin LOB4,  
PC-3 was 90.13 µg/mL for (+)-pinocenbrin LOB2 and  MCF-7 was 96.33 µg/mL for 
LOB25 .  This results showed that cytotoxic activity of the isolated compounds from 
Lindera oxyphylla have moderate activity These results also  indicate that cell lines 
differ in their sensitivity to the same test agent, which may be determined by multiple 
cell type-specific signalling cascades and transcription factor activities.  
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Figure 4.27:  EC50 (µg/ml) of five compounds of Lindera oxyphylla 
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Table 4.33: Effect of compounds from Lindera oxyphylla on different cells type  
                    expressed as EC50 values in 24 hours using MTT assay. 
 
             
       
                                  
 Table 4.34: EC50 values of compounds in different cell lines from Litsea costalis. 
 
 
  
 
Cell lines 
LOB15 
EC50( µg/mL) 
LOB25 
EC50( µg/mL) 
LOB4 
EC50( µg/mL) 
LOB28 
EC50( µg/mL) 
LOB2 
EC50( µg/mL) 
 
A549 
 
 
>100 
 
 
>100 
 
65.03 
 
>100 
 
>100 
A375 >100 >100 >100 >100 >100 
WRL-68 >100 >100 >100 >100 >100 
PC-3 >100 >100 30.12 >100 90.13 
HT-29 >100 >100 >100 >100 >100 
 
MCF-7 
 
79.57 
 
96.33 
 
47.67 
 
>100 
 
>100 
Cell lines 
 
LCB3 
IC50 µg/mL 
 
LCB10 
IC50 µg/mL 
 
 
 
LCB4 
IC50 µg/mL 
 
 
 
LCB17 
IC50 µg/mL 
 
 
 
LCL7 
IC50 µg/mL 
 
WRL68 >100 81.73 ± 3.7 
 
>100 
 
>100 
- 
MCF-7 
48 ± 3.05 
>100 
 
34. 65± 0.1 
 
1.4 ± 0.1 
- 
.MDA-
MB231 
>100 
>100 
 
>100 
 
>100 
- 
CEMSS 
>100 
>100 
>100 
 
 
>100 
- 
PC3 
>100 
1.19 ± 0.19 
 
>100 
 
>100 
- 
HepG2 
18± 2.1 
>100 
 
>100 
 
1.00± 0.1 
 
10±1 
HT29 
>100 
>100 
 
>100 
 
1.32± 0.1 
- 
CCD841 
>100 
>100 
 
>100 
 
>100 
- 
Jurkat 
>100 
>100 
 
>100 
 
1.22± 0.1 
- 
A549 
>100 
85.13 ± 7.3 
 
>100 
 
>100 
- 
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 In Table  4.34 the selected compounds showed mild cytotoxicity against various 
cancer cell lines. In  MCF- 7 EC50 values  was 48 ± 3.05 and HepG2 was 18 ± 2.1 for 
biseugenol A  LCB3, WRL68 was 81.73 ± 3.7 , PC3 was 1.19 ± 0.19 and A549 was 
85.13 ± 7.3 for  biseugenol B  LCB10, MCF-7 was 34.65 ± 0.1 for Litsin LCB4, 
MCF-7 was 1.4 ± 0.1, HepG2 was 1.00 ± 0.1, HT29 was 1.32 ± 0.1  and Jurkat was 1.22 
± 0.1 for biseugenol C  LCB17 . 
 In addition of HepG2 test showed  (Figure 4.28) for  costalin LCL7, Other tests 
like clonogenic assay and quantification of apoptosis (AO/PI) were also carried out. 
 
4.8.4.1 MTT assay costalin LCL7 
 MTT assay was used to determine the cytotoxicity of costalin against 
human hepatocellular liver carcinoma cell line (HepG2). This assay served as an index 
used to determine cytotoxicity of compound to stimulate or inhibit cell viability and 
growth by detecting the reduction of tetrazolium salt to blue formazan by mitochondrial 
enzyme activity of succinate dehydrogenase in living cells. HepG2 cell lines were 
treated with different concentrations of the compound for 24, 48, 72h, and the cells 
viability were measured by MTT assay. The costalin  was found to inhibit the growth of 
HepG2 cells in a dose-dependent manner with IC50 of 10 ± 1, 8.5 ± 1 and 6.5 ± 1µg/mL 
for 24, 48 and 72 hours, respectively (Figure 4.28). 
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  Figure 4.28 : Effects of costalin LCL7 treatment in the human hepatocellular  
  carcinoma HepG2 cells.  
 
4.8.4.2 Clonogenic assay costalin LCL7 
 To further evaluate the antitumor potential of costalin, we used clonogenic assay 
to elucidate the effects of costalin on the growth of HepG2 cells. Costalin treated 
HepG2 cells inhibited the clonogenic growth of HepG2 cells at concentrations of 6.5, 10 
and 16 µg/mL by 28%, 54% and 98%, respectively, in comparison with untreated cells 
as control (Table 4.35). The clonogenic efficiency (CE) of HepG2 cells at the dosage of 
6.5, 10 and 16 μg/mL was reduced to 7, 4 and 0 (μg/mL), respectively, as compared to 
the untreated control cells. Clonogenicity of HepG2 cells were reduced in a dose-
dependent manner after treatment with costaline and no viable colony was observed at 
concentration higher than 16 μg/mL. This result indicated that costalin was able to 
inhibit HepG2 cell proliferations (Figure 4.29 and Table 4.35). 
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Table 4.35: The cloning efficiency (CE) of the costalin LCL7 on HepG2 cell line after 24 hrs. 
 
 CE*: clonogenic efficiency; 
*
IC50 
 
 
       
 
 
       
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.29: Comparison of colony formation rates at different concentrations of 
 costalin LCL7  on HepG2 cells at 24 hr. Data are mean ± SD (n = 3).  
  
 
 
 
4.8.4.3 Quantification of apoptosis (AO/PI) costalin LCL7 
 The percentages of viable, apoptotic and necrotic cells were determined in more 
than 200 cells. Acridine orange (AO) and propidium iodide (PI) are intercalating nucleic 
acid specific fluorochromes which emit a green and orange fluorescence, respectively, 
when they are bound to DNA. Of the two, only AO can cross the plasma membrane of 
Compound Concentrations 
(µg/mL) 
No. of 
Cells 
Total viable 
colony numbers 
before treatment 
Number of 
Apoptotic 
Colonies 
Death of 
clonogenic 
cells 
(%) 
Clonogenic 
efficiency 
(%) 
(Control) - 5×10
3
 500 5  ± 1.5 1 9 
 
Costalin 6.5 5×10
3
 500 137 ± 12 28 7 
 
Costalin 10 5×10
3
 500 266  ± 15 54 4 
 
Costalin 16 5×10
3
 500 500  ± 12 - 0 
 
C
o
lo
n
y
 
F
o
rm
a
ti
o
n
 
R
a
te
s 
Concentration (μg/mL) 
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viable and early apoptotic cells. Viewed by fluorescence microscopy, viable cells 
appear to have a green nucleus with intact structure while apoptotic cells exhibit a 
bright-green nucleus showing condensation of chromatin as dense green areas.  Late 
apoptotic cells and necrotic cells will stain with both AO and PI. Comparatively, PI 
produces the highest intensity emission. Hence, late apoptotic cells exhibited an orange 
nucleus showing condensation of chromatin whilst necrotic cells display an orange 
nucleus with intact structure (Figure 4.30). This assay provides a useful quantitative 
evaluation and was done three times (n = 3). 
 
 
 
 
 
 
 
 
 
 
` In addition of MTT test for  biseugenol A LCB3 and biseugenol B LCB10 other 
tests like clonogenic assay and quantification of apoptosis (AO/PI) were also carried 
out. 
 
 
 
Figure 4.30: HepG2 cells stained with AO/PI. Panel (A) shows the green viable 
HepG2 cells with diffused chromatin as control (Magnification, 20X).  
 
C B 
A 
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4.8.4.4 Cell viability study of  biseugenol A LCB3 and biseugenol B LCB10 
 The IC50 values of biseugenol A LCB3 and biseugenol B LCB10 were  shown 
in (Table 4.36). Cell viability was analysed using the MTT assay, measuring metabolic 
activity. In cells with normal metabolism, a tetrazolium salt is converted to formazan, 
measurable by change in absorbance. Among the three compounds, biseugenol B 
LCB10 exhibited the most significant anti-cancer effects, but it was interesting to note 
that only in PC3 cell lines that is showed very potent cytotoxicity effect. All other cell 
lines except WRL68 (IC50: 81.73 ± 3.7 µg/ml) and A549 (IC50: 85.13± 7.3 µg/ml) had 
no effect until 100 µg/ml.  
 On the other hand we found that biseugenol A LCB3 was only significantly 
active on HepG2 cells as there was no sign of toxicity by this compound in other tested 
cell lines. Considering these data, biseugenol B LCB10 shown to have high level of 
significance to be exploited in the molecular level for development as a lead compound 
in the anti-cancer drug discovery against prostate cancer.  
 Table 4.36. EC50 values of biseugenol A LCB3 and biseugenol B LCB10  in different  cell 
         lines. 
 
 
Cell Line biseugenol A  LCB3( µg/mL) biseugenol B  LCB10 (µg/mL) 
WRL68 >100 81.73±3.7 
MCF7 48±3.05 >100 
MDA-MB-231 >100 >100 
CEMSS >100 >100 
PC-3 >100 1.19±0.19 
HepG2 18±2.1 >100 
HT29 >100 >100 
CCD841 >100 >100 
Jurkat >100 >100 
A549 >100 85.13±7.3 
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4.8.4.5 Clonogenic assay biseugenol A LCB3 and biseugenol B LCB10 
       In order to evaluate the ability of the biseugenol A LCB3 and biseugenol B LCB10 
to inhibit the growth of HepG2 cells, cells were treated with increasing amounts of 
compounds. The number of colony-forming cells was reduced in a concentration-
dependent manner. The cloning efficiency (CE) of biseugenol A LCB3 on HepG2 cells 
at the dosage of 26, 36 and 50 μg/mL was 0.073, 0.044 and 0.00, respectively, but CE of 
untreated HepG2 cells (as control) was 0.098. The cloning efficiency (CE) of 
biseugenol B LCB10 on PC-3 at the dosage of 1.19, 3 and 5 μg/mL was 0.046, 0.025 
and 0.00, respectively,  but CE of untreated   PC-3 cells (as control) was 0.097 (Table 
4.37 and Table 4.38) and (Figure 4.31). No viable colony could be observed at dosage 
of 50 and 5 μg/mL for HepG2 and PC-3, respectively which indicated the inhibition of 
proliferation activity of HepG2 and PC-3 cells in vitro condition. This result was 
consistent with the result of MTT assay. 
 
Table 4.37. The cloning efficiency (CE) of the biseugenol A LCB3 on HepG2 cells in 48 hrs. 
 
CE*: clonogenic efficiency; 
*
IC50 
 
 
 
 
 
 
 
 
 
 
 
Compound Concentrati
on 
(µg/mL) 
Number of 
Cells/Plate 
Total viable colony 
number before 
treatment 
Number of 
Apoptotic Colonies  
(size of 50-200 µm) 
CE* 
Untreated 
HepG2 
(Control) 
- 5×10
3
 500 10 0.098 
biseugenol A 18 (µg/mL)
*
 5×10
3
 500 190 0.062 
 
biseugenol A 36 (µg/mL) 5×10
3
 500 290 0.042 
 
biseugenol A 50 (µg/mL) 5×10
3
 500 500 0 
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Table 4.38. The cloning efficiency (CE) of the biseugenol B LCB10 on PC-3 cells in 48 hrs. 
 
CE*: clonogenic efficiency; 
*
IC50 
 
 
 
 
 
 
  
 
      Figure 4.31: Comparison of colony formation rate using different concentrations of     
compounds biseugenol A LCB3 and biseugenol B LCB10 on HepG2 
and PC-3 cell lines respectively in 48 hrs. 
 
  4.8.4.6. Quantification of apoptosis biseugenol A LCB3 and biseugenol B LCB10 
 Apoptosis was quantified using propidium iodide (PI) and acridine-orange (AO) 
double staining and examined under fluorescence microscope (Lieca, Germany) 
attached with Q-Floro Software. Briefly, treatment was carried out in a 25 ml culture 
flask. Cells were plated at a concentration of 1×10
6
 cell/mL and treated with IC50 of 26 
µg/mL. Flasks were incubated in an atmosphere of 5% CO2 at 37°C for 48 hrs. 
Harvested cells were washed, stained with fluorescent dyes and observed under a UV-
fluorescence microscope within 30 min before the fluorescence color starts to fade. 
 
Compound Concentratio
n 
(µg/mL) 
Number 
of 
Cells/Plate 
Total viable 
colony number 
before treatment 
Number of Apoptotic 
Colonies  
(size of 50-200 µm) 
CE* 
UntreatedPC-
3 (Control) 
- 5×10
3
 500 12 0.097 
biseugenol B 1.19 (µg/mL)
*
 5×10
3
 500 270 0.046 
 
biseugenol B 3 (µg/mL) 5×10
3
 500 375 0.025 
 
biseugenol B 5 (µg/mL) 5×10
3
 500 500 0 
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E
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4.8.4.7 Quantification of apoptosis (AO/PI) biseugenol A LCB3 and biseugenol B 
  LCB10 
 
 The percentages of viable, apoptotic and necrotic cells were determined in more 
than 200 cells. Acridine orange (AO) and propidium iodide (PI) are intercalating nucleic 
acid specific fluorochromes which emit a green and orange fluorescence, respectively, 
when they are bound to DNA. Of the two, only AO can cross the plasma membrane of 
viable and early apoptotic cells. Viewed by fluorescence microscopy, viable cells appear 
to have a green nucleus with intact structure while apoptotic cells exhibit a bright green 
nucleus showing condensation of chromatin as dense green areas. Late apoptotic cells 
and necrotic cells will stain with both AO and PI. Comparatively, PI produces the 
highest intensity emission. Hence, late apoptotic cells exhibited an orange nucleus 
showing condensation of chromatin. On the other hand necrotic cells display an orange 
nucleus with intact structure. This assay provides a useful quantitative evaluation and 
was done in triplicates (n = 3) (Figure 4.32). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.32 : Apoptosis quantification of HepG2 and PC-3 cells stained with AO/PI. Panel (A) and 
(C) show the green viable HepG2 and PC-3 cells,  
A B 
C D 
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In addition of MCF-7 test for  Litsin  LCB4, other tests like clonogenic assay and 
quantification of apoptosis (AO/PI) were also carried out. 
4.8.4.8   MTT assay Litsin LCB4 
 MTT assay was used to determine the Litsin LCB4 cytotoxicity against MCF-7. 
This assay served as an index used to determine cytotoxicity of compound to stimulate 
or inhibit cell viability and growth by detecting the reduction of tetrazolium salt to blue 
formazan by mitochondrial enzyme activity of succinate dehydrogenase in living cells. 
MCF-7 cell lines were treated with different concentrations of Litsin LCB4 1 for 48 h, 
and the cells viability were measured by MTT assay. The compound was found to 
inhibit the growth of MCF-7 cells in a dose-dependent manner with IC50 of 17 ± 1 
µg/mL (Fig 4.33). 
 
 
 
 
 
 
 
 
Figure.4.33: Percentage viability of MCF-7 cells treated with different 
      concentration meagureed after 48 hours  using MTT assay. 
 
4.8.4.9 Clonogenic assay Litsin LCB4 
 In order to evaluate the ability of the compound inhibit growth of MCF-7 cells, 
cells were treated with increasing amounts of compound. The number of colony-
forming cells was reduced in a concentration-dependent manner by the compound. The 
cloning efficiency (CE) of MCF-7 at the dosage of 17, 35 and 45 μg/mL was 0.056, 
0.024 and 0.00 respectively and CE of untreated MCF-7 cells was 0.098 as control. No 
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viable colony could be observed at the dosage of 50 μg/mL, which indicated compound 
can pronounced inhibit the proliferation of MCF-7cell (Table 4.38). This result is 
consistent with the result of MTT assay. 
Table.4.39: The cloning efficiency (CE) of the new compound Litsin LCB4 on MCF-7 cells  
                    after 48 hrs. 
CE*: clonogenic efficiency; 
*
IC50 
 
 
   
 
 
 
 
 
 
 
Figure.4.34: Comparison of colony formation rate using different 
                     concentrations of Litsin LCB4 on MCF-7 after 48 hr. 
 
 
4.8.4.10 Quantification of apoptosis (AO/PI) Litsin LCB4 
 The percentages of viable, apoptotic and necrotic cells were determined in more 
than 200 cells. Acridine orange (AO) and propidium iodide (PI) are intercalating nucleic 
acid specific fluorochromes which emit a green and orange fluorescence, respectively, 
Compound Concentration 
(µg/mL) 
Number 
of 
Cells/Plate 
Total viable colony 
number before 
treatment 
Number of 
Apoptotic Colonies 
 (size of 50-200 µm) 
CE* 
Untreated 
MCF-7 
(Control) 
- 5×10
3
 500 10 0.098 
Litsin 17 (µg/mL)
*
 5×10
3
 500 220 0.056 
 
Litsin 35 (µg/mL) 5×10
3
 500 380 0.024 
 
Litsin 45 (µg/ml) 5×10
3
 500 500 0 
 
0
0.02
0.04
0.06
0.08
0.1
0.12
Untreated MCF-7
(control)
compound 17
(µg/ml)
compound 35
(µg/ml)
compound 45
(µg/ml)
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when they are bound to DNA. Of the two, only AO can cross the plasma membrane of 
viable and early apoptotic cells. Viewed by fluorescence microscopy, viable cells 
appear to have a green nucleus with intact structure while apoptotic cells exhibit a bright 
green nucleus showing condensation of chromatin as dense green areas. Late apoptotic 
cells and necrotic cells will stain with both AO and PI. Comparatively, PI produces the 
highest intensity emission. Hence, late apoptotic cells exhibited an orange nucleus 
showing condensation of chromatin. On the other hand necrotic cells display an orange 
nucleus with intact structure. This assay provides a useful quantitative evaluation and 
was done in triplicates (n = 3) (Figure 4.36). 
 
 
 
 
 
 
 
 
 
 
 
4.8.4.11 Litsin LCB4-induced caspase-3/7, 8, and 9 activations 
 An activation of caspases (aspartate specific cysteine protease) is one of the 
biochemical changes during apoptosis. All the levels of caspase-3/7, 8 and 9 induced 
by Litsin LCB4 treatment were markedly increased (2–6 folds) as compared to the 
untreated group. High level of caspase 3/7, 8 and 9 was found at 24 (p < 0.01), 48(p < 
0.05) and 24(p < 0.01) hours, respectively. However, low level of caspase 3/7, 8 and 9 
Figure4.35: MCF-7 cells stained with AO/PI. Panel (A) shows the green viable MCF-7 
cells with diffused chromatin as control (Magnification, 20X).  
 
A B C 
273 
 
was found at 6 (p < 0.05), 3 (p < 0.01) and 6 (p < 0.01) hrs (Figure 4.36, 4.37, 4.38), 
respectively. These results indicate that apoptosis induced by litsin was mediated via 
caspase activations. 
 
 
  
 
 
 
 
 
   Figure 4.36. Relative luminescence expression of Caspase 3/7 in the MCF7 cells 
                      treated with different concentrations of Litsin LCB4.  
 
 
 
 
 
 
 
 
 
 
 
 Figure.4.37. Relative luminescence expression of caspase 8 in the MCF7 cells 
                       treated with different concentrations of  Litsin LCB4 .  
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          Figure 4.38. Relative luminescence expression of Caspase 9in the MCF7 cells 
                        treated with different concentrations of Litsin LCB4.  
     
 In the intrinsic pathway, the release of cytochrome from the mitochondria into 
the cytosol is fundamental to apoptosome formation and downstream caspase activation. 
The release of cytochrome c and the activation of caspase 3/7, 9 and 8 by Litsin LCB4 
at different time clearly showed that the apoptosis happened are through this pathway. 
There are evidences that members of the Bcl2 protein family are key mediators of 
cytochrome c release in the context of apoptotic stimuli (Kluck et al., 1997) (Green, 
2006). Many lines of evidence established that activation of caspase is a central 
mechanism of apoptosis (Vaux and Kobmeyer et al.,  1999). The treatment with Litsin 
LCB4 on MCF7 cells activated the caspases 3/7, 8 and 9. Caspase 9 is found in the 
intermembrane space of mitochondria, and released in a Bcl2-inhibitable fashion upon 
induction of permeability transition in isolated mitochondria and upon apoptosis 
induction in cells. The released caspase 9 is then activate post-mitochondrial caspases 
including caspase 3 and 7, the disassembly of the cell occurs in what is known as the 
execution phase of apoptosis (Li et al., 2010) (Susin et al., 1999). Even though, caspase 
8 activation was found both upstream and downstream of mitochondria, it is closely 
involved with apoptosis signaling through the extrinsic pathway (Jin et al., 2009). 
Besides, in many instance caspase 8 may interlinked to mitochondrial pathways by 
cleavage of Bcl2 family member Bid to tBid (Gu et al., 2005). 
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In addition of Anticancer test for Biseugenol C, other tests like BC inhibits TNF-α-
induced NF-kB nuclear translocation, induced caspases activation were also carried out. 
4.8.4.12 BC inhibits TNF-α-induced NF-kB nuclear translocation 
 The role of BC in the inhibition of activated NF-kB induced by the 
inflammatory cytokine, TNF-α using Alexa Fluor 488-conjugated anti-NF-kB antibody 
was investigated. In control cells (Fig. 4.39), high NF-kB fluorescent intensity was 
found in cytoplasm but faintly in nuclei, which indicated that there was no NF-kB 
activation at the non-stimulated condition. Meanwhile, TNF-α alone stimulated cell 
significantly increased the NF-kB fluorescent intensity in the nuclei. BC exhibited 
significant inhibitory effects on the activation of NF-kB (Fig. 4.40). In the cells treated 
with curcumin, a known inhibitor of NF-κB activation, it was observed that significant 
inhibition of TNF-α-induced NF-κB nuclear translocation as evidenced by low nuclear 
NF-κB-related fluorescence intensity (Fig. 4.40). In parallel, the morphological changes 
of NF-kB translocation indicated by immunofluorescence staining (Fig. 4.40) showed 
an inhibitory effect of BC on TNF-α-induced NF-kB translocation in a dose-dependent 
manner with a strong inhibition at 2 and 3 µg/ml concentration of BC. 
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                                                                Figure 4.39: NF-kB fluorescent intensity 
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                                    Figure 4.40: NF-kB fluorescent intensity in the nuclei 
 
4.8.4.13 BC induced caspases activation 
 To determine whether caspases are involved in apoptosis induction by BC, the 
protein levels of active caspases in BC-treated cells were evaluated. Activation of both 
the caspases were found to be time-dependent (Figure 4.41). Caspase-8 activity was 
significantly elevated at the 6 hour of treatment and progressed to a maximal level (2.5-
fold over vehicle control) after 24 hours of incubation (Fig. 4.41). The same pattern of 
caspase expressions were observed for capsase-9. Cell permeable-specific inhibitors of 
caspase-8 (z-IETD-FMK) and caspase-9 (z-LEHD-FMK) were added into BC treatment 
to determine whether the activation of caspase-8 and -9 by BC can be blocked by these 
inhibitors. The results obtained were clearly showed the activation of caspase-8 and -9 
by BC in MCF-7 cells. 
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                                                  Figure 4.41: active caspases in BC-treated cells 
 
4.8.4.14 BC up-regulated Bax and suppressed the expression of Bcl2 and HSP70  
             protein 
 
 The changes occurred to the MMP and cytochrome c release led us to confirm 
the role of mitochondria in the apoptosis occurred by BC at protein level using western 
blot analysis. Exposure of MCF7 cells to BC increased the pro-apoptotic protein, Bax 
and decreased the expression of anti-apoptotic, Bcl2 protein. Further, the expression of 
HSP70 did down regulated in a concentration-depended manner (Figure 4.42). 
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Figure 4.42: The changes occurred to the MMP and cytochrome c release led us to 
                     confirm the role of mitochondria in the apoptosis occurred by BC 
 
 
4.8.4.15 BC-induced apoptosis in MCF7 cells 
 To confirm the presence of apoptosis, we examined nuclear morphological 
changes of MCF7 cells by determining nuclear condensation and fragmentation 
hallmark for apoptosis (Fig.4.43). Hoechst 33342 staining showed that a part of the cells 
displayed nuclear condensation at 24 h after BC treatment. The nuclear intensity which 
is directly corresponding to apoptotic chromatin changes: blebbing, fragmentation and 
condensation where quantitated in (Figure 4.44) Meanwhile, concurrent increase in the 
cell permeability also was observed. 
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        Figure 4.43: MCF7 cells by determining nuclear condensation and fragmentation 
            hallmarkforapoptosis
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Figure 4.44: Quantitative analysis of BC mediated apoptosis parameter. Changes in A)   
                      total nuclear intensity, B) cell permeability, C) mitochondrial membrane             
 potential and D) cytochrome c localization were all measured  
 simultaneously in MCF7 cells. 
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CONCLUSION 
  
 Two species from family Lauraceae have been studied for their chemical 
constituents. They were  Lindera oxyphylla (KL 5359) and Litsea costalis (Nees) 
Kosterm (KL 5410). Phytochemical studies of these two species from Lauraceae led to 
the isolation and structural elucidation  of alkaloids,  flavonoids, linderone, phenolic 
compounds, neolignan, oxyneolignan, aldehyde and  benzamide as shown in (Table 
5.1).  Structural elucidation was established through several spectroscopic methods, 
notably UV, IR, MS (HRMS, GCMS, and LCMS), and 1D, 2D-NMR (
1
H-NMR, 
13
C 
NMR, COSY, DEPT, HMQC, HMBC, NOESY, and single crystal X-ray diffraction 
analysis. The bark of lindera oxyphylla yielded three flavanones, namely  (+)-onysilin 
LOB4, (+)- pinostrobin LOB7 and (+)-pinocenbrin LOB2; one chalcone, namely 
flavokawain B LOB15 and two ketones, namely, 2-cinnamoyl-3-hydroxy-4,5-
dimethoxycyclopenta-2,4-dienone or linderone A LOB25 which is a new compound 
and known (E)-2-(1-hydroxy-3-phenylallylidene)-4,5-dimethoxycyclopent-4-ene-1,3-
dione or  linderone LOB28. Seven compounds have been isolated from the leaves of 
this species and these compounds were one flavanone, namely kaempferol LOL34 and  
a ketone, (E)-4,5-dimethoxy-2-(1-methoxy-3-phenylallylidene)cyclopent-4-ene-1,3-
dione or methylinderone LOL18, and five aporphine alkaloids, namely (+)-
laurotetanine LOL20, N-methyllaurotetanine LOL35, (+)-norboldine   LOL50, (+)-10-
O-methylhernovine LOL63 and (+)-norisoboldine LOL65.  nine compounds have 
been isolated from the bark of Litsea costalis (Nees) Kosterm and these compounds 
were 3, 4-dimethoxycinnamaldehyde LCB7, 2-hydroxy-5-methoxybenzaldehyde  
LCB11, 2, 5-dimethoxybenzaldehyde  LCB15, 4,4'-diallyl-6,6'-dimethoxy-[1,1'-
biphenyl]-2,2'-diol LCB9, 4,4'-diallyl-5,5'-dimethoxy-[1,1'-biphenyl]-2,2'-diol 
LCB3 which is a new compound and belongs to neolignin group  of compound and 
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named biseugenol A , 2, 2'-oxybis (4-allyl-1-methoxybenzene)  LBC10 which is a new 
from lignan  group of compound and named biseugenol B, 1,2-bis (5-allyl-2-
methoxyphenyl)hydrazine LCB17 which is a new compound and named as 
biseugenol C, (E)-4(4-hydroxy-1, 1-dimethoxybut-2-en-1-yl) benzene-1, 2-diol LCB4 
which is also a new compound and named litsin and (E)-4-styrylphenol  LCB58. 
eight compounds have been isolated from the leaves of this species and these 
compounds were cinnamide  LCL4, 2,4-dimethoxybenzamide  LCL2, 3,4- 
dimethoxybenzamide LCL5, 4-allyl-1, 2-dimethoxybenzane LCL15, 2S,4S-2-(3',4'-
methylenedioxyphenyl)-5,7-dimethoxy chroman -4-ol LCL7 which is a new compound 
which belongs to chroman group of compound and named costalin,  (+)- pinostrobin 
LCL9, (+)-onysilin LCL13 and (+)-pinocenbrin LCL14. 
 These constituents showed interesting biological bioactivities such as 
antioxidant and cytotoxicity activities. The results showed the IC50 values for DPPH 
assay from compounds of Lindera oxyphylla,  flavokawain B LOB15 (+)-onysilin 
LOB4  was, (+)-pinocenbrin LOB2, linderone LOB28 and linderone ALOB25 were  
8.5, 78.97, 41.32,  157.58  and  149.45 μg/mL, respectively. 
 The IC50 for DPPH assay for  compounds from Litsea costalis (Nees) Kosterm  
showed that IC50 for biseugenol C LCB17 was 16.34 μg/mL, 2,5-
dimethoxybenzaldehyde  LCB15 was 161.81 μg/mL, biseugenol B LCB10 was 81.92 
μg/mL, 2-hydroxy-5-methoxy benzaldehyde  LCB11 was 81.92 μg/mL, biseugenol A 
LCB3 was 4.77 μg/mL, 3,4-dimethoxycinnamaldehyde  LCB7 was 73.24 μg/mL, litsin 
LCB4 was  26.69 μg/mL and costalin LCL7 was  76.45 μg/mL.  Ascorbic acid was 
used as  positive control and exlutited value  IC50  of 4.62 µg/mL. 
 The FRAP experiments for the isolated compounds from Lindera oxyphylla 
showed that the absorbance of flavokawain B  LOB15 was 1.0 ± 0.06, (+)-onysilin 
LOB4 was 0.7 ± 0.02,  (+)-pinocenbrin LOB2 was 0.6 ± 0.01, linderone  LOB28 was 
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0.5 ± 0.02 and  linderone A LOB25 was 0.5 ± 0.03. 
 Metal Chelating assay  for the isolated  compounds showed that the Inhibition 
% of Lindera oxyphylla,  flavokawain B  LOB15 was  25.69± 0.01,  (+)-Onysilin LOB4 
was 26.11 ± 0.01, (+)-pinocenbrin LOB2 was 33.37 ± 0.01, linderone LOB28 was 
13.09 ± 0.006  and  linderone ALOB25 was 13.51± 0.01. 
 The Anti Cancer study showed mild cytotoxicity against various cancer cell 
lines; MCF-7 was 79.57 µg/mL for flavokawain B  LOB15 , PC3  was 30.12 , A549  
was 65.03  and MCF-7 was 47.67 for (+)-onysilin LOB4,  PC-3 was 90.13 for (+)-
pinocenbrin LOB2 and  MCF-7 was 96.33 for LOB25. These constituents showed 
interesting biological bioactivities such as antioxidant and cytotoxicity activities Litsea 
costalis; Anti Cancer: showed mild cytotoxicity against various cancer cell lines; 
MCF-7 was 48 ± 3.05 and HEPG2 was 18 ± 2.1 for biseugenol A  LCB3, WRL68 was 
81.73 ± 3.7 , PC3 was1.19 ± 0.19 and A549 was 85.13 ± 7.3 for , biseugenol B LCB10, 
MCF-7 was 34.65 ± 0.1 for Litsin LCB4, MCF-7 was1.4 ± 0.1, HEPG2 was 1.00 ± 0.1, 
HT29 was 1.32 ± 0.1 and Jurkat was 1.22 ± 0.1 for biseugenol C LCB17. 
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Table 5.1: Chemical constituent from Lindera oxyphylla and Litsea costalis 
 
Species Part of 
Plants  
Remark Types of skeleton 
 
 
Lindera 
oxyphylla 
(KL 5359) 
 
 
 
 
 
Bark 
(+)-Onysilin 4 Flavanone 
Linderone 28 Linderone 
Flavokawain B 15 Chalcone 
Linderone A  25 Linderone 
(+)-Pinocenbrin 2 Flavanone 
(+)-pinostrobin 7 Flavanone 
 
 
Leaves 
Methyl Linderone 34 Linderone 
Kaempferol 5 Flavonol 
(+)- laurotetanine 20 aporphine 
N-Methyllaurotetanine 35 aporphine 
(+)- norboldine 50 aporphine 
(+)-10-O-N-methylhernovine 63 aporphine 
(+)-  norisoboldine 65 aporphine 
 
 
 
 
 
Litsea costalis 
(KL 5410) 
 
 
 
 
 
Bark 
3, 4-dimethoxycinnamaldehyde 7 Aldehyde 
2-hydroxy-5-methoxy benzaldehyde 11 Aldehyde 
2, 5-dimethoxybenzaldehyde  15 Aldehyde 
4,4'-diallyl-6,6'-dimethoxy-[1,1'-
biphenyl] -2,2'-diol (biseugenol  ) 9 
neolignan 
4,4'-diallyl-5,5'-dimethoxy-[1,1'-
biphenyl] -2,2'-diol (biseugenol A ) 3 
neolignan 
2,2'-oxybis(4-allyl-1-methoxy benzene) 
(biseugenol B)  10 
Oxyneolignan 
1,2-bis(5-allyl-2-methoxyphenyl) 
hydrazine (biseugenol C)  17 
Hydrazine 
(E)-4(4-hydroxy-1, 1-dimethoxybut-2-en-
1-yl) benzene-1, 2-diol (Litsin)4 
Phenolic  Compound 
4-Hydroxystibene 58 Stilbene 
 
 
Leaves 
 
 
 
Cinnamide 4 Amide 
2,4-dimethoxybenzamide  2 Benzamide 
3,4- dimethoxybenzamide  5 Benzamide 
2S,4S-2-(3',4'-methylenedioxyphenyl)-5,7-
dimethoxychroman-4-ol   (Costalin)7 
Flavonoid 
(+)-Pinocenbrin 9 Flavanone 
4-allyl-1,2-dimethoxybenzane 15 Lignan 
(+)-Pinostrobin 14 Flavonoid 
(+)-Onysilin 13 Flavonoid 
  4-allyl-2methoxyphenol 17 Lignan 
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Figure 5.1: Submitted structures of chemical constituents from two genera 
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EXPERIMENTAL 
6.1 Solvents 
 Industrial grade solvents were used for extraction and these solvents were 
distilled twice before use. Analytical gred solvents were used for chromatographic 
separation of the compounds. HPLC grade solvent were used for high performance 
liquid chromatography analysis. 
  Chemicals used  for  antioxidant assay  were  DPPH (1,1' diphenyl-2-picryl-
hydrazyl), trichloroacetic acid, sodium phosphate monobasic, sodium phosphate 
dibasic,  ascorbic acid , potassium ferricyanide,  ferrozine and ethylenediamine 
tetraacetic acid were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Ferric 
chloride and methanol were purchased from Chemolab Supplies (Kuala Lumpur, 
Malaysia). 
6.2 Instruments 
 Melting points were taken on hot stage Gallen Kamp melting point apparatus 
 and uncorrected.  
 Compact hot plate stirrer with a Ceran top plate of 135x135mm and heating 
 from 40-400 
0
C. The brushless DC motor enables precise speed control from 80-
 1600 rpm. 
 UV spectra were obtained using Shimadzu UV-160 Ultraviolet-Visible 
 Spectrometer. Solvent used was methanol (CH3OH) while the wavelength in 
 which the spectrum was recorded is 200-700 nm.  
 IR spectra were obtained with CHCl3 on a Perkin Elmer Spectrum 2000-FTIR 
 Spectrometer.  
 Optical rotations were determined on JASCO (Japan) P1000 automatic digital 
 polarimeter. 
 The mass spectra were measured on a JMS 700 spectrometer using NBA as the 
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 matrix for FAB analysis. The Automass Thermofinnigan was used for HRESI  
 and  ESI
-  
 analysis. The EIMS spectra were obtained on Shimadzu GC-MS 
 QP2000A spectrometer 70 eV. 
 The NMR (
1
H, 
13
C and 2D) spectra were recorded in deuterated chloroform on  
 JEOL JNM-FXIOO (400 MHz).  Chemical shifts were reported in ppm and the 
 coupling constants were given in Hz. 
 
6.3 Chromatography 
 6.3.1 Thin Layer Chromatography (TLC) 
 Aluminum supported silica ge1 60F 254 TLC sheets (Merck 1.05554.0001); 
glass ported silica ge1 60F254 TLC plates (Merck 1.05715.0001) were used for TLC. 
Fractions were monitored by TLC profiling and appropriate fractions were combined 
and when necessary subjected to further separation by chromatographic  technical TLC. 
TLC was routinely used to detect and separate the various alkaloids. The alkaloid spots 
were visualized under UV light (254 and 365 nm), followed by spraying with 
Dragendorff’s reagent which gave orange colour.  
6.3.2 Column chromatographic  
 Silica ge160F, 70-230 mesh ASTM (Merck 7734) and silica ge160F, 230-400 
mesh ASTM (Merck 9385) were used for column chromatography.  
A slurry of silica gel 60 (appoximately 30:1 silica gel to sample ratio) in solvent was 
poured into a glass column with gentle tapping to remove the trapped air bubbles.  The 
crude exract was dissolved in a minimum amount of solvent and loaded on the top of 
packed column. The extract was eluted with appropriate solvent system at a certain flow  
rate and the fraction was collected using 10 mL test tubes. Fractions with the same TLC 
profiling were combined and evaporated to dryness. 
 
 291 
 
6.3.3 High Performance Liquid Chromatography (HPLC) 
 Waters HPLC System was used for HPLC separation, equipped with Binary 
Gradient Module, System Fluidics Organizer and UV detector set at the range from 
200-400 nm. Chromatographic analysis and separations were performed supelco (15 cm 
x 10 mm x 5µm) HPLC columns. HPLC grade methanol and deionized water were used 
as mobile phase solvents with HPLC grade formic acid as buffer. All solvents and 
samples were filtered with 0.45 μm nylon membrane filter (Waters) prior to HPLC 
analysis. The data were collected and analysed by using MassLynx software. 
6.4 Plant Materials 
 The plant materials were collected and identified by phytochemical team, 
Chemistry Department, Faculty of Science, University of Malaya. The specimens were 
deposited at the Chemistry Herbarium, Faculty of Science, University of Malaya. The 
locality and the times of collection are shown in the (Table 6.1). 
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Table 6.1: Yield of crude extracted from Lindera oxyphylla and Litsea costalis (Nees) 
                  Kosterm (Lauraceae) 
 
 
6.5 Reagents 
 Mayer's and Dragendorff's reagent were used for alkaloid screening and to detect 
the presence of alkaloids.  
6.5.1 Mayer’s reagent (Potassium mercuric iodide)   
 A solution of mercury (II) chloride (1.4 g) in distilled water (60 mL) was mixed 
into a solution of potassium iodide (5.0 g) in distilled water (10 mL). The mixture was 
then made up to 150 mL with distilled water. Positive result is indicated by the 
formation of white cloudy or precipitate. 
 
Species 
 
Herbarium 
Specimen 
Number 
 
Location and 
Date 
of collection 
 
Part of 
plant 
Weight of 
crude 
extract (g) 
 
% 
Yield 
 
 
 Lindera oxyphylla 
(Lauraceae) 
 
 
 
 
 
KL5359 
 
Hutan Simpan 
Ulu Muda, 
Baling, Kedah 
09/02/2007 
 
 
 
 
Leaves 
 (2.00 kg) 
 
 
N-hexane, 5 g 
 
DCM, 2 g 
 
MeOH, 1 g 
 
0.25 
 
0.1 
 
0.05 
 
Lindera oxyphylla 
(Lauraceae) 
 
 
 
KL5359 
 
Hutan Simpan 
Ulu Muda, 
Baling, Kedah 
09/02/2007 
 
 
 
Bark 
 (3.00 kg) 
 
 
N-hexane, 13 g 
 
DCM, 1 g 
 
MeOH, 1 g 
 
 
0.43 
 
0.03 
 
0.03 
 
Litsea 
costalis(Nees) 
Kosterm  
(Lauraceae) 
 
 
 
 
KL5410 
 
 
 
Hutan Simpan 
Piah Lasah Sg, 
Siput, Perak 
12/04/2007 
 
 
 
 
Leaves 
 (1.5kg) 
 
 
 
N-hexane, 3 g 
 
DCM, 2 g 
 
 
 
 
 
0.2 
 
0.13 
 
 
 
Litsea costalis 
(Nees) 
Kosterm  
(Lauraceae) 
 
 
 
KL5410 
 
 
Hutan Simpan 
Piah Lasah Sg, 
Siput, Perak 
12/04/2007 
 
 
 
Bark 
 (2 kg) 
 
 
 
n-Hexane, 5 g 
 
DCM, 10 g 
 
MeOH, 2 g 
 
 
 
0.25 
 
0.5 
 
0.1 
 293 
 
6.5.2 Dragendorff's reagent (Potassium bismuth iodide) 
 Solution A: Bismuth (III) nitrate (0.85 g) in a mixture of glacial acid (10 mL) 
 and distilled water (40 mL).  
 Solution B: Potassium iodide (8.0 g) in distilled water (20 mL) Stock solution: 
 A mixture of equal volumes of solution A and solution B. The stock solution (20 
 mL) was diluted in a mixture of acetic acid (20 mL) and distilled water (60 mL)  
 Dragendorff's test: Positive result is indicated by the formation of   orange, 
 yellow or red spots on TLC plate. 
                                                                                                        
6.6 Extraction and Isolation  
6.6.1 Extraction and isolation of Lindera oxyphylla. 
 The dried and ground bark of Lindera oxyphylla (KL5359), (3.0 kg) was 
extracted with n-hexane (10.0 L) for 72 hours followed by evaporation of solven to give 
crude extract (13.0 g). The crude extracts were subjected  to exhaustive column 
chromatography over silica gel using n-hexane/dichloromethane as a solvent system 
with ratio 100:0→0:100 to give 30 fractions. Fractions 1 to 4 were combined and the 
resulted compounds was separated using PTLC Merck KGaA silica gel 60 F254; using  
N-hexane-dichloromethane; 98:2 as a solvent system  to afford (+)-onysilin LOB4 (50.0 
mg; 0.4% ). linderone LOB28 (10.0 mg; 7.69%) was obtained from the combination of 
fraction 20 to 28 using n-hexane-dichloromethane; 80:20) as a solvent system. 
 The plant residue was dried and left to soak with CH2Cl2 (12.0 L) for 4 days 
followed by filtration and solvent evaporation to give crude extract (1.0 g). The crude 
extract was subjected to exhaustive column chromatography over silica gel using 
dichloromethane/ methanol  as a solvent system with ratio 100:0→0:100 to give 25 
fractions. Fraction 1 to 7 were combined and separated using PTLC Merck KGaA silica 
gel 60 F254; uing CH2Cl2:MeOH; 98:2 as a solvent system to afford (+)-pinostrobin 
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LOB7 (5.0 mg; 0.5 %), flavokawain B LOB15 (5.0 mg, 0.5%) was obtained from 
fraction 8 to 15 using CH2Cl2:MeOH; 95:5 as a solvent system  and linderone A LOB25 
(10.0 mg, 1.0%) was obtained from fraction 20 to 25 using CH2Cl2:MeOH; 92:8 as a 
solvent. 
 Plant residue was soaked with MeOH (12.0 L) for 4 days. The solvent was 
filtered and evaporated to give crude extract (1.0 g ) . The crude extract was introduced 
into column chromatography over silica gel using CH2Cl2 and gradually enriched with 
methanol to give 3 fractions. Fraction 2 was further separated using PTLC and 
CH2Cl2:MeOH; 90:10 to afforded  (+) - pinocenbrin LOB2 (5.0 mg, 0.5%). 
 The air-dried and ground leaves (2.0 kg) of Lindera oxyphylla were extracted 
with n-hexane (10.0 L) for 72 hours followed by filtration and evaporation of solvent to 
give crude extract (5.0 g). The crude extract were subjected to exhaustive column 
chromatography over silica gel using dichloromethane/methanol  as a solvent system 
with ratio 100:0→0:100 to give 35 fractions. Fraction 34  was separated using PTLC 
Merck KGaA silica gel 60 F254; and CH2Cl2:MeOH; 98:2 as  solvent system to afford 
methyllinderone LOL 34 (5.0 mg, 0.1%).  
 The residual plant material was dried and moistened with 10% NH4OH and left 
for 4 hrs. before soaking with CH2Cl2 (12.0 L) for 4 days. After filtration, the 
supernatant was concentrated to 500 mL followed by acidic extraction with 5% HCl 
until a negative Mayer’s test result was obtained. The aqueous solution was basified to 
pH 11 with NH4OH and re-extracted with CH2Cl2. The CH2Cl2 extract  was filtered, 
dried over anhydrous sodium sulphate, and evaporated to give crude alkaloid (2.0 g). 
The crude extract were subjected to exhaustive column chromatography over silica gel 
using dichloromethane/methanol  as a solvent system whit ratio 100:0→0:100 to give 
65 fractions. Fraction 15 to 20 were combined and the resulted compounds was 
separated using PTLC Merck KGaA silica gel 60 F254; and CH2Cl2-MeOH; 98:2 as a 
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solvent to afford (+)- laurotetanine LOL20 (10.0 mg, 0.5%), N-methyllaurotetanine 
LOL35 (5 mg, 0.25%), was obtained from fraction, 30 to 35 using CH2Cl2-MeOH; 97:3 
as a solvent and (+)-norboldine LOL50 (10.0 mg, 0.5%)  was obtained from fraction 49 
to 50 using CH2Cl2-MeOH; 95:5 as a solvent. (+)-10-O-N-methylhernovine (+)-
LOL63 (10.0 mg, 0.5%), was obtained from fraction 62 to 63 using CH2Cl2-MeOH; 
92:8 as a solvent and (+)-norisoboldine LOL65 (5.0 mg, 0.025%), was obtained from 
fraction 64 to 65 using CH2Cl2-MeOH; 92:8 as a solvent.   
 Plant residue was soaked with MeOH (12.0 L) for 4 days. The solvent was 
filtered and evaporated to give crude extract (1.0 g ) . The crude extract was introduced 
into column chromatography over silica gel using CH2Cl2 gradually enriched with 
methanol to give 18 fractions. Fraction 5 was separated using PTLC and CH2Cl2-
MeOH; 98:2 to afforded  kaempferol LOL5 (1.0 mg, 0.1%).  
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Dried & Grounded Plant Sample
Cold extraction with n-Hexane
n-Hexane extract Plant residue
Extract with CH2Cl2
CH2Cl2 exractPlant residue
Extract with 
MeOH
Plant residue
(discard)
MeOH extract
Fractionation by silica column
PTLC and HPLC
Pure compounds
Evaporate to 500mL
Extract with 5%HCl
HCl layer
Basified to pH 11
Extract with CH2Cl2
CH2Cl2 extract
 
 
Scheme 6.1: Isolation and purification of chemical constituents from plant 
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Scheme 6.2: Isolation and purification of chemical constituents from N-hexane crude 
          extract  of Lindera oxyphylla (bark) 
 
 
 
 
 
 
 
 
 
 
 
 
n-hexane crude extract from bark of 
Lindera oxyphylla 
Fractionation by silica gel 
column was initialized with 100% 
N-hexane then the polarity was 
increased with DCM          
 
F1 -F5 
Hexane-DCM         
98:2 
F6 -F10 
Hexane-
DCM         
90:10 
      F11 -F15 
Hexane-DCM        
85:15 
F16 -F20 
Hexane-DCM         
70:30 
F21 -F25 
Hexane-DCM         
60:40 
      F26 -F30 
Hexane-DCM         
50:50 
Further purification separately by 
PTLC with solvent system 
 Hexane-DCM  98:2 
 
LOB4 LOB2
8 
Further purification separately by 
PTLC with solvent system 
 Hexane-DCM  90:10 
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Scheme 6.3: Isolation and purification of chemical constituents from  dicholoromethane 
          crude extract of Lindera oxyphylla (bark) 
 
 
 
 
 
 
 
 
 
 
 
 
 
DCM crude extract from bark of Lindera 
oxyphylla 
Fractionation by silica gel 
column was initialized with DCM 
then the polarity was increased with 
MeOH          
F1 -F5 
DCM-MeOH         
98:2 
F6 -F10 
DCM-MeOH         
90:10 
      F11 -F15 
DCM-MeOH         
85:15 
F16 -F20 
DCM-MeOH         
70:30 
F21 -F25 
DCM-MeOH         
60:40 
Further purification seperately by 
PTLC with solvent system 
 DCM-MeOH         98:2 
 
Further purification seperately by 
PTLC with solvent system 
 DCM-MeOH  92:8 
 
Further purification seperately by 
PTLC with solvent system 
 DCM-MeOH         95:5 
 LOB7 
LOB15 
LOB25 
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Scheme 6.4: Isolation and purification of chemical constituents from methanol crude 
          extract of Lindea oxyphylla (bark) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Methanol Crude extract from bark of 
Lindera oxyphylla 
Fractionation by silica gel column 
was initialized with 100% DCM then  
the polarity was increasing with by 
methanol       
 
           F1  
DCM-MeOH         
98:2 
           F2 
DCM-MeOH         
85:15 
          F3 
DCM-MeOH         
60:40 
Further purification seperately by 
PTLC with solvent system 
 DCM-MeOH    90:10 
 
LOB2 
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Scheme 6.5: Isolation and purification of chemical constituents from N-hexane crude 
          extract of Lindera oxyphylla (leaves) 
 
 
 
 
 
 
 
 
 
 
 
 
n-hexane Crude extract from  Leaves of 
Lindera oxyphylla 
Fractionation by silica gel 
column was initialized with 100% 
N-hexane then the polarity was 
increased with DCM          
)         
 
F1 -F8 
Hexane-DCM         
98:2 
F9 -F16 
Hexane-
DCM         
90:10 
      F17 -F25 
Hexane-DCM         
85:15 
F25 -F35 
Hexane-DCM         
70:30 
Further purification seperately by 
PTLC with solvent system 
 N-hexane-DCM  90:10 
 
LOL3
4 
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Scheme 6.6: Isolation and purification of chemical constituents from dicholoromethane 
          crude extract  of Lindera oxyphylla ( leaves) 
 
 
 
 
 
 
 
 
 
 
Fractionation by silica gel 
column was initialized with 100% 
DCM then the polarity was increased 
with MeOH          
 
      F41 -F50 
DCM-MeOH         
60:40 
       F31 -F40 
DCM-MeOH         
70:30 
      F21 -F30 
DCM-MeOH         
85:15 
      F11 -F20 
DCM-MeOH         
90:10 
       F1 -F10 
DCM-MeOH         
98:2 
Further purification seperately by 
PTLC with solvent system 
 DCM-MeOH  95:5 
 
Further purification seperately by 
PTLC with solvent system 
 DCM-MeOH    98:2 
 
Further purification seperately by 
PTLC with solvent system 
 DCM-MeOH   97:3 
 
DCM Crude extract from Leaves of 
Lindera oxyphylla 
   F51 -F65 
DCM-MeOH         
60:40 
LOL20 
LOL35 
LOL50 
Further purification seperately by 
PTLC with solvent system 
 DCM-MeOH  92:8 
 
LOL63 LOL65 
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Scheme 6.7: Isolation and purification of chemical constituents from methanol crude 
           extract of Lindera oxyphylla (leaves) 
 
 
 
  
 
 
 
 
 
 
Fractionation by silica gel column 
was initialized with 100% DCM then  
the polarity was increasing with by 
methanol 
 
           F1-5  
DCM-MeOH         
98:2 
           F6-11 
DCM-MeOH        
85:15 
          F11-18 
DCM-MeOH         
60:40 
Further purification seperately by 
PTLC with solvent system 
 DCM-MeOH    98:2 
 
LOL5 
Methanol Crude extract from Leaves of 
Lindera oxyphylla 
 303 
 
6.6.2 Extraction and isolation of Litsea costalis (Nees) Kosterm 
 The dried and ground bark of Litsea costalis (Nees) Kosterm (KL 5410), (2.0 
kg) was extracted with n-hexane (10.0 L) for 72 hours followed by solvent evaporation 
to give crude extract (5.0 g). The crude extract was then  subjected  to exhaustive 
column chromatography over silica gel using n-hexane/dichloromethane as a solvent 
system with ratio 100:0→0:100 to give 15 fractions. Fractions 1 to 5 were combined 
and were separated using PTLC Merck  silica gel 60 F254; using N-hexane-
dichloromethane; 95:5 as a solvent system  to afford cinnamaldehyde LCB7 (7.0 mg; 
0.35 %). 2-Hydroxy-5-methoxybenzaldehyde  LCB11 (2.0 mg; 0.04 %) was obtained 
from fraction, 6 to 10 using n-hexane;dichloromethane; 90:10 as a solvent system and 2, 
5-dimethoxybenzaldehyde LCB15 (5.0 mg; 0.1 %)  was obtained from fraction, 11 to 
15 using n-hexane;dichloromethane; 90:10. 
 The residual plant material was dried and moistened with 10% NH4OH and left 
for 4 hours. before soaking with CH2Cl2 (12.0 L) for 4 days. After filtration, the 
supernatant was concentrated to 500 mL followed by acidic extraction with 5% HCl 
until a negative Mayer’s test result was obtained. The aqueous solution was basified to 
pH 11 with NH4OH and re-extracted with CH2Cl2. The CH2Cl2 extract was filtered, 
dried over anhydrous sodium sulphate, and evaporated to give crude alkaloid (10.0 g). 
The crude extract were subjected to exhaustive column chromatography over silica gel 
using dichloromethane/methanol  as  solvent system with ratio 100:0→0:100 to give 20 
fractions. Fraction 1 to 3 were combined separated using PTLC Merck KGaA silica gel 
60 F254; and CH2Cl2;MeOH; 98:2 as a solvent system to afford 4,4'-diallyl-5,5'-
dimethoxy-(1,1'-biphenyl)-2,2'-diol or biseugenol A LCB3 (10.0 mg, 0.5%) was 
obtained from fractions 10 to 17 and give three mix compounds and were separated 
using HPLC (70% MeOH and 30% H2O aqueous with 0.1% formic acid, 3.0 ml/min, 
254 nm) to give pure compounds, 4,4'-diallyl-6,6'-dimethoxy-(1,1'-biphenyl)-2,2'-diol 
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or biseugenol  LCB9 (50 mg, 10.0%),  2,2'-oxybis(4-allyl-1-methoxybenzene),  
biseugenol B LCB10 (3000 mg, 30%), and 1,2-bis(2-allyl-6-methoxyphenyl) 
hydrazine, biseugenol C LCB17 (3000 mg, 30%). 
 
 
 
Figure 6.1:  HPLC spectrum of LCB10 and LCB17. 
 
 Plant residue was soaked with MeOH (12.0 L) for 4 days. The solvent was 
filtered and evaporated to give crude extract (2.0 g). The crude extract was introduced 
into column chromatography over silica gel using CH2Cl2 gradually enriched with 
methanol to give 60 fractions. Fractions 1 to 4 were combined and  separated using 
PTLC and CH2Cl2;MeOH; 98:2 to afford (E)-4(4-hydroxy-1,1-dimethoxybut-2-en-1-
yl)benzene-1, 2-diol , litsin LCB4 (50 mg 0.5%). mean white,  (E)-4-styrylphenol 
LCB58 (5.0 mg, 2.5%) was obtained from fractions 50 to 58 using CH2Cl2;MeOH; 
90:10 as a solvent system. 
 The dried and ground leaves of Litsea costalis (Nees) Kosterm (KL 5410), (1.5 
kg) was extracted with n-hexane (10.0 L) for 72 hours followed by solvent evaporation 
to give crude extract (3.0 g). The crude extract was then  subjected  to exhaustive 
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column chromatography over silica gel using n-hexane/dichloromethane as a solvent 
system with ratio 100:0→0:100 to give 5 fractions. Fractions 1 to 2 were combined and 
separated using PTLC Merck KGaA silica gel 60 F254; and n-hexane-dichloromethane; 
98:2 as a solvent system to afford 2,4-dimethoxybenzamide  LCL2 (2.0 mg, 0.1%). 
Cinnamaldehyde LCL4 (2.0 mg, 0.1%) was obtained from fraction 4 using n-hexane-
dichloromethane; 95:5 as eluting solvent system and 3,4-dimethoxybenzamide  LCL5 
(2.0 mg, 0.1%)  was obtained from fraction 4 to 5 using n-hexane- dichloromethane; 
90:10. 
 The residual plant soaking  CH2Cl2 (12.0 L) for 4 days. After filtration re-
extracted with CH2Cl2. The CH2Cl2 extract was filtered, dried over anhydrous sodium 
sulphate, and evaporated to give crude extract (2.0 g). The crude extract was subjected 
to column chromatography over silica gel using dichloromethane/ methanol a solvent 
system with ratio 100:0→0:100 to give 15 fractions. Fractions 5 to 7 were combined 
and the resulted compounds are separated using PTLC Merck KGaA silica gel 60 F254; 
and CH2Cl2-MeOH; 98:2 as eluting solvent system to afford 2S,4S-(3',4'-
methylenedioxyphenyl)-5,7-dimethoxychroman-4-ol, costalin LCL7 (50 mg, 25%), (+)-
pinostrobin LCL9 (5.0 mg, 0.25%) was obtained from fractions 8 to 9 using 
CH2Cl2;MeOH; 97:3 as a solvent , 4-allyl-1,2-dimethoxybenzane LCL15 (3.0 mg, 
0.15%), (+)-onysilin LCL13 (3.0 mg; 0.15 %) was obtained from fractions 10 to 13 
using CH2Cl2;MeOH; 96:4 as a solvent ,  (+)-pinocembrin LCL14 (3.0 mg, 0.15%) was 
obtained from fraction 14  using CH2Cl2;MeOH; 95:5 as a solvent and 4-allyl -
2meyhoxyphenol LCL17 (3.0 mg, 0.15%) was obtained from fraction 15  using 
CH2Cl2;MeOH; 95:5 as a solvent. 
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Scheme 6.8: Isolation and purification of chemical constituents from N-hexane crude of 
          Litsea costalis (bark) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N-hexane Crude extract from ofbark of 
Litsea costalis 
Fractionation by silica gel 
column was initialized with 100% 
N-hexane then the polarity was 
increased with DCM          
 
        F1 -F5 
Hexane-DCM         
98:2 
           F6 –F10 
Hexane-DCM        
70:30 
      F10 –F15 
Hexane-DCM         
50:50 
Further purification seperately by 
PTLC with solvent system 
 Hexane-DCM 95:5 
 
LCB7 LCB1
5 
Further purification seperately by 
PTLC with solvent system 
 Hexane-DCM 90:10 
 
LCB1
1 
Further purification seperately 
by PTLC with solve seperately 
nt system 
 Hexane-DCM 92:8 
 
LCB9 
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Scheme 6.9: Isolation and purification of chemical constituents from dicholoromethane 
          crude of Litses costalis (bark) 
 
 
 
 
 
 
 
 
 
 
 
DCM Crude etract from bark of Litsea 
costalis 
Fractionation by silica gel 
column was initialized with DCM 
then the polarity was increased with 
MeOH          
F1 -F5 
DCM-MeOH         
98:2 
   F10 –F17 
DCM-MeOH         
90:10 
Further purification seperately by 
PTLC with solvent system 
 DCM-MeOH 98:2 
 
Further purification seperately by 
HPLC with solvent system 
 MeOH-Water 70:30 
 
LCB3 
LCB10 LCB17 
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Scheme 6.10: Isolation and purification of chemical constituents from methanol crude 
            of Litsea costalis (bark) 
 
 
 
 
 
 
 
 
 
 
 
Methanol Crude extract from bark of 
Litsea costalis 
Fractionation by silica gel column 
was initialized with 100% DCM then 
the polarity was increasing with by 
methanol       
 
           F1-20  
DCM-MeOH         
98:2 
           F21-40 
DCM-MeOH         
85:15 
          F41-60 
DCM-MeOH         
60:40 
Further purification seperately by 
PTLC with solvent system 
 DCM-MeOH    90:10 
 
LCB58 
Further purification seperately by 
PTLC with solvent system 
 DCM-MeOH    98:2 
 
LCB4 
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Scheme 6.11: Isolation and purification of chemical constituents from n-Hexane crude 
            of Litsea costalis (leaves) 
 
 
 
 
 
 
 
 
 
 
n-hexane Crude extract from Leaves of 
Litsea costalis 
Fractionation by silica gel 
column was initialized with 100% 
N-hexane then the polarity was 
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90:10 
         F3 
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           F5 
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70:30 
Further purification seperately by 
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 Hexane-DCM 98:2 
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         F4 
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85:15 
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Further purification seperately by 
PTLC with  solvent system 
 Hexane-DCM 95:5 
 
LCL4 
Further purification seperately by 
PTLC with solvent system 
 Hexane-DCM 90:10 
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                Scheme 6.12: Isolation and purification of chemical constituents from       
                  dicholoromethane crude of Litsea costalis (leaves) 
 
 
 
 
 
 
 
 
 
 
Fractionation by silica gel 
column was initialized with 100% 
DCM then the polarity was increased 
with MeOH          
 
       F1 –F3 
DCM-MeOH         
98:2 
      F4 –F7 
DCM-MeOH         
85:15 
       F8 –F9 
DCM-MeOH         
70:30 
      F10 –F13 
DCM-MeOH         
60:40 
Further purification seperately by 
PTLC with solvent system 
 DCM-MeOH    98:2 
 
Further purification seperately by 
PTLC with solvent system 
 DCM-MeOH  95:5 
 
Further purification seperately by 
PTLC with solvent system 
 DCM-MeOH   97:3 
 
DCM Crude extract frm  Leaves of 
Litsea costalis 
   F13 –F15 
DCM-MeOH         
60:40 
LCL7 
LCL9 
LCL13 
Further purification seperately by 
PTLC with solvent system 
 DCM-MeOH  95:5 
 
LCL17 LCL14 LCL15 
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Table 6.2: Chromatography solvent systems and the yield of compounds isolated from 
                   Lindera oxyphylla (KL5359)  
 
 
 
Part of Plant 
 
Solvent systems 
 
 
Compounds 
 
Yield 
(mg) 
 
 
Yield 
(%) 
 
 
 
 
 
Bark of 
Lindera 
oxyphylla 
(KL 5359) 
 
 
98: 2 (N-hexane) 
 
(+)-Onysilin LOB4 
 
50.00 
 
0.4 
 
90:10 (N-hexane) 
Linderone LOB28 
 1000 
7.69 
98:2 (DCM) 
(+)-Pinostrobin LOB7 
 5.00 
0.5 
95:5 (DCM) 
Flavokawain B LOB15 
 5.00 
0.5 
92:8 (DCM) 
Linderone A  LOB25 
10.00 1.00 
90:10 (MeOH) 
(+)-Pinocembrin LOB2 
5.00 
0.5 
 
 
 
Leaves of 
Lindera 
oxyphylla 
(KL 5359) 
 
 
 
 
 
 
 
90:10 (N-hexane) 
 
Methyllinderone LOL34 
 
5.00 
 
0.1 
 
98:2 (DCM) 
 
(+)-Laurotetanine LOL20 
 
10.00 
 
0.05 
97:3 (DCM) 
 
N-Methyllaurotetanine LOL35 
 
5.00 0.25 
95:5 (DCM) 
 
(+)-Norboldine LOL50 
 
10.00 0.05 
95:5 (DCM) 
 
(+)-010-N-methyl Hernovine LOL63 
 
10.00 0.05 
92:8 (DCM) (+)-Norisoboldine LOL65 5.00 0.25 
98:2 (MeOH) Kaempferol LOL5 0.1 0.01 
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Table 6.3: Chromatography solvent systems and the yield of compounds isolated from  
                   Litsea Costalis (Nee.)Kosterm (KL5410)  
 
 
 
Part of Plant  
 
Solvent systems 
 
 
Compounds 
 
Yield 
(mg) 
 
 
Yield 
(%) 
 
 
 
 
 
Bark of 
Litsea costalis 
(KL 5410) 
 
 
95:5 (N-hexane) 
 
3, 4-dimethoxycinnamaldehyde 
LCB7 
 
7.00 
 
 
0.35 
 
90:10 (N-hexane) 
2-hydroxy-5-methoxybenzaldehyde 
LCB11 
 
2.00 
 
0.04 
85:15 (N-hexane) 
2, 5-dimethoxybenzaldehyde LCB15 
 5.00 
0.1 
98:2 (DCM) 
4,4'-diallyl-5,5'-dimethoxy-(1,1'-
biphenyl)-2,2'-diol LCB3 
 
10.00 
0.5 
HPLC 
4,4'-diallyl-6,6’-dimethoxy-(1,1'-
biphenyl)-2,2'-diol LCB9 
 
50.0 
 
10.0 
HPLC 
2,2'-oxybis(4-allyl-1-methoxy 
benzene) 
LCB10 
3000 
 
30 
HPLC 
1,2-bis(2-allyl-6-methoxy 
phenyl)hydrazine 
LCB17 
3000 
30 
98:2 (MeOH) 
(E)-4(4-hydroxy-1, 1-dimeth oxybut-
2-en-1-yl) benzene-1, 2-diol 
LCB4 
50.00 
0.5 
98:2 (MeOH) 
(E)-4-styrylphenol  LCB58 
5.00 2.5 
 
 
 
Leaves of 
Litsea costalis 
(KL 5410) 
 
 
 
 
 
 
98:2 (N-hexane) 
 
Cinnamide   LCL4 
 
2.00 
 
0.1 
 
98:2(N-Hexane) 
 
2,4-dimethoxybenzamide   LCL2 2.00 
 
0.1 
90:10 (N-hexane) 
 
3,4-dimethoxybenzamide  LCL5 2.00 0.1 
98:2 (DCM) 
 
2S,4S-2-(3',4'-methylene dioxyphenyl 
)- 5,7-dimethoxy chroman-4-ol 
LCL7 
 
50.00 
 
25 
98:2 (DCM) 
 
(+)- pinostrobin LCL9 
 
5.00 0.25 
97:3 (DCM) (+)-Onysilin LCL13 3.00 0.15 
92:8 (DCM) 4-allyl-1,2dimethoxybenzane LCL15 3.00 0.15 
95:5(DCM) (+)-pinocembrin LCL14 3.00 0.15 
  4-allyl-2methoxyphenol LCL17 3.00 0.15 
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6.7 Physical propertion and Spectral Data of Isolated compounds  
6.7.1 Bark of Lindera oxyphylla (KL 5359)   
 
  LOB4: (+) – Onysilin yellow amorphous solid 
Molecular Formula                                     : 
 [α]  
 
                                                           :   
C17H16O5  
+3.1(2.00×10
-4
g/100 mL, Me0H) 
UVmax (MeOH), nm                                     :    293 (4.00) and 349 (1.43) nm 
IR (KBr)  υmax cm
-1                                                           
 3446 and 1644   cm
-1
 
Mass spectrum m/z [M+H]
+ 
                       : 301.0824 
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.3 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.3 
 
  LOB7: (+)-pinostrobin yellow amorphous solid 
Molecular Formula                                     : 
 [α]  
 
                                                           :   
C16H14O4  
+1.52 (2.00×10
-4
g/100 mL, MeOH) 
UVmax (MeOH), nm                                     :    223 (2.316) and 306 (1.273) nm 
IR (KBr)  υmax cm
-1                                                           
 3429 and 1642   cm
-1
 
Mass spectrum m/z [M+H]
+ 
                       : 271.088 
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.4 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.4 
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  LOB15: Flavokawain B Red crystal 
Molecular Formula                                     : 
 [α]  
 
                                                           :   
C17H16O4  
+12.3 (2.00×10
-4
g/100 mL, MeOH) 
UVmax (MeOH), nm                                     :    241 (1.297) and 336 (1.86) nm 
IR (KBr)  υmax cm
-1                                                           
 3436 and 1634 cm
-1
 
Mass spectrum m/z [M-H]
+ 
                       : 283.7380 
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.5 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.5 
 
 LOB2: (+)-Pinocembrin yellow amorphous solid 
Molecular Formula                                     : 
 [α]  
 
                                                           :   
C15H12O4  
+2.81 (2.00×10
-4
g/100 mL, EtOH). 
UVmax (MeOH), nm                                     :    241 (1.519) and 290 (2.783) nm 
IR (KBr)  υmax cm
-1                                                           
 3417  and 1640 cm
-1
 
Mass spectrum m/z [M-H]
+ 
                       : 255.0475 
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.6 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.6 
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 LOB28: Linderone yellow crystal 
Molecular Formula                                    : C16H14O5  
Mp: 92
0
C 
UVmax (MeOH), nm                                     :    246 (1.529) and 364 (1.631) nm 
IR (KBr)  υmax cm
-1                                                           
 3435 and  1632 cm
-1
 
Mass spectrum m/z [M+H]
+ 
                       : 287.0677 
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.7 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.7 
 
 LOB25: Linderone yellow amorphous solid 
Molecular Formula                                    : C16H14O5  
UVmax (MeOH), nm                                     :    246 (1.291) and 309 (1.580) nm 
IR (KBr)  υmax cm
-1                                                           
 3431 and 1639 cm
-1
 
Mass spectrum m/z [M+H]
+ 
                       : 287.0677 
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.8 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.8 
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6.7.2 Leaves of Lindera oxyphylla (KL 5359)   
 
 LOL34: Methyl Linderone yellow amorphous solid   
Molecular Formula                                    : C17H16O5  
UVmax (MeOH), nm                                     :    241 (0.908) and 357 (1.158) nm 
IR (KBr)  υmax cm
-1                                                           
 1702   cm
-1
 
Mass spectrum m/z [M]
+ 
                       : 300.88 
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.9 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.9 
 
 LOL5: Kaempferol yellow amorphous solid 
Molecular Formula                                     :                                                C15H10O6
UVmax (MeOH), nm                                     :    253 (0.434) and 364 (0.616) nm 
IR(KBr)  υmax cm
-1                                                           
: 3431 and 1646   cm
-1
 
Mass spectrum m/z [M-H]
+ 
                       : 285.04 
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.10 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.10 
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 LOL20: (+)-laurotetanine dark brown amorphous solid 
Molecular Formula                                     :                                                
[α]  
 
                                                           : 
C19H21NO4
+29.4º (2.00×10
-4
g/100 mL, MeOH) 
UVmax (MeOH), nm                                     :    217 (2.345) and 242 (3.098) nm 
IR (KBr)  υmax cm
-1                                                           
 3429 cm
-1
 
Mass spectrum m/z [M+H]
+ 
                       : 328.1566 
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.11 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.11 
 
 LOL35: N-methyllaurotetanine brownish amorphous solid 
Molecular Formula                                     :                                                
[α]  
 
                                                           : 
C24H35NO4
+15.0 (2.00×10
-4
g/100 mL, MeOH)   
UVmax (MeOH), nm                                     : 222 (2.098) and 320 (3.564) nm 
IR(KBr)  υmax cm
-1                                                           
: 3391 cm
-1
 
Mass spectrum m/z [M+H]
+ 
                       : 401.1625 
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.12 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.12 
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 LOL50: (+)-Norboldine           brown amorphous solid 
Molecular Formula                                     :                                                
[α]  
 
                                                           : 
C18H19NO4
+9.87 (2.00×10
-4
g/100 mL, MeOH) 
UVmax (MeOH), nm                                     :    2 76 (3.765) , 317 (2.987) nm 
IR (KBr)  υmax cm
-1                                                           
 3432  cm
-1
 
Mass spectrum m/z [M+H]
+ 
                       : 314.1397 
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.13 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.13 
 
 LOL63: (+)-O10-N-methylhernovine    brownish amorphous powder 
Molecular Formula                                     :                                                
[α]  
 
                                                           : 
C19H21NO4
+4.50
 
(2.00×10
-4
g/100 mL, MeOH) 
UVmax (MeOH), nm                                     :    2 44 (1.65) and 276 (2.76) nm 
IR (KBr)  υmax cm
-1                                                           
 3390 cm
-1
 
Mass spectrum m/z [M+H]
+ 
                       : 328.20 
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.14 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.14 
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 LOL65: (+)-norisoboldine brownish amorphous powder 
Molecular Formula                                     :                                                
[α]  
 
                                                           : 
C18H19NO4
+11.52
 
(2.00×10
-4
g/100 mL, MeOH) 
UVmax (MeOH), nm                                     :    2 41 (1.87) , 250 (1.98) and 270 (2.98) nm 
IR (KBr)  υmax cm
-1                                                           
 3436 cm
-1
 
Mass spectrum m/z [M+H]
+ 
                       : 314.1399 
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.15 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.15 
 
6.7.3 Bark of Litsea costalis (KL5410) 
 LCB7: Cinnamaldehyde  brown oil 
Molecular Formula                                     :                                                C11H12O3
UVmax (MeOH), nm                                     :    306 (1.874) and 326 (1.876) nm 
IR (KBr)  υmax cm
-1                                                           
  2848 and 1668 cm
-1
 
Mass spectrum m/z [M+H]
+ 
                       : 191.04 
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.18 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.18 
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 LCB11: salicylaldehyde  light yellow amorphous solid 
Molecular Formula                                     :                                                C8H8O3
UVmax (MeOH), nm                                     :    306 (1.845) and 231 (1.723) nm 
IR (KBr)  υmax cm
-1                                                           
 3431 and 1669 cm
-1
 
Mass spectrum m/z [M+H]
+ 
                       : 153.0504 
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.19 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.19 
 
 LCB15: 2,5-DimethoxyBenzaldehyde  light yellow solid 
Molecular Formula                                     :                                                C9H10O3  
UVmax (MeOH), nm                                     :    306 (2.703) and 234 (2.537) nm 
IR (KBr)  υmax cm
-1                                                           
 1669 and 2848 cm
-1
 
Mass spectrum m/z [M+H]
+ 
                       : 167.064 
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.20 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.20 
 LCB3: Biseugenol A  brown oil 
Molecular Formula                                     :                                                
                                                  
C20H22O4
UVmax (MeOH), nm                                     :    2 47 (3.121) 291 (2.214) and 3.6 (1.462 )nm 
 
 
IR (KBr)  υmax cm
-1                                                           
 3427 and  1642 cm
-1
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Mass spectrum m/z [M+H]
+ 
                       : 325.1394 
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.21 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.21 
 
 LCB9: Biseugenol   brown oil 
Molecular Formula C20H22O4 
UVmax (MeOH), nm                2 47 (3.121) 291 (2.214) and 3.6 (1.462 )nm 
 
IR (KBr)  υmax cm
-1       
 3427 and  1642 cm
-1
 
Mass spectrum m/z [M+H]
+
 325.1394 
1
H-NMR (CDCl3) δ, ppm                             Refer Table 3.22 
13
C-NMR (CDCl3) δ ppm                            Refer Table 3.22 
 
LCB10: Biseugenol B  brown oil 
Molecular Formula                                     :                                                
                                                       
C20H22O3
 
UVmax (MeOH), nm                                     :    
 
2 78 (2.337) and 239 (2.767) nm 
 
IR (KBr)  υmax cm
-1                                                           
 1591 and 1638 cm
-1
 
Mass spectrum m/z [M-H]
- 
                       : 309.20 
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.23 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.23 
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 LCB17: Biseugenole C  yellow oil 
Molecular Formula                                     :                                                
                                                         
C20H24N2O2
UVmax (MeOH), nm                                     :    225 (2.413) and 239 (2.763) nm 
 
IR (KBr)  υmax cm
-1                                                           
 
 
3517 and  1515 cm
-1
 
 
Mass spectrum m/z [M]
+ 
                       : 
 
324.7967 
 
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.24 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.24 
 
LCB4: Litsin  white amorphous solid 
Molecular Formula                                     :                                                
[α]  
 
                                                           : 
C12H16O5
+ 2.93 (2.00×10
-4
g/100 mL, MeOH) 
UVmax (MeOH), nm                                     :    2 61 (2.486) and 223 (2.202) nm 
IR (KBr)  υmax cm
-1                                                           
 3434 and  1640 cm
-1
 
Mass spectrum m/z [M]
+ 
                       : 240.72 
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.25 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.25 
LCB5: (E)-4-Styrylphenol  brown amorphous solid 
Molecular Formula                                     :                                                
[α]  
 
                                                           : 
C14H12O  
-22.8º (2.00×10
-4
g/100 mL, MeOH)    
UVmax (MeOH), nm                                     :    306 (0.418) and 213 (0.424) nm 
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IR (KBr)  υmax cm
-1                                                           
 3425 and  1643 cm
-1
 
Mass spectrum m/z [M]
+ 
                       : 196.0295 
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.26 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.26 
 
6.7.4 Leaves of Litsea costalis (KL5410) 
 
 LCL4: Cinnamide colorless crystalline needle 
Molecular Formula                                     :                                                C9H9NO
UVmax (MeOH), nm                                     :    223 (1.204) and 278 (0.875) nm 
IR (KBr)  υmax cm
-1                                                           
 3353 and  1669 cm
-1
 
Mass spectrum m/z [M+H]
+ 
                       : 148.30 
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.27 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.27 
 
 LCL2: 2,4-Dimethoxybenzamide  brown oil 
Molecular Formula                                     :                                                C9H11NO3  
UVmax (MeOH), nm                                     :    261 (2.474) and 258 (2.486) nm 
IR (KBr)  υmax cm
-1                                                           
 3353 and  1669 cm
-1
 
Mass spectrum m/z [M]
+ 
                       : 181.044 
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1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.28 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.28 
 
LCL5: 3,4-dimethoxyBenzamide  brown oil 
Molecular Formula                                     :                                                C9H11NO3  
UVmax (MeOH), nm                                     :    261(2.474) and 258 (2.486) nm 
IR (KBr)  υmax cm
-1                                                           
 3448 and 1607 cm
-1
 
Mass spectrum m/z [M]
+ 
                       : 181.044 
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.29 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.29 
 
 LCL7: Costalin  white  amorphous solid 
Molecular Formula                                     :                                                C18H18O6
UVmax (MeOH), nm                                     :    293 (4.00) and 349 (1.433) nm 
IR (KBr)  υmax cm
-1                                                           
 3431, 1576 and 1446 cm
-1
 
Mass spectrum m/z [M]
+ 
                       : 331.0867 
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.30 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.30 
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 LCL9: (+)-Pinostrobin Yellow amorphous solid 
Molecular Formula                                     :                                                C16H14O4
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.4 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.4 
 
 LCL14: (+)-Pinocembrin yellow samorphous olid 
Molecular Formula                                     :                                                C15H12O4
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.10 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.10 
 
 LCL13: (+)-Onysilin  Yellow amorphous solid 
Molecular Formula                                     :                                                C17H16O5
1
H-NMR (CDCl3) δ, ppm                            : Refer Table 3.3 
13
C-NMR (CDCl3) δ ppm                           : Refer Table 3.3 
 
LCL15: 4-allyl-1,2-Dimethoxybenzene :brown oil 
Molecular Formula :C11H14O2 
UVmax (MeOH), nm                                        :225 (2.413)  and 239 (2.763) nm  
IR (KBr)  υmax cm
-1                                                           
 3517 and 1515 cm
-1
 
Mass spectrum m/z [M-1]
- 
                        177.87 
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1
H-NMR (CDCl3) δ, ppm                             Refer Table 3.23 
13
C-NMR (CDCl3) δ ppm                           
 
Refer Table 3.23 
 
LCL17: 4-allyl-2-methoxyphenol :yellow oil 
Molecular Formula :C10H12O2 
UVmax (MeOH), nm                                        :225 (2.413)  and 239 (2.763) nm  
IR (KBr)  υmax cm
-1                                                           
 3517 and 1515 cm
-1
 
Mass spectrum m/z [M-1]
- 
                        177.87 
1
H-NMR (CDCl3) δ, ppm                             Refer Table 3.23 
13
C-NMR (CDCl3) δ ppm                           
 
Refer Table 3.23 
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